ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
WP477	Cytoplasmic ribosomal proteins	82/4673	84/5488	0.000153395386999995	0.0846742536239973	0.0846742536239973	2197/9801/6134/4736/6135/6136/6137/23521/9045/6138/6139/6141/6142/6143/6144/6146/9349/6147/6152/6154/6155/6157/6158/6159/6122/6156/6160/6161/6164/11224/6165/25873/6167/6168/6169/6170/6171/6125/6128/6129/6130/6132/6133/6175/6176/6181/6205/6206/6207/6208/6209/6210/6217/6222/6223/6187/6224/6227/6228/6229/6230/6231/6232/6233/6234/6235/6188/6189/6191/6192/6193/6194/6195/6196/6197/27330/6198/6199/6201/6202/6203/3921	82
WP619	Type II interferon signaling	33/4673	33/5488	0.00488288690038492	0.761938250983407	0.761938250983408	4261/3627/4283/1536/5610/2633/3106/3383/2537/3433/3459/3460/3553/3659/3660/3662/3394/10379/9636/3716/3717/4843/4938/5580/5698/5781/5967/8651/9021/6688/6772/6773/6890	33
WP111	Electron transport chain: OXPHOS system in mitochondria	66/4673	69/5488	0.00530630119980548	0.761938250983407	0.761938250983408	1353/1355/1327/9377/1329/1337/1340/1345/1346/1347/9167/1349/1350/1351/4694/4705/55967/4695/4696/4698/4700/4701/4702/4704/4706/4707/4716/4708/4709/4711/4712/4713/4714/4715/4717/4718/4719/4720/4722/4724/4725/4726/374291/4728/4723/4731/6341/6389/6390/6391/6392/9016/9481/291/292/293/6834/7351/29796/10975/7381/7384/7385/7386/7388/27089	66
WP5095	Overview of proinflammatory and profibrotic mediators	55/4673	57/5488	0.00604647060545831	0.761938250983407	0.761938250983408	6356/6357/6359/6362/6363/6347/6364/6366/6367/6368/6369/6370/56477/6348/6351/6352/6355/1435/1440/6376/2919/3627/6373/10563/9547/58191/2920/2921/6374/6372/4283/10148/3589/3600/3606/3552/3553/3557/11009/90865/3569/3574/3976/4049/4312/4314/4318/4790/5008/6696/7040/7124/8741/10673/7422	55
WP183	Proteasome degradation	53/4673	55/5488	0.00783848200606399	0.761938250983407	0.761938250983408	3105/3106/3107/3133/3134/3135/4734/5682/5683/5684/5685/5686/5687/5688/5689/5699/5690/5691/5692/5693/5694/5695/5696/5698/5700/5701/5702/5704/5705/5706/5707/5716/5717/5718/5719/5708/5710/5711/9861/5713/5714/5720/5721/10197/6184/6185/7317/7318/7314/7316/7321/7322/7323	53
WP2849	Hematopoietic stem cell differentiation	42/4673	43/5488	0.00828193751068921	0.761938250983407	0.761938250983408	28/91/863/947/4261/1435/1440/7852/2313/2353/2354/2624/79366/10320/3552/3553/3569/3663/3690/3757/4254/51176/4005/4066/4582/4601/4602/3071/4773/4851/5292/399/8780/861/23541/6688/6776/7068/7148/80342/23650/7409	42
WP5115	Network map of SARS-CoV-2 signaling pathway	164/4673	180/5488	0.0110153538634546	0.849122313396365	0.849122313396365	59272/60/71/183/196/335/341/8542/55937/9776/637/332/684/11119/715/716/84433/836/838/841/842/6356/6359/6347/6364/6366/6367/6348/6351/6352/6355/891/9133/1234/929/9332/914/10666/919/916/917/920/925/926/983/1051/629/3075/3426/5199/1294/1508/1509/1514/1522/2919/3627/10563/58191/2920/2921/6374/6372/4283/3577/3579/54541/23586/64798/1843/1958/1974/1977/1978/84985/2247/2335/2353/2534/11345/2811/2934/51512/3043/3091/3122/3123/3127/3312/3429/10964/2537/64135/8519/10410/3486/8517/3603/3606/8807/3552/3553/7850/90865/3569/3574/3654/3661/10379/3699/3716/3717/3725/3726/23367/3932/3959/116844/81631/64386/2475/4599/4615/4791/55922/22861/114548/4939/10038/8554/5588/5743/5777/5879/6009/6194/6237/6241/6288/6289/6403/5104/5054/8631/4086/4090/6772/55240/29110/7048/7124/8743/9540/7187/7189/7226/55823/64601/57617/65082/51028/27072/54663/7535	164
WP5218	Extrafollicular B cell activation by SARS-CoV-2	59/4673	62/5488	0.0123061204840053	0.849122313396365	0.849122313396365	57379/60468/604/29760/718/720/6363/6366/1236/930/933/958/959/969/973/941/3732/1378/1380/7852/643/10148/2113/83416/2308/1880/3312/29851/23308/3433/8519/3455/3569/3662/3394/9636/3687/3689/4094/4240/931/283131/5079/5133/639/5788/6402/57823/6776/6850/30009/7099/51284/9168/7124/8741/10673/7494/9839	59
WP5088	Prostaglandin signaling	26/4673	26/5488	0.0151433836684051	0.858886281670506	0.858886281670506	196/834/6347/6348/729230/940/1435/2919/3627/4283/3552/3553/3569/3665/3824/4318/4790/114548/5294/5732/5734/9536/29108/7040/7124/7422	26
WP3945	TYROBP causal network in microglia	57/4673	60/5488	0.0155595340882338	0.858886281670506	0.858886281670506	10257/55803/54518/51411/714/718/822/951/920/8832/64764/58191/1806/2000/23307/79690/202309/26157/2876/3059/3142/10261/3587/3606/3684/3687/3689/10008/654346/10184/84695/4066/4094/4688/3071/10577/375387/5341/170954/29108/54502/5996/6195/864/64092/375035/10019/6510/9056/6696/6776/10312/7046/113277/7133/7305/678	57
WP4172	PI3K-Akt signaling pathway	232/4673	259/5488	0.0213675058935315	0.957147821072443	0.957147821072443	208/10000/284/285/1386/468/1388/572/596/598/10018/672/842/595/894/896/898/9134/930/11140/1017/1019/1021/1026/1101/1147/1277/1278/1280/1282/1284/1285/1286/1287/1291/1292/1293/256076/1298/1385/10488/90993/64764/84699/148327/9586/1435/1436/1440/1441/54541/1942/1943/1944/1945/1946/1950/1956/1975/1977/1978/1969/2149/356/2258/2247/2252/2254/2260/2263/2261/2321/2322/2324/2335/2309/92579/2690/2783/59345/10681/2791/54331/2786/2793/2885/2932/2997/3082/3326/7184/3454/3455/3479/3480/3481/3551/8517/3559/3560/3561/3563/3566/3569/3570/3574/3575/3643/3672/22801/3673/3676/3678/3655/3679/8516/3680/3685/3688/3690/3691/3693/3694/3695/3716/3717/3718/3791/3815/4254/284217/3908/3909/3910/3911/3912/3913/3914/3915/3918/10319/9170/57121/10161/5604/5605/5595/4170/4193/4233/2475/4602/4790/4804/4846/4893/4915/5008/9180/5105/5106/5154/5155/56034/80310/5156/5159/5170/5228/23239/23035/118788/5290/5293/5294/5295/5296/8503/23533/146850/5585/29941/5515/5516/5518/5520/55844/5523/28227/55012/5525/5526/5527/5528/5529/5562/5578/5618/5728/5747/5879/5934/5970/5649/6009/6194/6198/6199/6446/10110/23678/6655/6696/6794/6850/8115/7010/7039/7058/7059/117145/7097/7099/3371/7148/7157/7248/7249/7422/7423/7424/7450	232
WP2516	ATM signaling pathway	34/4673	35/5488	0.0252552495146527	0.957147821072443	0.957147821072443	25/1386/472/637/672/835/891/898/993/995/983/1017/1026/1111/11200/8738/1385/2177/1647/8517/3725/5601/9656/4193/4194/4683/4792/10111/5888/5883/8737/8243/9874/7157	34
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	34/4673	35/5488	0.0252552495146527	0.957147821072443	0.957147821072443	284/285/405/578/597/598/637/332/664/665/1906/54583/3091/55662/3098/3485/3486/3939/4170/4843/5160/5211/5230/5315/5366/5743/5054/6566/6513/6515/7039/7043/7157/7422	34
WP4754	IL-18 signaling pathway	204/4673	228/5488	0.0334268125142818	0.957147821072443	0.957147821072443	32/35/59/11096/57679/8125/321/382/55738/84364/467/567/572/596/598/637/274/330/669/682/7832/836/841/26093/6362/6363/6347/6364/6348/6351/6352/890/9133/948/975/9308/1051/1071/8837/1147/9076/9069/24146/1365/1364/1277/1278/1281/1374/1499/58191/2920/2921/54205/7913/1674/1891/1994/2023/2035/8772/83541/355/356/55294/2335/2353/1112/2896/2932/3033/338442/3068/3162/3234/3257/3315/26353/3383/8870/3551/3606/10068/8809/8807/3553/3559/3569/55272/3654/3659/3664/81618/3725/3757/3801/4254/10365/23395/3932/84823/83752/9208/4050/5609/6885/5595/5601/8720/4205/56257/4312/4322/4323/4313/4314/4318/23787/4615/4666/29781/653361/4688/4717/4776/4790/4791/4792/4794/64332/4843/27035/8431/3164/142/51230/5295/5585/7941/5335/5337/8985/10848/9374/5562/5578/5579/5580/5728/5743/5763/5778/5806/5834/5905/22821/5966/5970/5993/6004/6205/6198/860/23623/6257/8698/6385/10500/80031/9021/6667/10418/6696/83931/9399/30009/7052/7076/7078/55858/7114/7124/7127/7128/4982/7132/8600/79931/7157/7185/7189/26133/54822/10194/83549/56886/8078/7422/51341/80149/55625/7702/51222/55311	204
WP2865	IL1 and megakaryocytes in obesity	21/4673	21/5488	0.0339554132489621	0.957147821072443	0.957147821072443	6347/2149/2205/1839/3383/3606/3553/3554/3654/4318/4615/4790/114548/5290/7941/6280/8991/7076/7077/7096/7097	21
WP3617	Photodynamic therapy-induced NF-kB survival signaling	31/4673	32/5488	0.0379912695883887	0.957147821072443	0.957147821072443	597/599/329/330/332/595/959/8837/1147/2920/3383/3551/3552/3553/3569/4312/4313/4314/4318/4790/4791/5743/5966/5970/5971/6401/7124/7132/7189/7412/7422	31
WP4494	Selective expression of chemokine receptors during T-cell polarization	20/4673	20/5488	0.0399029012777401	0.957147821072443	0.957147821072443	6348/6351/1230/729230/1233/1234/1236/940/920/959/2833/7852/3459/3460/3594/3595/8809/3566/7040/7043	20
WP2328	Allograft rejection	65/4673	70/5488	0.0402798018554637	0.957147821072443	0.957147821072443	5243/712/713/714/717/718/720/721/729/730/836/840/841/842/6363/6366/940/958/959/1604/941/942/1289/1459/1493/6373/10563/4283/643/355/356/50943/10578/3002/3105/3106/3107/3108/3109/3111/3112/3113/3115/3117/3119/3122/3123/3127/3133/3134/3135/3552/3553/3559/120892/5156/55825/5551/5590/6772/7040/7124/10376/7422/7431	65
WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	95/4673	104/5488	0.0422990329201462	0.957147821072443	0.957147821072443	34/226/8553/720/721/836/54862/55536/1051/1139/1374/1385/1387/1390/10664/1499/1644/10522/1889/1958/2033/54738/2305/2597/2624/2625/2697/23171/3030/3032/3065/9734/3280/3091/7184/3552/3553/3557/3569/3570/3725/3757/3764/3784/4128/4150/4208/4602/4760/4790/4791/4800/9722/2908/4915/5087/5316/5354/5452/5460/10891/133522/5566/5567/5573/5575/5576/5577/5978/5979/6095/864/6330/6507/291/6532/6550/6667/6670/6750/6751/6752/7068/7124/7166/11076/7259/6844/7422/7433/4904/7531/7532/10971/7534	95
WP4752	Base excision repair	30/4673	31/5488	0.0434687312436589	0.957147821072443	0.957147821072443	328/27301/2237/3146/3978/3980/8930/4350/4595/252969/55247/4913/4968/142/10038/5111/11284/5423/5424/5425/10714/57804/5426/5427/54107/56655/23583/6996/7374/7515	30
WP4961	STING pathway in Kawasaki-like disease and COVID-19	18/4673	18/5488	0.0551002613956069	0.957147821072443	0.957147821072443	1147/2152/2212/79792/3551/9641/8517/3553/3661/3708/4790/4792/4794/114548/79671/5966/5970/29110	18
WP3624	Lung fibrosis	45/4673	48/5488	0.0595365330050842	0.957147821072443	0.957147821072443	23250/655/6356/6347/6348/6351/6352/729230/1051/1215/1440/2920/57105/91039/1832/1906/1950/255520/2006/10144/2247/2252/26585/3082/3162/3479/3553/3569/4313/4318/4502/727897/5073/5154/5155/5328/5806/5265/6498/4092/6696/7039/7040/7076/7124	45
WP3942	PPAR signaling pathway	45/4673	48/5488	0.0595365330050842	0.957147821072443	0.957147821072443	30/34/51/8309/8310/2180/2181/2182/51703/51129/335/345/364/948/1374/1376/1593/1622/1962/2168/2169/2170/2171/2172/9415/3158/3611/4023/4199/4312/5105/5106/5170/5360/5465/5467/5468/6256/6257/6319/6342/376497/11001/10999/10580	45
WP534	Glycolysis and gluconeogenesis	36/4673	38/5488	0.063845970973492	0.957147821072443	0.957147821072443	226/229/230/1738/2023/2026/2027/2203/2597/2805/2806/2821/3098/3099/3101/3939/3945/4190/4191/25874/5091/5105/5160/5211/5213/5214/5223/5230/5313/5315/6513/6514/6515/6517/6518/7167	36
WP143	Fatty acid beta-oxidation	27/4673	28/5488	0.064798826588799	0.957147821072443	0.957147821072443	34/35/37/38/2180/2181/2182/51703/55902/1374/1376/1384/1666/1738/1892/1632/2639/2710/2820/3033/3030/3032/3991/4023/57104/788/7167	27
WP1601	Fluoropyrimidine activity	27/4673	28/5488	0.064798826588799	0.957147821072443	0.957147821072443	8714/10257/10057/9429/978/1066/8824/1719/1806/2068/2356/8836/4524/5471/6240/6241/2030/23583/6996/7083/7157/1890/7298/83549/7371/7378/7517	27
WP4630	Measles virus infection	103/4673	114/5488	0.0686954422186571	0.957147821072443	0.957147821072443	103/317/572/578/596/598/637/836/841/842/868/595/894/896/898/9134/30835/940/915/916/917/1017/1019/1021/1147/1457/1459/1460/54205/23586/5610/9451/1965/8667/8772/355/356/2213/2353/3303/3304/3305/3306/3310/3312/64135/3454/3455/3551/9641/8517/3552/3553/3559/3560/3561/3569/3654/51135/3661/3665/10379/3716/3718/3725/6885/5601/4478/4599/4615/4790/4791/4792/4793/4938/4939/4940/5290/5293/5295/5296/8503/9367/25898/5970/6504/6772/6773/6774/6776/6777/23118/29110/7097/7099/51284/54106/7128/7157/8717/7187/7189/7297	103
WP3937	Microglia pathogen phagocytosis pathway	35/4673	37/5488	0.0716764510903066	0.957147821072443	0.957147821072443	10095/712/713/714/1535/1536/2207/2209/3055/3684/3689/4067/653361/4688/4689/3071/5286/5290/5293/5294/5295/5296/8503/146850/5336/5777/5879/5880/27036/6850/54210/7305/7409/7410/10451	35
WP368	Mitochondrial long chain fatty acid beta-oxidation	16/4673	16/5488	0.0760759270068374	0.957147821072443	0.957147821072443	34/35/37/80221/2180/2181/2182/1374/1376/1632/1962/3033/3030/55825/6342/788	16
WP4884	Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex	16/4673	16/5488	0.0760759270068374	0.957147821072443	0.957147821072443	914/919/916/917/920/925/926/2534/3122/3123/3127/3569/3932/64386/55922/7535	16
WP5033	Genes associated with the development of rheumatoid arthritis	16/4673	16/5488	0.0760759270068374	0.957147821072443	0.957147821072443	640/51744/958/4261/1493/115352/3123/3559/3572/3663/3685/26147/26191/6583/6775/7185	16
WP530	Cytokines and inflammatory response	16/4673	16/5488	0.0760759270068374	0.957147821072443	0.957147821072443	920/1435/1440/2919/2920/3122/3123/3589/3600/3552/3553/3569/3574/5154/7040/7124	16
WP4329	miRNAs involvement in the immune response in sepsis	34/4673	36/5488	0.0803802033498598	0.957147821072443	0.957147821072443	6348/6351/1147/3002/3383/3551/8517/3552/3569/3654/51135/3659/3663/3665/3934/6885/406937/114614/4615/4790/4791/4792/5966/5970/5971/10454/23118/7099/51284/51311/7124/7187/7189/7412	34
WP558	Complement and coagulation cascades	42/4673	45/5488	0.081548807991733	0.957147821072443	0.957147821072443	712/713/714/715/716/717/718/719/721/728/729/730/733/1604/629/1675/3075/3426/1213/1191/1378/1380/2159/2149/2152/2153/3818/3827/3998/5648/5327/5328/5329/5627/5265/5104/5054/5345/710/7035/7056/7450	42
WP2848	Pluripotent stem cell differentiation pathway	25/4673	26/5488	0.0841813139466976	0.957147821072443	0.957147821072443	652/1435/1436/3577/1950/2247/3082/3479/3589/3569/3570/3624/3815/4254/10637/4851/4907/5154/5155/6469/7040/7043/8600/7422/7474	25
WP4545	Oxysterols derived from cholesterol	25/4673	26/5488	0.0841813139466976	0.957147821072443	0.957147821072443	26027/55856/10965/122970/11332/10005/23597/8309/9023/1593/51302/1576/9420/1628/1717/10682/2053/1880/80270/3638/7376/8856/6097/6342/11001	25
WP4559	Interactions between immune cells and microRNAs in tumor microenvironment	25/4673	26/5488	0.0841813139466976	0.957147821072443	0.957147821072443	6347/6352/29126/941/942/1493/3627/3559/3560/3561/3566/51135/4790/4791/5133/10401/8651/6774/7040/7043/7048/7099/51284/51311/7189	25
WP4949	16p11.2 proximal deletion syndrome	57/4673	62/5488	0.0846438593983445	0.957147821072443	0.957147821072443	226/283897/841/8030/10576/7203/10575/22948/908/10574/10694/10423/11151/7430/79153/7290/8479/3476/3486/253980/3835/58508/8085/5606/5608/5595/4150/4478/9961/4790/2908/79447/143/5111/5468/5515/5516/5518/5528/5531/9989/151987/5728/23475/5966/26470/6477/6693/9344/6950/124446/7157/7189/23025/10497/83719/653808	57
WP306	Focal adhesion	154/4673	173/5488	0.0856429933199586	0.957147821072443	0.957147821072443	60/71/87/81/208/10000/2909/394/572/9564/596/329/330/640/824/857/858/595/894/896/1101/1277/1278/1280/1282/1284/1286/1290/50509/1292/1398/1399/1499/1729/1793/1950/1956/2002/2064/2268/2316/2317/2318/2321/2335/2534/2885/2932/3055/3082/3479/3480/3611/3672/22801/3673/3676/3678/3655/3679/8516/3680/3685/3688/3690/3691/3693/3694/3695/3725/3791/284217/3908/3909/3910/3911/3912/3913/3914/3915/3918/10319/5604/5595/5601/4233/103910/4636/10398/4638/5058/5062/10298/55742/29780/64098/5154/5155/56034/80310/5156/5159/5170/5228/5290/5293/5295/5296/8503/23396/5499/5500/4659/4660/5578/5579/5728/5747/5753/5829/5879/5880/5908/2889/5923/5649/387/6093/9475/6464/25759/6696/55359/10420/7058/7059/7094/83660/3371/8711/10188/7148/7294/7408/7409/7410/10451/7414/7422/7423/7424/7450/331/7791	154
WP1946	Cori cycle	15/4673	15/5488	0.0893867643856636	0.957147821072443	0.957147821072443	226/2539/2597/2821/2875/3098/3939/5214/5223/5230/6513/6514/6517/6888/7167	15
WP3664	Regulation of Wnt / B-catenin signaling by small molecule compounds	15/4673	15/5488	0.0893867643856636	0.957147821072443	0.957147821072443	324/8312/1452/1499/27122/1856/8321/8324/8325/2932/51176/4035/154141/6925/8658	15
WP4462	Platelet-mediated interactions with vascular and circulating cells	15/4673	15/5488	0.0893867643856636	0.957147821072443	0.957147821072443	6347/6352/958/959/3383/3553/6401/6403/6404/7040/7043/7097/7099/51284/7412	15
WP4558	Overview of interferons-mediated signaling pathway	15/4673	15/5488	0.0893867643856636	0.957147821072443	0.957147821072443	3454/3455/3459/3460/163702/3588/10379/3716/3717/5290/5295/5578/6772/6773/7297	15
WP4829	mBDNF and proBDNF regulation of GABA neurotransmission	24/4673	25/5488	0.0958043419027779	0.957147821072443	0.957147821072443	160/161/163/1385/1390/2555/2561/2562/2564/2568/3717/4804/4915/5290/5294/5295/5296/8503/5335/5728/387/6093/6464/6774	24
WP5094	Orexin receptor pathway	91/4673	101/5488	0.0975789717286601	0.957147821072443	0.957147821072443	8553/655/657/689/1026/1364/1346/2920/51523/1628/9201/11056/1734/1846/1958/1959/1960/2324/2353/2354/2355/4616/84662/1839/3280/3091/3159/8091/3284/3309/3383/3397/3553/3569/3663/3720/3726/3777/9314/3908/3939/3949/3991/4023/84230/23764/7873/5595/4322/4314/4846/3164/8013/4976/23596/26031/5069/50940/5162/5163/54704/8864/5295/5296/5337/5468/5578/5914/6241/861/862/860/6401/27230/6446/6498/6506/6513/6517/6696/6722/7019/3371/7124/9760/29896/7412/7422/51067/140612/9203	91
WP4718	Cholesterol metabolism with Bloch and Kandutsch-Russell pathways	40/4673	43/5488	0.100021795143828	0.957147821072443	0.957147821072443	9619/39/10965/2180/2181/2182/9023/1593/1595/1718/1717/10682/60481/3992/9415/2194/2222/2224/9453/3156/3157/3158/51478/3422/3930/4047/6307/4597/4598/29116/7376/50814/6309/6319/6646/8435/6713/6720/6721/7108	40
WP1433	Nucleotide-binding oligomerization domain (NOD) pathway	32/4673	34/5488	0.100739119441033	0.957147821072443	0.957147821072443	14/9744/9447/84674/22900/834/838/840/841/842/1147/50506/3551/8517/3606/3553/4210/4671/4792/58484/22861/55655/114548/10392/64127/639/29108/5879/5970/8767/10910/331	32
WP43	Oxidation by cytochrome P450	32/4673	34/5488	0.100739119441033	0.957147821072443	0.957147821072443	1528/80777/51706/51700/1727/51167/1545/57404/56603/1593/1594/1555/1557/1558/1559/1565/1573/120227/29785/113612/51302/1576/1551/57834/66002/8529/4051/285440/260293/1595/9420/5447	32
WP4337	ncRNAs involved in STAT3 signaling in hepatocellular carcinoma	14/4673	14/5488	0.105023212759631	0.957147821072443	0.957147821072443	3589/3590/3569/3570/3572/3716/3717/3718/4790/5970/6659/6774/652995/6935	14
WP4921	Mitochondrial complex III assembly	14/4673	14/5488	0.105023212759631	0.957147821072443	0.957147821072443	617/1537/90624/54902/55245/84300/29796/10975/7381/7384/7385/7386/7388/27089	14
WP5063	FOXP3 in COVID-19	14/4673	14/5488	0.105023212759631	0.957147821072443	0.957147821072443	940/941/942/50943/3559/3560/3561/3569/3570/3572/3575/6774/6776/6777	14
WP5090	Complement system in neuronal development and plasticity	76/4673	84/5488	0.105226669482771	0.957147821072443	0.957147821072443	317/57194/23250/286410/5205/57198/558/578/637/712/713/714/715/716/717/718/719/720/721/722/725/728/729/730/733/10487/843/836/840/841/842/1604/966/629/1675/3075/3426/5199/1191/1378/1380/286204/6376/54205/9191/56616/9787/355/356/2219/2621/3684/3685/3687/3689/3690/3993/4139/4140/5648/4155/10461/4240/56288/84612/5359/57088/5584/5590/5627/23513/710/7040/7043/7301/331	76
WP241	One-carbon metabolism	23/4673	24/5488	0.108913317742585	0.957147821072443	0.957147821072443	191/23382/10840/275/471/55349/1719/1786/1788/2346/2618/2745/27430/123263/4522/25902/10797/4524/4552/6470/6472/6948/7298	23
WP453	Inflammatory response pathway	23/4673	24/5488	0.108913317742585	0.957147821072443	0.957147821072443	940/958/959/941/942/1277/1278/1281/2335/3559/3560/3561/3566/3911/3912/3913/3915/3918/3932/7059/7132/7133/7535	23
WP364	IL6 signaling pathway	39/4673	42/5488	0.110575080073493	0.957147821072443	0.957147821072443	183/572/598/1387/2549/2885/2932/3055/3065/3569/3570/3572/3659/3716/3717/3726/5604/5605/6416/6885/5595/8648/51701/2063/5295/5296/639/5580/5781/5879/6198/6464/9021/6772/6774/7076/7297/7409/7432	39
WP4016	DNA IR-damage and cellular response via ATR	68/4673	75/5488	0.113102269147794	0.957147821072443	0.957147821072443	472/545/84126/580/604/672/675/79184/83990/995/8318/983/1017/22897/1111/11200/63967/9937/1869/9521/9156/2175/2177/55215/2237/2305/8924/3364/8517/4171/79648/9656/4193/4292/4436/4683/79728/142/5111/5347/5371/5423/5591/5810/10111/5888/5893/5883/5932/5965/9400/55159/80010/50485/6601/8243/6667/55775/7156/11073/7157/7323/51720/5976/7398/7486/7507/7520	68
WP2359	Parkin-ubiquitin proteasomal system pathway	53/4673	58/5488	0.119794342370072	0.957147821072443	0.957147821072443	8573/834/841/898/8454/55294/51182/3303/3304/3305/3306/3309/3310/3312/3313/5700/5701/5702/5704/5705/5706/5707/5716/5717/5718/5719/10213/5708/5710/5711/9861/5713/5714/25897/6477/6478/9627/10273/7846/10376/84790/79861/203068/7280/347733/10381/10383/84617/7317/51465/118424/7332/9246	53
WP4290	Metabolic reprogramming in colon cancer	38/4673	41/5488	0.122089203458459	0.957147821072443	0.957147821072443	47/50/229/2023/2194/2271/2539/2597/2618/2744/2746/2806/2821/3101/3418/3419/3939/4191/10606/5160/5162/5211/5223/5226/5230/5315/5471/29968/5831/22934/6390/6472/9123/6510/6513/8801/6888/7086	38
WP4210	Tryptophan catabolism leading to NAD+ production	13/4673	13/5488	0.123391006407507	0.957147821072443	0.957147821072443	51166/125061/23498/3620/8564/8942/55191/10135/64802/349565/54981/23475/6999	13
WP4197	Immune response to tuberculosis	22/4673	23/5488	0.123672072237499	0.957147821072443	0.957147821072443	3430/3437/8519/3454/3455/3459/3460/3659/10379/3716/3717/9282/4599/4938/8554/5696/5771/8651/6772/6773/6890/7297	22
WP4719	Eicosanoid metabolism via cyclooxygenases (COX)	22/4673	23/5488	0.123672072237499	0.957147821072443	0.957147821072443	30/51/8309/8310/231/66002/8529/1962/3248/8398/5467/5729/11251/5730/9536/5737/5740/22949/145482/5742/5743/6916	22
WP3527	Pre-implantation embryo	30/4673	32/5488	0.125630656072712	0.957147821072443	0.957147821072443	366/476/8538/999/1045/1649/1875/1958/1994/2101/2354/2624/2625/3159/3182/3662/9314/57504/4084/4603/4306/5087/5460/6597/30812/6926/83439/7004/7538/678	30
WP4396	Nonalcoholic fatty liver disease	120/4673	135/5488	0.13066708319862	0.957147821072443	0.957147821072443	51094/79602/208/10000/468/578/10018/637/836/840/841/6347/1327/9377/1329/1337/1340/1345/1346/1347/9167/1349/1350/1351/1537/54205/1649/9451/1965/2081/355/356/2931/2932/3551/3552/3553/3569/3570/3643/8660/3725/3953/4217/5601/6945/22877/51085/4694/4705/126328/55967/4695/4696/56901/4698/4700/4701/4702/4704/4706/4707/4716/54539/4708/4709/4711/4712/4713/4714/4715/4717/4718/4719/4720/4722/4724/4725/4726/374291/4728/4723/4731/4790/9971/5290/5293/5295/5296/8503/5313/5465/5562/5564/5565/5571/51422/5879/5970/6256/6389/6390/6391/6392/4092/9021/6720/7040/7124/7132/29796/10975/7381/7384/7385/7386/7388/27089/7412/7494	120
WP1982	Sterol regulatory element-binding proteins (SREBP) signaling	59/4673	65/5488	0.131468753957626	0.957147821072443	0.957147821072443	31/47/84532/22926/1385/1595/1622/2194/2222/2224/57678/2931/3156/3157/3422/3638/51141/3837/3949/23175/4023/4047/8720/51360/4190/51586/2475/4597/4800/7376/5290/5468/133522/5562/5564/5565/5566/5571/51422/5950/11236/56681/22937/949/6319/6396/10484/10483/10802/9632/9871/22872/25956/23411/6667/6713/6720/6721/7528	59
WP2877	Vitamin D receptor pathway	113/4673	127/5488	0.133749829899797	0.957147821072443	0.957147821072443	5243/11096/154/240/248/8853/490/9914/604/654/151888/768/838/875/892/595/898/929/4345/958/928/997/1017/1026/1030/1031/1032/1045/634/9075/79789/81037/1493/1594/1555/1559/1565/29785/1576/1673/11221/1946/2308/50486/2539/1647/727936/3091/29923/3117/3123/6927/3294/3397/3486/3488/9173/3662/3663/3394/3684/3726/9314/3827/9926/4041/126364/56262/55090/4600/4084/4650/4773/4814/27035/8204/5368/5467/639/5588/5734/10125/6256/6275/6277/6279/6280/6304/7869/1992/6517/10568/219855/6546/25928/6696/8027/79689/412/6822/7040/7056/7077/7078/7128/4982/8600/7292/7168/22906/54210/7421/113835	113
WP455	GPCRs, class A rhodopsin-like	79/4673	88/5488	0.138593600901823	0.957147821072443	0.957147821072443	1238/57007/51554/136/140/150/153/154/187/719/1230/729230/1233/1234/1236/10803/9034/1131/1132/1240/1269/3577/3579/2833/7852/643/10800/57105/1909/1910/2149/2150/2151/9002/2867/2357/2358/2359/2852/2838/23432/29909/84636/2841/2859/2863/8477/8111/8843/3269/3360/57121/10161/1241/10316/4886/5540/23596/5028/27334/64805/53829/9934/5029/5030/5031/5724/5729/11251/5732/5733/5734/5737/23637/266747/6751/6752/56670/2829	79
WP2272	Pathogenic Escherichia coli infection	44/4673	48/5488	0.139371845390731	0.957147821072443	0.957147821072443	25/60/71/9181/10552/10095/10109/10094/10093/10092/81873/929/999/9076/1499/2017/7430/2534/3059/3688/23643/4690/8440/4691/100506658/5578/387/6093/9475/7099/7846/10376/84790/79861/203068/7280/347733/10381/10383/84617/7454/8976/10971/7534	44
WP560	TGF-beta receptor signaling	44/4673	48/5488	0.139371845390731	0.957147821072443	0.957147821072443	25805/652/1387/1499/1950/2022/2033/2280/2353/3624/3694/3716/3725/51176/10637/3976/4052/5595/5601/4790/860/864/5054/6497/6498/4086/4089/4090/4091/4092/4093/6696/6772/6774/7030/7040/7046/7048/7049/7050/7124/9839/9372/23090	44
WP4756	Renin-angiotensin-aldosterone system (RAAS)	29/4673	31/5488	0.140014300535679	0.957147821072443	0.957147821072443	1636/183/466/1386/468/1388/801/808/91860/8536/57118/817/818/1215/1385/10488/90993/64764/84699/148327/9586/1511/2776/3283/3284/3708/3709/3710/5330	29
WP2361	Gastric cancer network 1	21/4673	22/5488	0.140256290833741	0.957147821072443	0.957147821072443	324/6790/1063/55125/144455/1894/54891/56992/9585/286826/4173/4605/4851/57122/54476/8607/6286/64094/7153/22974/11065	21
WP2911	miRNA targets in ECM and membrane receptors	21/4673	22/5488	0.140256290833741	0.957147821072443	0.957147821072443	1278/1281/1282/1284/1289/1290/50509/1291/1292/1293/2335/3672/22801/3693/3694/3910/3913/3915/6383/7058/7148	21
WP430	Statin inhibition of cholesterol production	21/4673	22/5488	0.140256290833741	0.957147821072443	0.957147821072443	64240/64241/84532/335/337/338/341/345/348/1071/8694/2222/3156/3949/4023/4035/4547/5360/949/6646/6713	21
WP4585	Cancer immunotherapy by PD-1 blockade	21/4673	22/5488	0.140256290833741	0.957147821072443	0.957147821072443	10538/29126/915/916/917/925/926/3105/3123/3725/3932/10725/4772/4773/4776/4790/5133/80380/5781/6774/7535	21
WP4721	Eicosanoid metabolism via lipooxygenases (LOX)	21/4673	22/5488	0.140256290833741	0.957147821072443	0.957147821072443	30/51/8309/8310/246/240/66002/8529/10800/57105/1800/1962/2358/2687/3248/1241/5465/5467/22949/145482/8989	21
WP5046	NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence	21/4673	22/5488	0.140256290833741	0.957147821072443	0.957147821072443	1994/2539/2805/2806/3159/3553/3569/4190/4191/10135/142/5562/5925/5970/23411/22933/23410/23408/6513/6517/7157	21
WP2023	Cell differentiation - expanded index	12/4673	12/5488	0.144966563202641	0.957147821072443	0.957147821072443	2146/10014/3398/9314/10637/4205/4208/4209/406937/860/6722/6774	12
WP4891	COVID-19 adverse outcome pathway	12/4673	12/5488	0.144966563202641	0.957147821072443	0.957147821072443	59272/183/6347/6348/1440/3627/3553/3559/3569/3574/7113/7124	12
WP5109	Familial hyperlipidemia type 2	12/4673	12/5488	0.144966563202641	0.957147821072443	0.957147821072443	335/337/338/1071/2053/2690/3949/26119/4023/255738/5360/7391	12
WP4868	Type I interferon induction and signaling during SARS-CoV-2 infection	28/4673	30/5488	0.155822175025752	0.957147821072443	0.957147821072443	59272/23586/5610/64135/3454/3455/9641/51135/3661/3665/10379/3716/4615/4938/4939/4940/6772/6773/29110/7097/7099/10333/51284/54106/7113/7187/7189/7297	28
WP4595	Urea cycle and associated pathways	20/4673	21/5488	0.1588526618533	0.957147821072443	0.957147821072443	8659/435/445/2271/2746/2805/2806/2875/3945/4190/4191/162417/4843/4846/4942/5009/5831/8604/10165/10166	20
WP4686	Leucine, isoleucine and valine metabolism	20/4673	21/5488	0.1588526618533	0.957147821072443	0.957147821072443	27034/36/38/197322/4329/549/586/587/594/1629/1738/1892/11112/26275/3028/3712/56922/23417/5095/5096	20
WP4341	Non-genomic actions of 1,25 dihydroxyvitamin D3	56/4673	62/5488	0.165522344310746	0.957147821072443	0.957147821072443	817/818/857/6347/958/959/1594/1673/2113/83982/10964/3551/3569/9636/3716/3725/5600/6300/5603/5595/5598/5601/5469/4790/4791/64127/4893/4939/23236/5330/5331/5333/51196/5336/5578/5579/5580/5581/5583/5588/5590/5971/91543/6256/6257/6667/6670/6772/6773/7097/7099/51311/7124/7132/7297/7421	56
WP176	Folate metabolism	42/4673	46/5488	0.16596971537458	0.957147821072443	0.957147821072443	191/335/338/847/875/6347/1435/1491/1719/2350/2618/2876/2877/2878/2879/3043/3383/3553/3569/3643/3949/4522/10797/4524/4552/4790/4791/5327/5970/55312/6288/6289/949/5054/6470/6472/6573/113235/6647/6648/7124/7157	42
WP4324	Mitochondrial complex I assembly model OXPHOS system	42/4673	46/5488	0.16596971537458	0.957147821072443	0.957147821072443	55744/51295/55572/4694/4705/55967/4695/4696/4698/4700/4701/4702/4706/51103/25915/29078/137682/55471/4707/4716/54539/4708/4709/4711/4712/4713/4714/4715/4717/4718/4719/4720/4722/4724/4725/4726/4723/4731/80224/51300/25880/54968	42
WP69	T-cell receptor signaling pathway	76/4673	85/5488	0.168895000871959	0.957147821072443	0.957147821072443	1386/8915/84433/867/868/1234/919/940/915/916/917/920/9308/925/1147/1385/1398/1399/28988/355/2353/2534/9846/2625/9402/2885/29851/3551/8517/3601/3552/3553/3569/3662/3702/3708/3725/3932/3937/10892/5604/5605/6885/1326/11184/5595/5601/4690/4772/4773/4790/4792/5058/5170/5295/5296/5335/5580/5588/9051/2185/5781/5966/5970/8767/10019/6464/8631/7040/3604/7189/7409/10451/7431/7454/7535	76
WP2289	Drug induction of bile acid pathway	11/4673	11/5488	0.170309280708036	0.957147821072443	0.957147821072443	5243/1244/8714/10257/1576/9971/8856/200931/123264/6822/7421	11
WP3871	Valproic acid pathway	11/4673	11/5488	0.170309280708036	0.957147821072443	0.957147821072443	18/36/116285/1555/1559/1962/3030/3032/3065/3028/3712	11
WP3971	OSX and miRNAs in tooth development	11/4673	11/5488	0.170309280708036	0.957147821072443	0.957147821072443	249/655/1499/6927/9314/406937/4851/4853/4854/4855/860	11
WP4211	Transcriptional cascade regulating adipogenesis	11/4673	11/5488	0.170309280708036	0.957147821072443	0.957147821072443	1051/1052/1054/1649/1959/2624/2625/10365/688/5468/6720	11
WP4495	IL-10 anti-inflammatory signaling pathway 	11/4673	11/5488	0.170309280708036	0.957147821072443	0.957147821072443	644/645/3162/3587/3588/3552/3569/3716/6772/6773/6774	11
WP4629	Aerobic glycolysis	11/4673	11/5488	0.170309280708036	0.957147821072443	0.957147821072443	226/2023/2597/2821/3098/3939/5213/5230/5315/6513/7167	11
WP4707	Aspirin and miRNAs	11/4673	11/5488	0.170309280708036	0.957147821072443	0.957147821072443	10257/283120/114614/4597/4790/4846/5163/5465/5742/5743/7422	11
WP4788	Autosomal recessive osteopetrosis pathways	11/4673	11/5488	0.170309280708036	0.957147821072443	0.957147821072443	1186/3551/4790/28962/9842/7879/29887/10312/8792/8600/7189	11
WP4947	Nitric oxide metabolism in cystic fibrosis	11/4673	11/5488	0.170309280708036	0.957147821072443	0.957147821072443	10498/23576/23564/4843/4846/3276/3275/10196/10419/55170/54496	11
WP5049	Glycolysis in senescence	11/4673	11/5488	0.170309280708036	0.957147821072443	0.957147821072443	230/2023/2539/2597/3098/3939/5230/5315/5562/5925/7157	11
WP5117	Cohesin complex - Cornelia de Lange syndrome	27/4673	29/5488	0.173154809629502	0.957147821072443	0.957147821072443	324/9212/113130/983/114799/157570/9700/55869/23383/23244/23047/5347/5515/5516/5518/5525/5526/5527/5528/5529/9232/5885/9985/8243/9126/10735/10734	27
WP4224	Purine metabolism and related disorders	19/4673	20/5488	0.179657368580526	0.957147821072443	0.957147821072443	100/158/270/316/353/471/1716/2618/3251/3614/4144/10606/5198/4860/5471/5631/50484/7172/7498	19
WP5064	7-oxo-C and 7-beta-HC pathways	19/4673	20/5488	0.179657368580526	0.957147821072443	0.957147821072443	26027/55856/10965/122970/11332/10005/23597/8309/1593/1628/1717/10682/2053/3290/3291/4864/10577/6342/11001	19
WP3529	Zinc homeostasis	26/4673	28/5488	0.192111860245404	0.957147821072443	0.957147821072443	4493/4494/4495/4496/4500/4499/4501/4502/4520/7779/55532/7782/64924/55676/148867/10463/27173/57181/201266/91252/23516/29985/55630/283375/25800/7922	26
WP4149	White fat cell differentiation	26/4673	28/5488	0.192111860245404	0.957147821072443	0.957147821072443	1051/1052/1385/1495/1649/1879/1959/2308/2624/2625/3661/3662/10365/9314/688/7026/2908/5468/5914/6095/6720/6776/6777/83439/7090/23090	26
WP623	Oxidative phosphorylation	33/4673	36/5488	0.196285170939575	0.957147821072443	0.957147821072443	537/3002/4705/126328/4695/4696/56901/4698/4700/4701/4702/4704/4706/4707/4716/4708/4711/4712/4713/4714/4715/4717/4718/4719/4720/4722/4724/4725/4726/374291/4728/4723/4731	33
WP4217	Ebola virus infection in host	106/4673	120/5488	0.196349509094017	0.957147821072443	0.957147821072443	60/71/87/81/6868/558/684/857/858/30835/11314/10462/1211/1212/1213/1387/1508/1514/153090/23586/1956/5610/1965/2033/2060/2316/2317/2318/2621/2934/26762/84868/3105/3106/3107/3108/3109/3111/3112/3113/3115/3117/3119/3122/3123/3127/3133/3134/3135/3384/3385/3480/9641/8826/3661/3665/3672/3673/3676/3678/3655/3685/3688/3690/3836/5595/10461/4240/4734/4790/4791/4864/10577/5058/5290/5293/5295/5296/8503/5868/7879/9367/5879/5922/5966/5970/5971/5981/387/388/85477/9021/6772/29110/91937/7099/7150/219931/7301/7410/55823/64601/57617/65082/27072/27183	106
WP702	Metapathway biotransformation Phase I and II	93/4673	105/5488	0.197918244492483	0.957147821072443	0.957147821072443	10327/231/1645/8574/22977/9486/50515/55501/113189/9435/9469/23563/1545/57404/56603/1593/1594/1555/1557/1558/1559/1565/1573/120227/29785/113612/51302/1576/1551/57834/66002/8529/4051/285440/260293/1595/9420/2052/2053/2326/2329/2330/9514/64090/79690/2877/2878/2879/2937/2938/2939/2941/79807/373156/2944/2947/2948/2949/9446/119391/2950/3176/9653/9957/9953/9394/11185/8514/4257/4258/4259/51126/122830/79829/80218/57106/10/9027/26151/3340/4837/6817/6799/27284/6783/6822/7172/54658/54575/79799/7366/7367/7364	93
WP1991	SRF and miRs in smooth muscle differentiation and proliferation	10/4673	10/5488	0.200075968200433	0.957147821072443	0.957147821072443	817/894/2002/9314/4205/4208/4209/406937/93649/6722	10
WP2879	Farnesoid X receptor pathway	10/4673	10/5488	0.200075968200433	0.957147821072443	0.957147821072443	5244/1576/2289/8660/8431/9971/10891/6256/11309/6822	10
WP2881	Estrogen receptor pathway	10/4673	10/5488	0.200075968200433	0.957147821072443	0.957147821072443	51/1545/57678/3725/8431/5105/5166/5465/6667/6774	10
WP3630	NAD metabolism, sirtuins and aging	10/4673	10/5488	0.200075968200433	0.957147821072443	0.957147821072443	2308/2309/3091/10135/4790/142/5468/23411/23410/7019	10
WP4589	Major receptors targeted by epinephrine and norepinephrine	10/4673	10/5488	0.200075968200433	0.957147821072443	0.957147821072443	107/109/196883/111/112/113/115/150/153/154	10
WP4846	SARS-CoV-2 and COVID-19 pathway	10/4673	10/5488	0.200075968200433	0.957147821072443	0.957147821072443	38/59272/1514/5045/8829/949/340024/51284/7113/56649	10
WP5108	Familial  hyperlipidemia type 1	10/4673	10/5488	0.200075968200433	0.957147821072443	0.957147821072443	51129/335/337/1071/3949/64788/4023/4035/5360/6400	10
WP5110	Familial hyperlipidemia type 3	10/4673	10/5488	0.200075968200433	0.957147821072443	0.957147821072443	335/337/348/1071/3949/4023/4035/5360/949/7436	10
WP5176	Disorders of bile acid synthesis and biliary transport	10/4673	10/5488	0.200075968200433	0.957147821072443	0.957147821072443	5244/1244/8309/5205/1593/9420/3295/80270/6342/11001	10
WP5188	Retinol metabolism	10/4673	10/5488	0.200075968200433	0.957147821072443	0.957147821072443	216/316/1551/10901/317749/10170/9227/8228/112724/195814	10
WP3645	NAD+ biosynthetic pathways	18/4673	19/5488	0.202873722944703	0.957147821072443	0.957147821072443	683/952/3620/55191/10135/64802/142/10038/143/23475/23411/22933/23410/23408/51548/6999/8658/80351	18
WP3657	Hematopoietic stem cell gene regulation by GABP alpha/beta complex	18/4673	19/5488	0.202873722944703	0.957147821072443	0.957147821072443	472/596/598/1387/1786/1788/2033/2120/2322/2309/2553/3002/4170/5728/4089/6597/7014/7543	18
WP384	Apoptosis modulation by HSP70	18/4673	19/5488	0.202873722944703	0.957147821072443	0.957147821072443	9131/317/637/835/836/839/840/841/842/54205/8772/355/356/3303/4214/4790/8737/7132	18
WP727	Monoamine transport	18/4673	19/5488	0.202873722944703	0.957147821072443	0.957147821072443	43/183/995/114907/3553/3554/3690/5516/5934/10066/6532/6804/6999/7041/7124/4982/7249/10497	18
WP5072	Modulators of TCR signaling and T cell activation	53/4673	59/5488	0.206212340624023	0.957661322487171	0.957661322487171	26523/8915/84433/868/919/940/915/916/917/921/925/1147/1606/8525/9158/10672/9402/2885/3551/8517/3702/3932/3937/10892/1326/11184/4209/4716/4790/4792/5094/5170/5295/5296/5335/5588/5777/5922/5966/5970/399/9616/58490/10019/4068/8651/84065/7128/7189/53347/7409/7535/677	53
WP4816	TGF-beta receptor signaling in skeletal dysplasias	46/4673	51/5488	0.21030923593033	0.957661322487171	0.957661322487171	81794/25805/652/1387/1499/1950/2022/2033/2200/2280/2353/3624/3694/3716/3725/51176/10637/3976/4052/5595/5601/4790/860/864/5054/6497/6498/4086/4089/4090/4091/4092/4093/6696/6772/6774/7030/7040/7046/7048/7049/7050/7124/9839/9372/23090	46
WP2839	Hair follicle development: organogenesis - part 2 of 3	25/4673	27/5488	0.21279005444132	0.957661322487171	0.957661322487171	652/595/894/999/1499/1896/2263/8321/2735/2736/23560/3624/3688/3911/51176/4041/4684/4790/5154/5156/5727/860/6469/6608/7474	25
WP4008	NO/cGMP/PKG mediated neuroprotection	25/4673	27/5488	0.21279005444132	0.957661322487171	0.957661322487171	10142/572/596/801/817/818/842/1259/1385/54205/1742/2977/3553/4790/4792/4843/4846/4881/5138/5139/5481/5593/5970/7124/331	25
WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	25/4673	27/5488	0.21279005444132	0.957661322487171	0.957661322487171	59272/6347/1147/2730/2939/2977/3162/3551/8517/3553/3569/3661/9817/4312/4314/4790/4792/27035/1728/5593/5970/6256/23657/7113/7124	25
WP1541	Energy metabolism	39/4673	43/5488	0.213469608137728	0.957661322487171	0.957661322487171	1386/818/1385/2033/2101/2308/2309/2932/3065/5469/4205/4208/4209/10514/8648/4899/5465/5467/5468/10891/133522/5530/5532/5533/5534/23082/5562/5564/5565/5571/51422/3276/6256/23411/23410/7019/51106/64216/7351	39
WP138	Androgen receptor signaling pathway	72/4673	81/5488	0.21686171251974	0.957661322487171	0.957661322487171	573/90427/672/811/10498/857/595/898/1026/1385/1387/1499/1616/11034/1956/2033/2119/2274/2288/2316/2308/2932/3065/3725/10524/11143/23028/3985/4193/8648/10499/8202/8031/9611/9612/8431/11315/23598/8554/9063/10401/5295/5296/5052/29893/5728/5747/5879/5883/5901/5925/5970/387/388/9604/6047/6049/6093/9475/860/25942/23411/4089/6605/6667/6774/10273/7341/7041/7050/7329/57178	72
WP1772	Apoptosis modulation and signaling	72/4673	81/5488	0.21686171251974	0.957661322487171	0.957661322487171	9131/84883/317/572/9531/578/596/597/598/10018/599/637/638/329/330/332/640/90427/664/666/834/843/835/836/837/839/840/841/842/8837/8738/54205/1616/56616/2021/8772/355/356/2353/3303/3551/3554/7850/3654/3725/8567/4217/5595/4170/4615/4671/4790/4792/8682/5366/5587/5783/51651/8737/8797/8795/8794/8793/7132/7133/8743/54472/7157/8717/7187/7189/331	72
WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	52/4673	58/5488	0.221341568191096	0.969686870170516	0.969686870170516	59272/164/682/841/6347/6348/6351/6352/11126/2919/3627/6373/10563/2920/2921/6374/6372/4283/3579/23586/79132/2033/8772/84868/3433/8519/3454/3455/3569/3570/3661/3665/3716/3902/23367/4599/4790/4928/8737/6772/6773/10010/29110/7040/51284/7124/9540/8717/7187/7188/7189/7706	52
WP2806	Complement system	65/4673	73/5488	0.223550224100741	0.970757024326142	0.970757024326142	133/335/715/716/717/718/719/720/722/728/729/730/811/930/958/1604/966/22918/629/1675/3075/3426/5199/1378/1380/1452/1634/2159/2160/2162/2208/2214/2219/2286/2357/2769/2771/2773/3383/3384/3673/3687/3689/3690/3818/3911/3912/3915/5648/5329/5566/5578/5621/5627/5806/6223/6401/6402/6403/6404/710/6696/7097/7295/7454	65
WP4300	Extracellular vesicles in the crosstalk of cardiac cells	17/4673	18/5488	0.228708688086662	0.970757024326142	0.970757024326142	332/967/975/1950/1956/3315/3479/3569/3791/4318/10611/5728/6647/8470/6696/6774/7099	17
WP5193	Cholesterol synthesis disorders	17/4673	18/5488	0.228708688086662	0.970757024326142	0.970757024326142	1595/1718/1717/10682/2222/2224/3156/3157/3284/3422/3930/4047/6307/4597/4598/6309/6713	17
WP545	Complement activation	17/4673	18/5488	0.228708688086662	0.970757024326142	0.970757024326142	712/713/714/715/716/717/718/720/721/729/730/733/1604/629/1675/5199/5648	17
WP1530	miRNA regulation of DNA damage response	58/4673	65/5488	0.23037893149769	0.970757024326142	0.970757024326142	25/317/472/545/84126/637/672/836/841/842/891/9133/595/894/896/898/9134/900/993/995/983/1017/1019/1020/1021/1026/1111/11200/1385/54205/1643/1869/2177/355/1647/4616/4176/4193/406937/4683/5366/5371/5591/5810/10111/5888/5893/5883/5925/5981/50484/27244/2810/8243/9874/11011/8795/7157	58
WP3851	TLR4 signaling and tolerance	24/4673	26/5488	0.235280677375742	0.979542405069406	0.979542405069406	1147/3551/9641/8517/3569/3635/3654/11213/51135/3661/3665/6885/4615/4790/4792/8737/10454/23118/29110/7099/7124/7187/7189/23471	24
WP2431	Spinal cord injury	77/4673	87/5488	0.236012934554766	0.979542405069406	0.979542405069406	199/301/328/358/7832/713/836/6347/595/900/729230/961/983/1017/1019/50515/1280/1282/1464/2919/3627/2920/1869/1875/1948/1956/1958/2043/2212/2280/2353/2309/1647/2697/3383/3552/3553/3554/3569/10288/4050/1241/5595/4155/4321/4318/4804/4843/3164/9423/5320/8398/5362/5530/5578/5743/5786/5879/5925/56963/387/388/9475/57142/6403/57556/6586/7040/7099/7124/8741/10673/7157/1462/7431/64131/7538	77
WP466	DNA replication	37/4673	41/5488	0.2506085273886	0.999999998939414	0.999999998939414	8318/990/8317/1017/81620/10926/51053/55388/4171/4172/4173/4174/4175/4176/4998/4999/5000/5001/23594/5111/5422/23649/5424/5425/10714/57804/5426/5427/5557/5558/5981/5982/5983/5984/5985/6119/7316	37
WP3877	MYD88 distinct input-output pathway	16/4673	17/5488	0.257367975283365	0.999999998939414	0.999999998939414	3552/3654/3725/4615/4790/92610/7096/81793/7097/7099/10333/51284/51311/54106/7189/7334	16
WP4560	MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement	16/4673	17/5488	0.257367975283365	0.999999998939414	0.999999998939414	87/1385/3685/3690/3708/3725/4026/5595/8076/4638/5335/5588/5747/5829/7082/7414	16
WP5220	Metabolic reprogramming in pancreatic cancer	36/4673	40/5488	0.270893295995152	0.999999998939414	0.999999998939414	47/587/10498/1431/1738/2194/2673/2746/64841/2805/2806/2821/2875/3098/3099/3156/3158/3939/3949/4190/4199/5160/5162/8050/5211/5238/5315/6120/22934/6566/6510/6513/8140/6646/7157/6675	36
WP1403	AMP-activated protein kinase (AMPK) signaling	49/4673	55/5488	0.271595470434285	0.999999998939414	0.999999998939414	31/32/51094/79602/208/51719/84254/10645/890/891/1026/1374/200186/29904/1978/1994/2194/2997/3156/3172/3643/3953/3991/2475/5209/5290/5293/5294/5295/5296/8503/23236/133522/5562/5564/5565/5567/5571/51422/6198/6199/6517/56731/6720/6794/55437/7157/7248/7249	49
WP15	Selenium micronutrient network	49/4673	55/5488	0.271595470434285	0.999999998939414	0.999999998939414	240/241/335/338/847/875/6347/1491/1734/2678/2876/2877/2878/2879/3043/3383/3553/3569/3643/8564/8942/3949/51734/4524/4790/4791/5327/55163/5052/7001/10549/25824/5742/5743/5970/55312/6288/6289/949/22928/5054/6647/6648/7124/7295/7296/10587/114112/7498	49
WP75	Toll-like receptor signaling pathway	74/4673	84/5488	0.278412077771806	0.999999998939414	0.999999998939414	208/10000/841/6348/6351/6352/929/958/941/942/1147/3627/6373/4283/8772/2353/3454/3455/3551/9641/8517/3553/3569/3654/51135/3661/3663/3665/3725/23643/5604/5605/5606/6416/5608/5609/6885/1326/5600/6300/5603/5595/5601/4615/4790/4792/4793/5290/5293/5294/5295/5296/8503/23533/5879/5970/8737/6696/6772/10454/23118/257397/29110/7096/7097/7099/10333/51284/51311/54106/7124/54472/7187/7189	74
WP707	DNA damage response	55/4673	62/5488	0.278871316669574	0.999999998939414	0.999999998939414	25/317/472/545/84126/637/672/836/841/842/891/9133/595/894/896/898/9134/993/995/983/1017/1019/1020/1021/1026/1111/11200/1385/54205/1643/1869/2177/355/1647/4616/4193/4683/5366/5371/5591/5810/10111/5888/5893/5883/5925/5981/50484/27244/2810/8243/9874/11011/8795/7157	55
WP3995	Prion disease pathway	29/4673	32/5488	0.27905619701103	0.999999998939414	0.999999998939414	10538/53335/596/836/1385/10664/1879/2002/2033/2260/2534/7184/3309/3662/5595/4208/4684/4790/5079/2923/5452/5621/5747/5885/5993/6256/9126/6688/6774	29
WP465	Tryptophan metabolism	29/4673	32/5488	0.27905619701103	0.999999998939414	0.999999998939414	51166/38/125061/216/8854/217/223/26/316/847/1545/1573/1576/66002/9420/1644/1718/1892/2639/23498/3033/3028/3620/11185/8942/4129/3276/6999/7166	29
WP2406	Cardiac progenitor differentiation	22/4673	24/5488	0.286018371681552	0.999999998939414	0.999999998939414	290/652/7852/2247/3170/2932/3479/3481/3624/3670/3791/3815/4208/4684/4851/3084/5156/5460/4920/140885/7040/7070	22
WP3613	Photodynamic therapy-induced unfolded protein response	22/4673	24/5488	0.286018371681552	0.999999998939414	0.999999998939414	440/467/468/22926/10018/811/1649/51726/4189/5611/9695/83939/9451/2081/7184/3309/10130/23645/6783/57761/7324/7494	22
WP3965	Lipid metabolism pathway	22/4673	24/5488	0.286018371681552	0.999999998939414	0.999999998939414	51099/31/47/55902/208/10000/2194/29923/3991/5160/57104/5562/5564/5565/5566/5567/5571/51422/5573/5575/5576/5577	22
WP3287	Overview of nanoparticle effects	15/4673	16/5488	0.289049325068057	0.999999998939414	0.999999998939414	10000/596/896/1001/1282/2335/3162/3569/3909/4798/5293/5742/5743/5747/7124	15
WP3413	NOTCH1 regulation of endothelial cell calcification	15/4673	16/5488	0.289049325068057	0.999999998939414	0.999999998939414	249/813/28514/54567/2261/2702/3672/182/3714/4256/4851/5327/6303/55553/7422	15
WP4478	LTF danger signal response pathway	15/4673	16/5488	0.289049325068057	0.999999998939414	0.999999998939414	177/929/3552/3553/3569/3654/51135/4057/4615/4790/7097/7099/7124/7189/54210	15
WP4493	Cells and molecules involved in local acute inflammatory response 	15/4673	16/5488	0.289049325068057	0.999999998939414	0.999999998939414	718/729/730/3383/3552/3569/3676/3683/3688/3689/3827/6403/6404/7124/7412	15
WP399	Wnt signaling pathway and pluripotency	67/4673	76/5488	0.289578073356721	0.999999998939414	0.999999998939414	324/8312/8313/595/894/896/960/1387/1454/1487/1499/1500/1856/1857/2033/26190/10023/8321/7976/8322/7855/8323/8324/8325/2932/3725/3949/51176/4041/4040/120892/6416/6885/5601/4316/4800/51701/5048/5328/5460/5467/5515/5516/5518/5520/5523/28227/5527/5529/5578/5579/5580/5581/5583/5584/5588/5590/5587/29127/387/6932/83439/7157/7481/7473/54361/7474	67
WP474	Endochondral ossification	48/4673	54/5488	0.289981946272227	0.999999998939414	0.999999998939414	9510/9507/11096/249/654/655/657/51719/801/50515/1280/4921/5167/2247/2260/2261/2487/2690/2737/9759/3157/3479/3480/3481/3549/11127/4208/4256/4322/4318/5327/5328/5566/5727/860/864/85477/871/54407/6660/55553/6696/6772/6777/7040/7067/7078/7422	48
WP4808	Endochondral ossification with skeletal dysplasias	48/4673	54/5488	0.289981946272227	0.999999998939414	0.999999998939414	9510/9507/11096/249/654/655/657/51719/801/50515/1280/4921/5167/2247/2260/2261/2487/2690/2737/9759/3157/3479/3480/3481/3549/11127/4208/4256/4322/4318/5327/5328/5566/5727/860/864/85477/871/54407/6660/55553/6696/6772/6777/7040/7067/7078/7422	48
WP45	G1 to S cell cycle control	54/4673	61/5488	0.296460755563715	0.999999998939414	0.999999998939414	1388/472/891/595/894/896/898/9134/901/902/993/8318/983/1017/1019/1021/1022/1026/1030/1031/1032/1385/10488/90993/84699/148327/1869/1871/1647/4171/4172/4173/4174/4175/4176/4193/4331/4998/4999/5000/5001/23594/5111/23649/5426/5427/5557/5558/5925/6119/7027/7029/7157/7465	54
WP2447	Amyotrophic lateral sclerosis (ALS)	28/4673	31/5488	0.303362336933093	0.999999998939414	0.999999998939414	57679/317/572/596/598/637/834/836/842/847/9973/1471/1616/79139/2876/5605/5608/4217/5530/5532/5533/5868/5879/6506/6647/7124/7132/7157	28
WP5198	Inflammatory bowel disease signaling	28/4673	31/5488	0.303362336933093	0.999999998939414	0.999999998939414	50943/2625/3108/3459/3594/3595/3606/8807/3552/50615/3561/3566/3569/3725/4094/4772/4790/64127/6095/6097/6772/6774/6775/30009/7040/7097/7099/7124	28
WP5202	Alstrom syndrome	28/4673	31/5488	0.303362336933093	0.999999998939414	0.999999998939414	81/2647/55330/26258/84984/55125/26052/84062/23432/114928/51668/26160/11020/80173/28981/4645/55968/5727/11159/5990/5991/6608/23557/6811/7029/7283/7415/80124	28
WP289	Myometrial relaxation and contraction pathways	103/4673	118/5488	0.305796230769952	0.999999998939414	0.999999998939414	57007/59/60/71/107/109/196883/111/112/113/115/133/408/466/1386/467/468/22809/1388/488/784/800/801/808/817/818/1264/1265/27297/1385/10488/8525/2353/2553/2697/2776/2783/59345/10681/2791/54331/2786/2869/2870/9446/2980/2981/3485/3486/3488/3489/3553/3569/3708/3709/3710/3725/23764/4790/4846/5142/5144/5569/5570/11142/5331/5333/5335/5336/5566/5567/5573/5575/5576/5577/5578/5579/5580/5581/5583/5588/5590/5587/10266/10268/5996/6001/10636/6004/64407/10287/5997/5998/5999/8490/8787/2810/6546/6667/7531/7532/10971/7534	103
WP195	IL-1 signaling pathway	47/4673	53/5488	0.309180122705599	0.999999998939414	0.999999998939414	1386/6347/1147/51295/3551/8517/3552/3553/3554/3556/3654/3656/11213/51135/3725/5604/5605/5606/6416/5608/5609/4214/10746/4215/6885/5595/5601/9261/4615/4790/4792/4793/57162/57161/5295/5296/5335/5590/5781/5966/5970/10454/23118/257397/54472/7189/7334	47
WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	211/4673	244/5488	0.312487350145707	0.999999998939414	0.999999998939414	31/208/10000/284/285/1386/468/1388/572/51719/81617/842/11140/1026/1101/1277/1278/1280/1281/1282/1284/1286/1289/1290/50509/1292/1385/10488/90993/64764/84699/148327/9586/200186/1435/1436/1440/1441/54541/1942/1943/1944/1945/1946/1950/1956/1975/1977/1978/1994/2034/1969/2149/2258/2247/2252/2254/2260/2263/2261/2321/2324/2335/3169/2308/2309/2690/2783/59345/2791/54331/2786/2793/2885/2932/2997/3082/3091/3326/7184/3454/3455/3479/3480/3551/8517/3559/3560/3561/3563/3566/3570/3575/3643/8660/22801/3673/3676/3678/3655/3679/8516/3680/3682/3683/3685/3687/3688/3689/3690/3691/3693/3694/3695/3716/3717/3718/3791/3815/4254/284217/3908/3909/3910/3911/3912/3913/3914/3915/3918/10319/3991/9170/57121/10161/5604/5605/5595/4193/4233/2475/4804/4843/4846/4893/5008/9180/5154/5155/56034/80310/5156/5159/5170/53918/5208/5209/5210/5228/23239/23035/5286/5290/5293/5294/5295/5296/23533/10891/5515/5516/5518/55844/5523/55012/5525/5526/5527/5528/5529/5562/5618/5728/5747/10890/9230/5649/6009/6194/6198/6199/6513/6514/6515/6517/6696/6720/6794/23216/8115/7010/7058/7059/3371/7148/7248/7249/7422/7423/7424/7450	211
WP299	Nuclear receptors in lipid metabolism and toxicity	21/4673	23/5488	0.314390586094281	0.999999998939414	0.999999998939414	5243/5244/1244/8714/225/5825/9619/64240/1594/1555/1559/1576/9971/8856/5465/5467/5468/5914/5915/5916/7421	21
WP4313	Ferroptosis	53/4673	60/5488	0.314751600015632	0.999999998939414	0.999999998939414	2180/2181/2182/51703/84883/1645/246/9474/10533/571/875/51510/79643/55847/27235/1356/1491/1536/1803/2222/2495/2512/2643/2730/2879/2937/3156/3162/3315/3658/10162/84557/81631/8031/27035/5093/5094/5447/5621/6303/112483/4891/6510/81539/23516/30061/23657/55240/7037/7157/7296/7417/7419	53
WP4946	DNA repair pathways, full network	96/4673	110/5488	0.317936791384965	0.999999998939414	0.999999998939414	328/27301/472/545/672/675/83990/902/1022/1069/1111/8451/64421/1642/1643/2067/2068/2071/2072/2073/2074/9156/22909/2175/2177/2178/2188/2189/55215/55120/57697/2237/2965/2966/2967/3146/3978/3980/3981/8930/4255/4292/4331/4350/4436/2956/4595/4683/252969/55247/4913/4968/79728/142/10038/5111/11284/5423/5424/5425/10714/57804/5426/5427/54107/56655/5429/51426/27434/5591/5886/5887/10111/5888/5889/5893/51455/5980/5981/5982/5983/5984/5985/6119/23583/6996/7014/7374/7398/57599/7486/7507/7508/7515/7518/7520	96
WP197	Cholesterol biosynthesis pathway	14/4673	15/5488	0.32393348999518	0.999999998939414	0.999999998939414	1595/1717/2222/2224/3156/3157/3422/4047/6307/4597/4598/50814/6309/6713	14
WP22	IL-9 signaling pathway	14/4673	15/5488	0.32393348999518	0.999999998939414	0.999999998939414	1025/2885/3561/3716/3718/5604/5605/5595/5295/5296/6772/6774/6776/6777	14
WP3927	BMP signaling in eyelid development	14/4673	15/5488	0.32393348999518	0.999999998939414	0.999999998939414	652/1956/2263/3725/4214/5595/5601/4851/5308/6469/4086/4089/4090/7039	14
WP4790	FGF23 signaling in hypophosphatemic rickets and related disorders	14/4673	15/5488	0.32393348999518	0.999999998939414	0.999999998939414	249/595/1026/1594/5167/56975/2263/2261/2591/4790/4791/5251/142680/6696	14
WP516	Hypertrophy model	14/4673	15/5488	0.32393348999518	0.999999998939414	0.999999998939414	467/11072/1977/1978/1839/3475/3606/3552/3554/3727/8013/7422/9948/6935	14
WP3298	Melatonin metabolism and effects	27/4673	30/5488	0.329148521063262	0.999999998939414	0.999999998939414	43/153/348/801/9575/1407/1408/1453/1454/1545/1557/1565/1889/1906/2308/2932/3654/4128/406938/4790/5187/8864/8863/5578/23411/6817/7189	27
WP4496	Signal transduction through IL1R	27/4673	30/5488	0.329148521063262	0.999999998939414	0.999999998939414	1147/51295/3551/3552/3553/3554/3556/3557/3569/3654/3656/11213/3725/5606/5608/4214/6885/4615/4790/4792/5970/10454/7040/7043/7124/54472/7189	27
WP4844	Influence of laminopathies on Wnt signaling	27/4673	30/5488	0.329148521063262	0.999999998939414	0.999999998939414	27161/324/8312/595/1021/1051/1052/1452/1499/23405/2010/2339/2932/3280/8091/51176/4000/5468/860/6517/6696/6720/6895/6932/83439/7088/26092	27
WP5097	CCL18 signaling pathway	27/4673	30/5488	0.329148521063262	0.999999998939414	0.999999998939414	59/205/467/960/999/1278/2033/2335/8322/3091/3939/100506334/440823/4313/4318/92140/5728/2185/100505648/6513/6772/7004/652995/7412/7424/7431/9839	27
WP585	Interferon type I signaling pathways	46/4673	52/5488	0.329177913274584	0.999999998939414	0.999999998939414	867/1385/1398/1399/1975/1977/1978/2534/9846/3454/3455/10379/8660/3716/3932/5606/5608/4214/2475/27250/8554/10401/5293/5295/5296/3276/5781/5777/5788/5879/2889/5966/6194/8986/9252/6198/8651/9021/6772/6773/6774/6775/6776/7297/7409/7535	46
WP3888	VEGFA-VEGFR2 signaling pathway	345/4673	401/5488	0.332462003200595	0.999999998939414	0.999999998939414	25/31/32/57007/23597/71/8754/9510/56999/154/226/154796/301/160/81575/378/382/22899/405/81873/10973/1386/468/22926/9564/596/598/274/332/660/682/56905/781/811/813/10645/824/832/857/867/6347/595/9034/10574/9578/1003/84952/79094/1192/1213/1267/22820/1385/1387/1397/1398/1445/1466/1495/1499/1500/1536/54205/1558/1666/54505/170506/54567/3301/11080/4189/1796/8813/1847/1958/1960/83939/9451/8664/8665/8667/1977/1981/1982/2002/2022/2035/1969/2048/29924/2060/2078/2081/2113/2130/7430/2152/8772/11124/23196/355/23291/152273/2274/29109/2314/2317/2321/91010/2335/2308/2309/4303/10818/6624/9513/2534/2549/2597/2624/26058/10755/2697/2746/2817/2876/2887/2885/2926/2932/1839/3065/9759/10014/51564/9734/9709/3142/3146/3303/3315/5654/10525/3383/3418/3486/3490/8821/51763/8826/3685/3688/3690/3693/182/3725/3791/9079/3939/3984/3998/55379/9209/55692/5604/5605/5606/6416/5608/5609/4217/6300/5595/5601/9261/8550/4193/4208/9645/4319/4323/4313/79812/4343/2475/4629/4627/4646/4673/653361/4688/4690/4691/10397/91624/4772/4773/4790/4792/4846/4855/3164/4929/8013/441478/8828/100506658/4952/8974/5034/26986/5058/5062/55872/57326/10130/5170/5226/5228/5230/5290/5295/5296/5328/5329/5331/5335/8985/4860/5496/5499/5515/5530/7001/9588/5562/5578/5579/5580/5581/5584/5590/5587/25865/5592/23215/5717/5710/5743/5747/2185/5757/5770/5781/5784/5777/5780/5795/5829/9444/8766/5867/5868/5879/5908/2889/1827/10231/5954/5970/387/57381/27289/6093/9475/4736/23521/6142/6154/6155/6125/6129/6181/6205/6194/9252/6198/1901/57758/6386/23753/6401/80031/6418/9047/83442/6461/6464/25759/357/6478/8402/6541/6546/6595/27044/6648/56907/6722/6729/6732/6747/6748/8027/6772/6774/10963/8867/6886/9344/7004/7019/7024/7086/124491/7111/29766/9168/7114/8794/7148/219931/7170/10758/9325/84790/7295/10628/9898/9100/7410/7414/7422/8936/7531	345
WP254	Apoptosis	70/4673	80/5488	0.342040417516162	0.999999998939414	0.999999998939414	317/572/578/596/598/10018/599/637/329/330/332/665/666/834/843/835/836/837/839/840/841/842/8837/1147/8738/54205/56616/8772/355/356/3002/3070/3479/3480/3481/3551/8517/3659/3660/3661/3662/3663/3664/3665/3725/4049/6416/4214/4170/4193/4790/4792/4793/4794/5295/5366/5551/5970/8737/9169/7124/8795/7132/7133/8743/7157/8717/7185/7187/331	70
WP2817	Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)	20/4673	22/5488	0.344816372048895	0.999999998939414	0.999999998939414	9914/598/857/595/1051/1147/1956/1977/2064/2065/3717/2908/5618/5770/8792/8600/7170/23508/7392/7528	20
WP3845	Canonical and non-canonical Notch signaling	20/4673	22/5488	0.344816372048895	0.999999998939414	0.999999998939414	1147/28514/54567/3280/23462/182/3714/51176/9794/84441/55534/4237/4851/4853/4854/4855/5663/5664/3516/6237	20
WP4482	Vitamin D in inflammatory diseases	20/4673	22/5488	0.344816372048895	0.999999998939414	0.999999998939414	1147/1843/3551/8517/3569/5606/5608/4214/9282/4772/4790/4792/2908/5530/5534/5970/6256/4089/7124/7421	20
WP2840	Hair follicle development: cytodifferentiation - part 3 of 3	45/4673	51/5488	0.349956815602047	0.999999998939414	0.999999998939414	6868/652/654/657/4345/947/1499/1523/27122/1824/1956/1959/2353/2354/8321/2619/2625/2736/23560/55806/3479/3488/3725/4254/3866/51176/8549/26018/4772/4790/4851/4853/2908/22822/8842/3516/864/6275/4086/4089/25928/11005/6925/7040/7474	45
WP1591	Heart development	26/4673	29/5488	0.356406298916546	0.999999998939414	0.999999998939414	8553/652/657/659/1499/2065/3170/2627/23462/3670/4208/406937/4772/4773/4776/4851/5308/5781/6469/4086/4089/6722/6909/7422/7423/7424	26
WP12	Osteoclast signaling	13/4673	14/5488	0.362172323829888	0.999999998939414	0.999999998939414	54/7965/9550/1513/8111/3454/3690/5155/6548/6696/8792/4982/8600	13
WP3969	H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity	13/4673	14/5488	0.362172323829888	0.999999998939414	0.999999998939414	595/999/1019/1466/1499/1869/283120/182/5469/5366/5925/6659/7289	13
WP4582	Cancer immunotherapy by CTLA4 blockade	13/4673	14/5488	0.362172323829888	0.999999998939414	0.999999998939414	940/941/942/1493/3123/5290/5293/5295/5296/8503/5515/5781/5777	13
WP53	ID signaling pathway	13/4673	14/5488	0.362172323829888	0.999999998939414	0.999999998939414	898/1017/2002/2004/2005/3397/3398/5079/7849/5925/5933/5934/6720	13
WP691	Tamoxifen metabolism	13/4673	14/5488	0.362172323829888	0.999999998939414	0.999999998939414	1545/1557/1558/1559/1565/1576/2326/6817/6783/6822/54575/7366/7364	13
WP2064	Neural crest differentiation	50/4673	57/5488	0.373669290922472	0.999999998939414	0.999999998939414	8312/8313/652/655/999/1004/1280/1499/28514/54567/1856/1857/2113/2247/2260/2263/2261/7976/2705/2932/3065/79885/9759/10014/10013/51564/55869/9734/3280/3198/3397/3670/3688/4155/4286/4359/4602/4790/4791/4851/4853/4854/4855/5376/3516/388/4086/6660/6925/83439	50
WP129	Matrix metalloproteinases	19/4673	21/5488	0.377302082489165	0.999999998939414	0.999999998939414	682/4312/4319/4321/4322/4323/4324/4327/4313/10893/64386/79148/4314/4316/4318/7076/7077/7078/7124	19
WP170	Nuclear receptors	25/4673	28/5488	0.385108339407288	0.999999998939414	0.999999998939414	2101/3172/9975/7376/8856/7025/7026/2063/2908/3164/4929/2494/5465/5467/5468/5914/5915/5916/6095/6097/6256/6257/7067/7068/7421	25
WP716	Vitamin A and carotenoid metabolism	25/4673	28/5488	0.385108339407288	0.999999998939414	0.999999998939414	64240/64241/216/8854/220/948/56603/8694/9249/4023/9227/29881/5914/5915/5916/5948/5950/157506/5959/54884/6256/6257/949/195814/6817	25
WP1533	Vitamin B12 metabolism	31/4673	35/5488	0.389568377634301	0.999999998939414	0.999999998939414	335/338/348/875/6347/6352/1491/8029/3043/3383/3553/3569/3643/3949/326625/4524/4552/4790/4791/5327/5970/6288/6289/949/5054/6472/6647/6648/6947/6948/7124	31
WP4658	Small cell lung cancer	79/4673	91/5488	0.393614771371065	0.999999998939414	0.999999998939414	208/10000/317/578/596/598/637/329/330/836/841/842/595/898/9134/1017/1019/1021/1026/1030/1147/1163/1164/1282/1284/1285/1286/1287/54205/1643/1869/1871/2272/2335/1647/4616/3551/8517/3673/3655/3685/3688/284217/3908/3909/3910/3911/3912/3913/3914/3915/3918/10319/4149/4790/4792/4793/4843/5290/5293/5295/5296/8503/51426/5728/5743/5747/5915/5925/5970/6256/6257/6500/7157/7185/7187/9618/7188/7189	79
WP3863	T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection	49/4673	56/5488	0.394575665308899	0.999999998939414	0.999999998939414	10598/8915/801/84433/867/940/915/920/959/925/1019/1147/1493/1739/2353/2534/9402/2885/2932/29851/3551/8517/3702/3725/3932/3937/10892/5604/5605/5609/6885/1326/5595/5601/4690/4773/4790/4792/5058/5133/5163/5290/5335/5588/5777/5788/6237/7124/7535	49
WP2855	Dopaminergic neurogenesis	12/4673	13/5488	0.403873244744244	0.999999998939414	0.999999998939414	216/1644/3170/2735/2736/4760/4929/5979/6469/6571/6774/7040	12
WP3591	Sleep regulation	12/4673	13/5488	0.403873244744244	0.999999998939414	0.999999998939414	100/191/114781/1471/2353/3606/3569/4862/8863/5729/5730/2030	12
WP3958	GPR40 pathway	12/4673	13/5488	0.403873244744244	0.999999998939414	0.999999998939414	2767/3710/5310/23236/5330/5331/5333/113026/51196/5335/5336/5334	12
WP4522	Metabolic pathway of LDL, HDL and TG, including diseases	12/4673	13/5488	0.403873244744244	0.999999998939414	0.999999998939414	302/335/338/348/1071/3949/26119/9388/4023/4547/255738/949	12
WP4760	PKC-gamma calcium signaling pathway in ataxia	12/4673	13/5488	0.403873244744244	0.999999998939414	0.999999998939414	767/773/2767/9630/2769/2776/2893/3708/5163/23236/5330/5331	12
WP4962	Airway smooth muscle cell contraction	12/4673	13/5488	0.403873244744244	0.999999998939414	0.999999998939414	154/801/952/2664/2776/3710/4638/23236/5500/387/6093/9475	12
WP5111	Familial hyperlipidemia type 4	12/4673	13/5488	0.403873244744244	0.999999998939414	0.999999998939414	84532/335/337/1071/355/3949/64788/4023/4035/4547/5360/6400	12
WP5174	Ulcerative colitis signaling	12/4673	13/5488	0.403873244744244	0.999999998939414	0.999999998939414	50943/2625/3108/3561/3566/4094/4772/4790/64127/7040/7097/7124	12
WP5178	Disorders of fructose metabolism	12/4673	13/5488	0.403873244744244	0.999999998939414	0.999999998939414	216/229/2203/132158/2821/3098/3795/5211/5236/6514/6652/7167	12
WP5192	Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids	12/4673	13/5488	0.403873244744244	0.999999998939414	0.999999998939414	56624/64781/3091/3480/2475/4790/5290/5337/1901/1903/56848/7248	12
WP2507	Nanomaterial induced apoptosis	18/4673	20/5488	0.411820912222295	0.999999998939414	0.999999998939414	9131/317/578/596/637/836/839/840/841/842/8837/54205/56616/2021/8772/355/356/5551	18
WP3580	Methionine de novo and salvage pathway	18/4673	20/5488	0.411820912222295	0.999999998939414	0.999999998939414	55256/191/262/51074/55349/58478/259307/4144/27430/84245/4482/22921/253827/4953/6611/6723/6898/7295	18
WP5098	T-cell activation SARS-CoV-2	66/4673	76/5488	0.413010697895316	0.999999998939414	0.999999998939414	8915/598/84433/6363/56477/595/919/940/915/916/917/920/941/942/1026/1147/1493/64798/2353/2309/2534/9402/2885/2932/3122/3123/29851/3454/3455/3551/8517/3594/3595/8809/3708/3717/3725/3932/3937/4049/10892/5604/5605/5595/2475/4615/4772/4790/4792/5170/5293/5295/5335/5533/5588/5728/10125/5970/6009/6775/7124/7157/7248/7249/7297/7535	66
WP117	GPCRs, other	24/4673	27/5488	0.415205660851118	0.999999998939414	0.999999998939414	140/154/1234/9620/1952/1951/1131/3577/3579/2833/1909/2149/29933/11245/2841/1880/9290/2918/59352/53829/5737/1901/6608/6752	24
WP24	Peptide GPCRs	24/4673	27/5488	0.415205660851118	0.999999998939414	0.999999998939414	10396/719/728/1230/729230/1233/1234/1236/10803/3577/3579/2833/7852/643/10663/1909/1910/2357/2358/2359/4886/5540/6751/6752	24
WP2267	Synaptic vesicle pathway	30/4673	34/5488	0.416595145929628	0.999999998939414	0.999999998939414	160/161/163/477/773/2055/1211/1213/1759/10059/1785/26052/4905/11315/246213/6570/6571/6507/6581/291/81539/6532/6804/2054/6809/6812/6855/23025/10497/6844	30
WP2332	Interleukin-11 signaling pathway	36/4673	41/5488	0.416943629962323	0.999999998939414	0.999999998939414	466/596/332/1147/1385/2242/2534/2885/3383/3551/3589/3590/3572/3673/3716/3717/5604/5605/5595/5170/8554/10401/5295/5296/5781/5970/6194/6195/6198/860/9021/6772/6774/7040/7297/7525	36
WP314	Fas ligand pathway and stress induction of heat shock proteins	36/4673	41/5488	0.416943629962323	0.999999998939414	0.999999998939414	60/71/317/397/596/843/836/839/840/841/842/8837/54205/1616/8772/11124/355/356/3315/3552/3725/4000/4001/84823/6416/4214/6885/9261/7867/5058/5062/142/5591/5925/8767/7124	36
WP3611	Photodynamic therapy-induced AP-1 survival signaling	41/4673	47/5488	0.440263062047997	0.999999998939414	0.999999998939414	1386/578/596/598/10018/602/637/90427/890/595/898/1026/8837/1956/2002/355/356/2252/2353/1839/3569/3725/3726/5606/6416/5608/5609/4217/5600/6300/5603/4170/4313/5156/5925/7124/7132/8743/7157/7188/7189	41
WP23	B cell receptor signaling pathway	82/4673	95/5488	0.442588053227893	0.999999998939414	0.999999998939414	1386/8915/604/640/29760/695/84433/867/930/933/973/974/975/1147/1380/1385/1398/1399/27071/1871/2002/2113/2308/2534/2549/9846/2885/2931/2932/3059/3551/8517/3608/3635/3662/3725/8462/7462/3932/4067/10892/5604/5605/5608/6885/11184/5601/4149/4208/4209/4690/4773/4790/4792/5170/118788/5294/5295/5296/8394/8395/23396/5335/5336/5579/5580/5781/5777/5788/5879/5880/2889/25780/5966/5970/6195/6452/6464/6850/7006/7409/7410	82
WP4880	Host-pathogen interaction of human coronaviruses - interferon induction	29/4673	33/5488	0.444601680791065	0.999999998939414	0.999999998939414	1147/23586/5610/2353/64135/3454/3455/3551/9641/8517/3661/10379/3716/3725/6885/4615/4790/4792/4938/4939/4940/8737/6772/6773/29110/51284/7187/7189/7297	29
WP2525	Trans-sulfuration and one-carbon metabolism	23/4673	26/5488	0.446624819255849	0.999999998939414	0.999999998939414	191/10768/23382/275/875/1491/1719/1786/1788/2730/2937/4144/27430/4522/25902/10797/441024/4524/26227/29968/6470/6472/7298	23
WP4206	Hereditary leiomyomatosis and renal cell carcinoma pathway	17/4673	19/5488	0.448305891793318	0.999999998939414	0.999999998939414	31/32/54583/3091/9817/3939/5160/5162/5163/5562/5564/5571/6194/4891/6513/7157/7422	17
WP4304	Oligodendrocyte specification and differentiation, leading to myelin components for CNS	17/4673	19/5488	0.448305891793318	0.999999998939414	0.999999998939414	652/1267/2919/2920/2247/2736/3479/3553/3976/4155/5155/5354/6469/6660/55553/30812/7124	17
WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	11/4673	12/5488	0.449079173267381	0.999999998939414	0.999999998939414	1385/3685/3690/3710/3725/5595/8076/5335/5588/5747/7134	11
WP4190	Mevalonate arm of cholesterol biosynthesis pathway	11/4673	12/5488	0.449079173267381	0.999999998939414	0.999999998939414	38/39/2222/2224/9453/3155/3156/3157/3422/4597/4598	11
WP4724	Omega-9 fatty acid synthesis	11/4673	12/5488	0.449079173267381	0.999999998939414	0.999999998939414	10965/2180/2181/2182/60481/79071/3992/9415/2194/6319/79966	11
WP4792	Purine metabolism	11/4673	12/5488	0.449079173267381	0.999999998939414	0.999999998939414	100/158/270/353/471/1716/3251/3614/4860/5631/7498	11
WP5171	Leukotriene metabolic pathway	11/4673	12/5488	0.449079173267381	0.999999998939414	0.999999998939414	4363/240/241/4051/1666/26063/1800/64174/2678/2687/22949	11
WP697	Estrogen metabolism	11/4673	12/5488	0.449079173267381	0.999999998939414	0.999999998939414	414/1545/1576/2938/2944/1728/412/6817/6783/54658/7364	11
WP4262	Breast cancer pathway	99/4673	115/5488	0.450782232778888	0.999999998939414	0.999999998939414	208/10000/324/369/472/545/8312/8313/578/672/675/595/1019/1021/1026/1070/1452/1457/1459/1460/1499/1643/28514/54567/1856/1857/1869/1871/1950/1956/2064/2247/2252/2254/2260/2324/2353/10023/23401/8321/7976/7855/8323/8324/8325/1647/4616/2885/2932/3280/23462/26508/3479/3480/3714/3725/3815/51176/4041/4040/5604/5605/5595/2475/4683/8648/8202/4791/4851/4853/4854/4855/4893/142/5290/5293/5295/5296/8503/51426/5728/10111/5888/5925/6198/6199/6464/25759/6500/6655/6667/6932/83439/8600/7157/7481/7473/54361/7474	99
WP3925	Amino acid metabolism	64/4673	74/5488	0.450796827497106	0.999999998939414	0.999999998939414	30/34/47/50/84532/126/128/5832/216/440/445/549/586/790/875/1431/1491/1644/1738/1962/2184/2271/2730/2744/2746/2752/2805/2806/84706/2937/3033/3067/11112/26275/3155/3158/3176/3417/23395/3939/4128/56922/4190/4191/4357/4942/4953/5009/8974/5091/5105/5160/8050/5166/5315/151742/5831/6389/6611/6723/8802/6898/6999/7166	64
WP2882	Nuclear receptors meta-pathway	214/4673	250/5488	0.462254774731467	0.999999998939414	0.999999998939414	5243/5244/1244/8714/10257/10057/64240/64241/11057/30/34/57007/51/177/196/11214/211/218/241/347902/51129/335/345/221079/405/84002/8553/329/330/645/10486/873/874/6347/6364/595/11140/10602/983/1019/1066/8824/23491/283848/80315/1374/1376/8454/1545/1555/1557/1559/1576/1551/66002/1622/29103/1907/1956/1958/1962/8507/2033/54566/1969/2042/2168/2194/2258/9982/2289/2308/2495/2512/2539/4616/79571/2730/2678/57678/387509/2877/2878/2938/2939/2941/2944/2947/2948/2949/2950/1839/3280/3082/3162/3326/3303/3589/3553/8660/3725/3726/3727/9817/3895/56262/23764/4097/4199/4240/4257/4258/4259/26509/8648/10499/8202/23054/4791/1728/8431/9971/8856/2908/3084/8204/5105/5142/5155/5166/5226/10769/5360/51426/5460/5465/5467/10891/5052/9588/5705/22949/5743/5997/6256/6286/6319/6342/6397/5265/5272/9792/1836/376497/6513/81031/154091/114134/6514/6515/6517/6518/11182/29988/27173/57181/201266/91252/23516/29985/55630/283375/25800/7922/115584/159963/6526/6527/200010/11254/340024/54716/6532/6533/6534/6536/23657/8140/11309/6594/8243/6667/6720/5552/27286/6774/2040/6817/6822/7039/7040/7048/7049/7056/7124/7128/84951/1831/7295/7296/114112/54658/7364/7421	214
WP4239	Epithelial to mesenchymal transition in colorectal cancer	104/4673	121/5488	0.463207713056128	0.999999998939414	0.999999998939414	208/10000/999/9076/9069/24146/51208/9075/1365/1364/7122/1366/9073/1282/1284/1285/1286/1287/92359/58190/1499/28514/54567/1832/8726/56648/2146/114793/2335/2305/8321/7976/8322/7855/8323/8324/8325/9518/2885/2932/3091/3397/3398/3678/182/3714/3728/26524/4041/4040/5604/5605/5606/6416/5608/5600/6300/5603/5595/4209/4324/4313/4318/4851/4853/4854/4855/8828/80224/100506658/5058/10016/5290/5293/5295/5296/8503/5310/5317/5318/5629/3516/6464/4089/6655/6678/11171/23512/7040/7043/7046/7048/7082/56649/7157/7189/7991/7481/7473/54361/7474/7483/6935/9839	104
WP4222	Phosphodiesterases in neuronal function	28/4673	32/5488	0.473505316387536	0.999999998939414	0.999999998939414	107/109/196883/111/112/113/115/1139/1385/2977/10846/50940/5153/5137/5138/5139/5140/5142/5143/5144/8654/5145/5147/5150/5151/8622/5152/84152	28
WP5124	Alzheimer's disease	178/4673	208/5488	0.477747455601787	0.999999998939414	0.999999998939414	6868/11047/177/208/10000/55626/317/324/51107/83464/348/351/369/468/22926/9776/22863/23130/55102/488/8312/8313/23621/572/8678/637/775/776/801/808/91860/823/824/836/840/841/842/1020/8851/1139/1147/1435/1452/1454/1457/1459/1460/1499/1536/54205/1649/1856/1857/5610/9451/1965/2081/8772/355/10023/23401/8321/7976/7855/8323/8324/8325/2597/2776/2932/3028/3416/3551/3552/3553/3569/3643/8660/3708/3709/3710/3800/64837/89953/4023/4035/4041/4040/5604/5605/5609/4217/5595/5601/90550/4311/2475/4790/4843/27035/4893/29982/5290/5293/5295/5296/8503/23236/5330/5331/5481/10105/5530/5532/5533/5534/5663/5664/5682/5683/5684/5685/5686/5687/5688/5689/5690/5691/5692/5693/5694/5695/5700/5701/5702/5704/5705/5706/5707/5718/5719/10213/5708/5710/9861/5713/5714/5743/9821/5970/10313/57142/291/292/293/7124/7132/7846/10376/84790/79861/203068/7280/347733/10381/10383/84617/9706/7416/7417/7419/55062/26100/7481/7473/54361/7474/7494	178
WP5121	Sphingolipid metabolism in senescence	22/4673	25/5488	0.479265138076888	0.999999998939414	0.999999998939414	427/1017/1019/1026/29956/79603/8560/1869/2629/2720/2475/23236/5578/5579/5925/10557/1901/166929/81537/55512/8877/7357	22
WP2446	Retinoblastoma gene in cancer	74/4673	86/5488	0.480868736276488	0.999999998939414	0.999999998939414	25/54443/580/8030/890/891/9133/595/896/898/9134/993/994/8318/8317/983/1017/1019/1021/1026/81620/1111/1633/1719/1786/1869/1871/11124/2189/3065/3146/3148/24137/5603/4172/4173/4175/4176/4193/2956/4998/5111/10733/5422/10714/5426/5427/5557/5591/3275/5925/5931/5983/5984/5985/6119/6240/6241/8819/25942/6502/6595/8243/10592/9126/6839/7027/7029/7153/7157/7272/7298/7465/79027	74
WP2118	Arrhythmogenic right ventricular cardiomyopathy	45/4673	52/5488	0.483535473421454	0.999999998939414	0.999999998939414	60/71/87/81/488/775/776/781/9254/93589/783/784/1495/1499/1674/1824/1832/2010/2697/3672/22801/3673/3676/3678/3655/3679/8516/3680/3685/3688/3690/3691/3693/3694/3695/3728/3908/51176/4000/5318/6443/6444/6546/6932/83439	45
WP395	IL-4 signaling pathway	45/4673	52/5488	0.483535473421454	0.999999998939414	0.999999998939414	1386/572/332/867/1051/1147/9046/2002/2033/2242/2316/2353/9846/2625/2885/3269/3551/3561/3566/3635/8660/3716/3717/3718/5600/5595/4790/4792/5290/5293/5295/5296/5781/5777/5970/6198/6464/8651/9021/9655/6772/6774/6776/6777/7297	45
WP3599	Transcription factor regulation in adipogenesis	16/4673	18/5488	0.486642272856989	0.999999998939414	0.999999998939414	1051/1052/1385/2308/3569/3643/8660/23175/2908/8204/5106/5468/10891/6256/6517/7124	16
WP3670	Interactions between LOXL4 and oxidative stress pathway	16/4673	18/5488	0.486642272856989	0.999999998939414	0.999999998939414	308/11140/1280/780/51295/54536/2252/2335/3490/84171/1728/4899/5310/23411/6839/7040	16
WP383	Striated muscle contraction pathway	16/4673	18/5488	0.486642272856989	0.999999998939414	0.999999998939414	59/71/81/1674/4604/4621/10398/8736/7111/7134/7125/7168/7169/7170/7171/7431	16
WP5044	Kynurenine pathway and links to cell senescence	16/4673	18/5488	0.486642272856989	0.999999998939414	0.999999998939414	51166/125061/196/1026/2308/23498/3620/7850/688/8564/8942/23475/6999/7099/7124/7157	16
WP5066	FOXA2 pathway	16/4673	18/5488	0.486642272856989	0.999999998939414	0.999999998939414	1244/8714/10257/31/338/2194/3169/3170/2308/2938/2939/8660/51085/4547/133522/6720	16
WP5194	Synthesis of ceramides and 1-deoxyceramides	16/4673	18/5488	0.486642272856989	0.999999998939414	0.999999998939414	53947/427/84002/2683/64781/29956/79603/91012/253782/1674/8694/259230/166929/8877/7357/7368	16
WP78	TCA cycle (aka Krebs or citric acid cycle)	16/4673	18/5488	0.486642272856989	0.999999998939414	0.999999998939414	50/1431/1738/2271/3418/3419/3420/3421/4191/6389/6390/6391/6392/8803/8802/8801	16
WP186	Homologous recombination	10/4673	11/5488	0.497742843124406	0.999999998939414	0.999999998939414	472/675/4683/5424/5425/10714/57804/10111/5888/5893	10
WP229	Irinotecan pathway	10/4673	11/5488	0.497742843124406	0.999999998939414	0.999999998939414	4363/1244/9429/590/1066/8824/1576/4864/54658/54575	10
WP4271	Vitamin B12 disorders	10/4673	11/5488	0.497742843124406	0.999999998939414	0.999999998939414	81693/51293/8029/166785/326625/25974/27249/4552/6947/6948	10
WP4553	FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma	10/4673	11/5488	0.497742843124406	0.999999998939414	0.999999998939414	604/54880/1848/8726/2146/84678/5595/84759/6045/23512	10
WP4723	Omega-3 / omega-6 fatty acid synthesis	10/4673	11/5488	0.497742843124406	0.999999998939414	0.999999998939414	10965/51/8310/2180/2181/2182/60481/3992/9415/8398	10
WP2857	Mesodermal commitment pathway	96/4673	112/5488	0.497937195357071	0.999999998939414	0.999999998939414	31/90/92/93/8728/84159/10973/57198/8312/8313/63035/8553/652/655/657/659/203228/8030/55704/595/11190/8646/23373/1466/23576/28514/2005/26610/8320/57669/2132/2260/3169/3170/8322/7855/8325/2625/2627/79977/8091/3172/3251/3624/3717/3720/9314/688/9113/51176/10637/23499/54799/4211/22823/79035/54892/51701/79668/5087/5090/84295/8554/5308/5460/5515/5566/5573/5915/5916/6001/6169/27244/29072/154091/4086/4089/4091/6722/6926/6925/83439/7003/8463/9760/27324/55809/85363/57045/51366/10451/115825/11169/7473/23528/58499	96
WP5130	Th17 cell differentiation pathway	50/4673	58/5488	0.500493339999111	0.999999998939414	0.999999998939414	196/919/915/916/917/920/9575/1407/2353/50943/2625/3091/3108/3459/3551/3553/50615/9466/3559/3566/3569/3570/3662/3716/3717/3725/3932/2475/4772/4790/4792/9572/5187/5335/5530/5588/5914/6095/6097/861/6256/9021/6772/6774/6776/30009/7040/7046/7297/7535	50
WP236	Adipogenesis	90/4673	105/5488	0.502282998136649	0.999999998939414	0.999999998939414	10555/183/196/651/652/1026/1051/1052/10658/1675/55847/1271/1385/1499/56603/1649/1869/1879/1959/2034/355/2308/2487/8321/1647/4616/2624/2625/2971/3091/3159/6927/3479/3569/3572/8660/688/1316/8609/3976/3991/4000/23175/64900/4023/4205/4208/4209/10135/8648/10499/9611/9612/4692/7025/2908/8204/5008/5105/5106/123/5465/5467/5468/10891/5618/5740/5914/5925/5933/5934/6095/6256/6319/5054/6517/8651/9021/6667/6695/6720/6772/6773/6774/6776/6777/7040/7124/57761/25937	90
WP4148	Splicing factor NOVA regulated synaptic proteins	27/4673	31/5488	0.503205263941896	0.999999998939414	0.999999998939414	375790/288/334/490/23705/57863/818/8573/858/10752/23332/22883/1600/1946/2035/2036/2037/23136/10243/4134/5601/23154/4756/5590/5909/2054/54386	27
WP5055	Burn wound healing	78/4673	91/5488	0.511906348568784	0.999999998939414	0.999999998939414	43/8038/596/836/6347/57124/916/1139/1265/1277/1278/2919/9547/3579/7852/1634/1950/2006/2162/2200/2260/2263/2261/2335/60674/3082/3146/3383/3600/3552/3553/3569/3624/3791/9314/3956/23643/440823/406937/4312/4322/4313/79148/4314/4318/100463486/4615/4790/4792/64332/10392/64127/5159/6282/6277/6280/871/6423/6678/6876/7040/7043/7076/7077/7096/7097/7099/10333/51284/51311/54106/3371/7124/7128/7157/7422/7431/7503	78
WP2875	Constitutive androstane receptor pathway	21/4673	24/5488	0.512996086983382	0.999999998939414	0.999999998939414	5243/1244/8714/211/1555/1557/1559/1576/1962/2308/2939/8648/10499/23054/10891/6256/8243/6667/6817/6822/54658	21
WP4698	Vitamin D-sensitive calcium signaling in depression	21/4673	24/5488	0.512996086983382	0.999999998939414	0.999999998939414	490/493/596/775/1593/1594/2539/2678/2879/3708/3709/3710/3786/23028/221656/55818/23135/6256/6546/7166/7421	21
WP4925	Unfolded protein response	21/4673	24/5488	0.512996086983382	0.999999998939414	0.999999998939414	468/22926/596/10018/637/835/841/1649/9451/1965/2081/3309/3553/8720/51360/5366/23645/8795/7157/10628/7494	21
WP167	Eicosanoid synthesis	15/4673	17/5488	0.526659448453244	0.999999998939414	0.999999998939414	246/240/241/1800/2678/5320/8398/50640/5730/9536/80142/5740/5742/5743/6916	15
WP325	Triacylglyceride synthesis	15/4673	17/5488	0.526659448453244	0.999999998939414	0.999999998939414	10554/10555/56894/56895/8540/8694/2710/8443/57678/2819/3991/4023/80168/346606/57104	15
WP391	Mitochondrial gene expression	15/4673	17/5488	0.526659448453244	0.999999998939414	0.999999998939414	1385/2101/2553/3054/50804/4899/5442/10891/133522/5530/23082/6667/7019/51106/64216	15
WP2884	NRF2 pathway	94/4673	110/5488	0.529930041065658	0.999999998939414	0.999999998939414	1244/8714/10257/10057/177/218/645/873/874/1066/8824/23491/283848/1958/1969/2042/2258/2495/2512/2539/2730/2678/2877/2878/2938/2939/2941/2944/2947/2948/2949/2950/1839/3082/3162/3326/3303/9817/23764/4097/4199/4258/4259/1728/3084/5155/5226/5467/5052/9588/22949/6256/5265/6513/81031/154091/114134/6514/6515/6517/6518/11182/29988/27173/57181/201266/91252/23516/29985/55630/283375/25800/7922/115584/159963/6526/6527/200010/11254/340024/54716/6532/6533/6534/6536/23657/7039/7040/7048/7295/7296/114112/54658/7364	94
WP2059	Alzheimer's disease and miRNA effects	179/4673	210/5488	0.533255842771479	0.999999998939414	0.999999998939414	6868/11047/177/208/10000/55626/317/324/51107/83464/348/351/369/468/22926/9776/22863/23130/55102/488/8312/8313/23621/572/8678/637/775/776/801/808/91860/823/824/836/840/841/842/1020/8851/54480/1139/1147/1435/1452/1454/1457/1459/1460/1499/1536/54205/1649/1856/1857/5610/9451/1965/2081/8772/355/10023/23401/8321/7976/7855/8323/8324/8325/2597/2776/2932/3028/3416/3551/3552/3553/3569/3643/8660/3708/3709/3710/3800/64837/89953/4023/4035/4041/4040/5604/5605/5609/4217/5595/5601/90550/4311/2475/4790/4843/27035/4893/29982/5290/5293/5295/5296/8503/23236/5330/5331/5481/10105/5530/5532/5533/5534/5663/5664/5682/5683/5684/5685/5686/5687/5688/5689/5690/5691/5692/5693/5694/5695/5700/5701/5702/5704/5705/5706/5707/5718/5719/10213/5708/5710/9861/5713/5714/5743/9821/5970/10313/57142/291/292/293/7124/7132/7846/10376/84790/79861/203068/7280/347733/10381/10383/84617/9706/7416/7417/7419/55062/26100/7481/7473/54361/7474/7494	179
WP2371	Parkinson's disease pathway	26/4673	30/5488	0.533581854962894	0.999999998939414	0.999999998939414	317/6311/835/836/839/840/842/898/9134/54205/1644/120892/5600/6300/5603/11315/65018/9627/23208/7317/7318/7314/51465/118424/7332/9246	26
WP4922	Mitochondrial complex IV assembly	26/4673	30/5488	0.533581854962894	0.999999998939414	0.999999998939414	152100/28958/1352/1353/84987/1355/51241/285521/90639/116228/1327/9377/1329/1337/1340/1345/1347/1349/1350/1351/25994/25953/389203/6834/51204/80775	26
WP4655	Cytosolic DNA-sensing pathway	48/4673	56/5488	0.5449704722734	0.999999998939414	0.999999998939414	103/9447/9140/9474/834/843/841/6351/6352/1147/3627/1540/23586/8772/3551/9641/8517/3606/3553/90865/3569/3661/3665/9636/4790/4792/4793/79671/5435/5437/5440/55703/661/10621/10622/84265/171568/51728/29108/5970/8737/11035/54941/29110/8717/11277/7706/81030	48
WP531	DNA mismatch repair	20/4673	23/5488	0.547654945079654	0.999999998939414	0.999999998939414	9156/3978/4292/4436/2956/5111/5424/5425/10714/57804/5426/5427/54107/56655/5981/5982/5983/5984/5985/6119	20
WP2333	Trans-sulfuration pathway	9/4673	10/5488	0.549694137332835	0.999999998939414	0.999999998939414	191/875/51380/1491/1786/2730/2805/27430/4357	9
WP2436	Dopamine metabolism	9/4673	10/5488	0.549694137332835	0.999999998939414	0.999999998939414	1644/4128/4129/1728/5515/5516/5566/5567/6647	9
WP4259	Disorders of folate metabolism and transport	9/4673	10/5488	0.549694137332835	0.999999998939414	0.999999998939414	10840/471/1719/2618/4522/4524/6472/113235/7298	9
WP5050	TCA cycle in senescence	9/4673	10/5488	0.549694137332835	0.999999998939414	0.999999998939414	2271/2805/4190/4199/4200/5160/5163/57546/7157	9
WP5118	SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome	9/4673	10/5488	0.549694137332835	0.999999998939414	0.999999998939414	472/672/9656/4683/56852/5885/10111/8243/9126	9
WP2858	Ectoderm differentiation	87/4673	102/5488	0.551931372349161	0.999999998939414	0.999999998939414	10257/54806/79658/55843/23229/11177/54828/54880/652/657/91653/56913/10486/6347/1004/50937/1952/1487/1499/1896/2263/2274/3170/2534/8322/7855/8325/2627/2720/2737/57476/10013/3148/3728/54207/3801/9079/4061/9935/54903/79731/4772/51701/7026/4926/8473/9924/5150/5236/5292/345557/5362/5420/5452/5467/8495/51422/5783/51762/56963/6016/4920/6238/6386/5269/27352/6469/6498/4089/57154/8835/114815/10253/7903/6781/6907/83439/4982/27324/7226/8848/25987/7343/54521/57621/51043/51222	87
WP2637	Interleukin-1 (IL-1) structural pathway	42/4673	49/5488	0.554329460806959	0.999999998939414	0.999999998939414	1386/1147/1977/2002/2353/3551/3552/3554/3556/3654/3656/51135/3665/5604/5605/5606/6416/5608/5609/4214/4215/6885/1326/5600/5595/5601/9261/4155/2872/4615/4790/4792/4793/5970/9252/6294/10454/23118/257397/10010/54472/7189	42
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	14/4673	16/5488	0.568122644485044	0.999999998939414	0.999999998939414	2194/3156/3157/3949/51586/2475/5465/10891/5562/6319/23411/51548/6720/6721	14
WP2916	Interactome of polycomb repressive complex 2 (PRC2) 	14/4673	16/5488	0.568122644485044	0.999999998939414	0.999999998939414	9774/8726/8178/2145/2146/3720/23515/22823/5931/23064/11329/23512/9967/23087	14
WP3931	Embryonic stem cell pluripotency pathways	69/4673	81/5488	0.572732408994215	0.999999998939414	0.999999998939414	10097/90/208/10000/324/369/8312/652/657/659/1499/1856/1857/1950/1956/2002/2258/2247/2252/2254/2260/2263/2261/2353/8321/7976/8322/7855/8323/8324/8325/2549/2885/2932/6927/3572/3716/3725/3976/4041/4040/5604/5605/5606/5608/6300/5597/5598/4193/2475/5154/5155/5156/5159/5293/5296/5728/5781/4086/4089/4090/4091/4092/4093/6774/7481/7473/54361/7474	69
WP4540	Hippo signaling regulation pathways	69/4673	81/5488	0.572732408994215	0.999999998939414	0.999999998939414	999/1009/1012/1015/64403/1001/1003/1004/1436/1499/1956/1969/2260/2263/2261/2321/2322/2324/2767/2771/2773/2774/2776/3480/3643/3791/3815/9113/26524/51176/4233/4485/2475/4804/4915/5156/5159/23236/5330/5331/5562/5564/5565/5566/5567/5571/51422/5573/5575/5576/5577/5578/5579/5580/5581/5583/5584/5588/5590/23683/5879/387/6788/6932/83439/7003/8463/7004/7010	69
WP4541	Hippo-Merlin signaling dysregulation	80/4673	94/5488	0.575502249640145	0.999999998939414	0.999999998939414	84962/154796/595/960/999/1009/1012/1015/64403/1001/1003/1004/1436/1495/1499/8451/3627/1642/1956/1969/2260/2263/2261/2321/2322/2324/2305/3480/3643/3672/22801/3673/3676/3678/3655/3679/8516/3680/3682/3683/3684/3685/3687/3688/3689/3690/3691/3693/3694/3695/3791/3815/9113/26524/4233/4485/4804/4893/4915/5058/5062/10298/5156/5159/5499/5500/4659/5566/5567/5573/5575/5576/5577/5747/60485/6788/7003/8463/7004/7010	80
WP3929	Chemokine signaling pathway	119/4673	140/5488	0.577963453066109	0.999999998939414	0.999999998939414	107/109/196883/111/112/113/115/208/10000/408/9564/6356/6359/6363/6364/6366/6367/6369/6370/56477/6348/6351/6352/1230/729230/1233/1236/10803/1147/1398/1399/1445/6376/3627/6373/10563/9547/58191/2921/6374/4283/3579/2833/7852/643/10663/1794/9844/2268/2309/2771/2773/2783/59345/10681/2791/54331/2786/2793/2885/2869/2870/2932/3055/3551/8517/3702/3717/3718/4067/5604/5595/653361/4790/4792/4793/4893/5058/56288/5290/5293/5294/5295/5296/8503/23533/23236/5330/5331/57580/5567/5579/5580/5590/5613/5747/2185/5829/5879/5880/5908/10235/5970/6093/9475/6464/25759/6655/6772/6773/6774/6777/26230/7409/7410/10451/7454/8976/2829	119
WP4659	Gastrin signaling pathway	91/4673	107/5488	0.578267150924203	0.999999998939414	0.999999998939414	302/64283/408/1386/572/9564/598/329/330/332/836/595/960/999/1026/1113/1147/9076/1385/1398/1499/1956/1958/1978/1994/2002/2353/2308/2309/2534/2776/2885/2932/51564/3067/3551/3688/182/3717/3725/10524/3815/9314/8649/5604/5595/5601/4208/4209/4316/2475/4790/4792/5058/5290/5295/5296/8503/5335/5468/5566/5578/5580/5581/5583/5588/5587/25865/5743/5747/5781/5829/5879/5970/387/388/29984/6093/6194/6198/5054/6464/6548/6550/6667/6774/6925/7032/7082/7422/7525	91
WP3286	Copper homeostasis	41/4673	48/5488	0.578339268951431	0.999999998939414	0.999999998939414	6868/8754/324/351/475/538/540/23621/836/595/9973/1353/2308/2309/2932/3725/4193/4493/4494/4495/4496/4500/4501/4502/4520/22823/5290/5621/5728/6341/4891/1317/1318/6647/6667/26872/55240/79689/7157/54739/331	41
WP4136	Fibrin complement receptor 3 signaling pathway	30/4673	35/5488	0.578755755701595	0.999999998939414	0.999999998939414	868/6347/929/1147/3627/2921/3551/8517/3569/3654/3656/51135/3661/3684/3689/23643/4615/4790/4843/5290/5327/83593/5966/5970/387/6850/7099/7124/7189/7305	30
WP357	Fatty acid biosynthesis	19/4673	22/5488	0.583044915277543	0.999999998939414	0.999999998939414	31/32/47/2180/2181/2182/51703/55902/1666/1891/55862/55268/1892/2194/3033/51102/5091/55825/6319	19
WP4320	Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome	19/4673	22/5488	0.583044915277543	0.999999998939414	0.999999998939414	10951/11335/23468/1107/1869/3065/51763/23028/51176/8932/53615/9112/9219/57504/5925/5931/6720/6839/7157	19
WP4969	RAS and bradykinin pathways in COVID-19	19/4673	22/5488	0.583044915277543	0.999999998939414	0.999999998939414	1636/59272/183/1576/3552/3553/3816/3818/3827/4790/4846/4881/5592/387/6093/5054/710/7124/7421	19
WP5083	Neuroinflammation and glutamatergic signaling	85/4673	100/5488	0.585201712417688	0.999999998939414	0.999999998939414	107/109/596/801/817/818/84254/10645/1385/1610/27185/1738/2247/2353/2744/2752/2805/2893/2899/116443/2918/3459/3460/3479/3587/3588/3552/3553/3554/7850/3566/3569/3570/3572/3643/3716/3976/56262/23507/84230/55144/80131/4049/5595/4790/4791/5160/26227/23236/5330/5331/5499/5500/5566/5578/5579/29968/6470/6472/6505/6506/6507/6509/6513/6515/81539/54407/92745/6536/4089/4092/9021/63826/6772/6774/7040/7043/7046/7048/7049/7124/7132/7133/7188/54795	85
WP2018	RANKL/RANK signaling pathway	46/4673	54/5488	0.590023321982101	0.999999998939414	0.999999998939414	54/208/867/1147/1513/2274/2353/9846/3383/3551/8517/3725/4067/5604/5608/5609/6885/5595/5601/4286/2475/4772/4790/4791/4792/9060/5295/5296/5335/5747/5879/5970/5971/6688/6772/6850/10454/23118/8792/4982/8600/7185/7187/7188/7189/7412	46
WP2583	T cell receptor and co-stimulatory signaling	24/4673	28/5488	0.595789589514097	0.999999998939414	0.999999998939414	801/940/925/926/1452/1493/8445/2534/2931/2932/3702/3932/4773/4790/4792/5133/5163/5335/5530/5578/5728/5777/10125/7535	24
WP4786	Type I collagen synthesis in the context of osteogenesis imperfecta	24/4673	28/5488	0.595789589514097	0.999999998939414	0.999999998939414	9509/1277/1278/79709/90993/60681/8321/3708/4015/4041/4040/8720/51360/5033/8974/5034/5351/5479/5176/871/55151/8792/4982/8600	24
WP4823	Genes controlling nephrogenesis	24/4673	28/5488	0.595789589514097	0.999999998939414	0.999999998939414	23607/948/1499/7852/2118/2263/2737/6928/3611/8516/3688/3791/3913/4690/8440/4853/5155/5159/5979/6092/6469/6943/7422/54361	24
WP3646	Hepatitis C and hepatocellular carcinoma	40/4673	47/5488	0.602419902488658	0.999999998939414	0.999999998939414	598/330/332/672/836/840/842/595/960/1026/1284/2017/3577/356/2487/2885/3091/6927/3569/3570/3716/3725/51176/5595/4312/26509/4790/4843/5420/5743/5781/5879/6241/4089/6774/7040/7046/7157/7410/7422	40
WP4879	Overlap between signal transduction pathways contributing to LMNA laminopathies	40/4673	47/5488	0.602419902488658	0.999999998939414	0.999999998939414	60/27161/324/8312/1019/1026/1051/1052/1387/1452/1499/1513/23405/1869/2010/2339/2932/3065/3280/8091/3726/51176/23592/4000/4128/4129/4673/4851/5468/5925/860/6696/6720/6895/6932/83439/7040/7088/7112/4982	40
WP1545	miRNAs involved in DNA damage response	13/4673	15/5488	0.610724743755486	0.999999998939414	0.999999998939414	25/472/595/896/898/993/1021/1026/1385/1869/406937/5893/7157	13
WP2291	Deregulation of Rab and Rab effector genes in bladder cancer	13/4673	15/5488	0.610724743755486	0.999999998939414	0.999999998939414	23086/9648/8567/25924/5874/9501/84958/54843/94120/94121/94122/83874/201294	13
WP4240	Regulation of sister chromatid separation at the metaphase-anaphase transition	13/4673	15/5488	0.610724743755486	0.999999998939414	0.999999998939414	51529/699/701/9184/991/1062/9700/8379/4085/9232/5885/8243/9126	13
WP497	Urea cycle and metabolism of amino groups	13/4673	15/5488	0.610724743755486	0.999999998939414	0.999999998939414	5832/435/445/1152/2628/2746/162417/4942/4953/5009/5831/6611/6723	13
WP5149	Lipid metabolism in senescent cells	13/4673	15/5488	0.610724743755486	0.999999998939414	0.999999998939414	240/1026/8399/81579/84647/26279/8605/255189/8398/7941/5743/6578/7157	13
WP5182	Pro-survival signaling of neuroprotectin D1	13/4673	15/5488	0.610724743755486	0.999999998939414	0.999999998939414	330/836/840/841/842/54205/8772/5516/8737/11035/7124/7132/8717	13
WP2795	Cardiac hypertrophic response	45/4673	53/5488	0.612592705001206	0.999999998939414	0.999999998939414	208/801/817/1022/1025/1147/1950/2247/2263/2932/9759/10014/51564/9734/3479/3551/9641/8517/5604/5605/5606/6416/5608/5609/4214/6885/11184/5595/5598/4205/2475/4773/4790/3084/5170/5320/5530/5578/5587/5592/5879/7040/7046/7124/7132	45
WP2509	Nanoparticle triggered autophagic cell death	18/4673	21/5488	0.61893389062108	0.999999998939414	0.999999998939414	55626/83734/9140/22863/64422/115201/9474/10533/596/8678/10036/3643/84557/51100/7248/7249/9706/7405	18
WP3658	Wnt/beta-catenin signaling pathway in leukemia	18/4673	21/5488	0.61893389062108	0.999999998939414	0.999999998939414	324/8313/607/595/1452/1499/2322/8323/2932/3728/51176/4041/4040/5371/5467/26108/5914/862	18
WP4532	Intraflagellar transport proteins binding to dynein	18/4673	21/5488	0.61893389062108	0.999999998939414	0.999999998939414	1778/1781/51143/51626/140735/83658/6993/6990/51668/55764/9742/11020/112752/56912/57560/28981/57728/57539	18
WP4941	GPR143 in melanocytes and retinal pigment epithelium cells	18/4673	21/5488	0.61893389062108	0.999999998939414	0.999999998939414	196883/115/408/1385/2769/2776/3708/4286/23236/5330/5331/6490/5566/5567/5579/5176/7306/7422	18
WP4746	Thyroid hormones production and peripheral downstream signaling effects	61/4673	72/5488	0.619644913473295	0.999999998939414	0.999999998939414	109/10000/364/1386/572/842/10488/1499/1734/50506/405753/2260/2308/10818/2885/2932/3685/3690/3709/389434/23028/51780/152831/5604/11183/7867/4193/11343/2475/57224/4851/4881/7849/5208/5290/23236/57104/5468/10891/5566/5588/5593/6009/6194/27330/6198/6256/6469/51548/117247/6567/5172/9882/7067/7068/7157/7248/7249/8458/54361/9658	61
WP2876	Pregnane X receptor pathway	23/4673	27/5488	0.62728498008306	0.999999998939414	0.999999998939414	5243/1244/8714/10257/1555/1557/1559/1576/1551/66002/2308/2939/8648/10499/8202/8856/8204/10891/5705/6256/27286/6822/54658	23
WP3996	Ethanol effects on histone modifications	23/4673	27/5488	0.62728498008306	0.999999998939414	0.999999998939414	55902/125/126/191/216/8854/220/217/1386/1719/10919/55140/8520/3065/9759/10014/10013/51564/55869/9734/4524/6573/7298	23
WP4963	p53 transcriptional gene network	66/4673	78/5488	0.628198058967145	0.999999998939414	0.999999998939414	136/8659/317/6790/7832/6347/898/900/993/995/1017/1026/6376/1643/54541/64798/55332/144455/2073/355/356/2517/1647/2876/3383/3663/10379/9636/3976/4255/406937/4292/4436/2475/4688/4851/5111/5366/5371/5429/51426/5562/5564/5565/5571/51422/5728/50484/6303/5268/5054/27244/83667/2810/6513/23657/7124/8795/8793/9540/94241/9618/7249/9706/7508/7520	66
WP3594	Circadian rhythm genes	120/4673	142/5488	0.64095109021876	0.999999998939414	0.999999998939414	100/107/191/196/405/9915/56938/468/22809/8553/114781/8945/1019/1364/9575/1374/1385/1390/23373/1407/1408/1453/1454/1471/8454/1628/1644/1655/1958/1960/2033/2146/355/26224/23291/2673/2767/2776/2932/3065/50865/6928/3184/3398/3569/3725/3727/687/4297/55366/9500/5601/56339/9112/4547/10514/4669/10135/10499/9611/4804/4841/4843/4862/9572/9975/2063/8204/8473/23596/5187/8864/8863/23239/5371/5465/5468/10891/5499/5500/5551/5562/5591/5593/10419/60675/5629/55269/5728/5730/10743/5936/83759/5971/9475/6095/6097/6233/5054/23064/150094/25942/23411/6500/6532/6550/6720/6839/79723/9967/8914/8792/7150/7153/7157/7166/7298/7316/9099/463	120
WP98	Prostaglandin synthesis and regulation	33/4673	39/5488	0.643084259741354	0.999999998939414	0.999999998939414	10257/231/1645/301/302/306/307/308/309/873/1906/1909/1910/3248/3290/3291/4286/5468/10891/133522/5729/5730/5732/5733/5734/9536/5737/5740/5742/5743/6281/6277/6916	33
WP5053	Development of ureteric collection system	38/4673	45/5488	0.650436530102799	0.999999998939414	0.999999998939414	652/653/655/168667/657/659/595/9620/1499/2118/79633/2263/80144/158326/2625/10220/2674/2735/2736/2737/2719/23426/6928/3611/8516/3688/5087/5914/5915/5916/5979/6091/6092/6469/4086/6608/57216/7481	38
WP272	Blood clotting cascade	12/4673	14/5488	0.654078770230386	0.999999998939414	0.999999998939414	2159/2160/2152/2153/8263/3816/3818/5327/5328/5054/5345/7450	12
WP2895	Differentiation of white and brown adipocyte	12/4673	14/5488	0.654078770230386	0.999999998939414	0.999999998939414	652/655/1051/1054/51316/5468/10891/133522/4086/4090/4093/23090	12
WP3935	Leptin-insulin signaling overlap	12/4673	14/5488	0.654078770230386	0.999999998939414	0.999999998939414	8525/3643/8660/3717/3953/5170/5294/8503/8651/8835/9021/6774	12
WP4159	GABA receptor signaling	12/4673	14/5488	0.654078770230386	0.999999998939414	0.999999998939414	18/223/160/161/163/2550/2555/2561/2562/2564/2568/10243	12
WP5061	Fatty acid transporters	12/4673	14/5488	0.654078770230386	0.999999998939414	0.999999998939414	2180/2181/2182/51703/948/1622/2168/2169/2170/2171/2172/10999	12
WP2878	PPAR-alpha pathway	17/4673	20/5488	0.655054109362449	0.999999998939414	0.999999998939414	30/34/335/345/595/983/1019/1374/1376/1622/1962/2168/5360/5465/6256/6342/376497	17
WP3640	Imatinib and chronic myeloid leukemia	17/4673	20/5488	0.655054109362449	0.999999998939414	0.999999998939414	5243/9429/25/1436/2321/2309/9846/1647/3815/4066/4839/5156/5159/5292/11040/6502/200734	17
WP3872	Regulation of apoptosis by parathyroid hormone-related protein	17/4673	20/5488	0.655054109362449	0.999999998939414	0.999999998939414	578/596/597/598/83596/23786/79370/440603/599/637/666/2931/2932/3655/3691/4170/5294	17
WP3959	DNA IR-double strand breaks and cellular response via ATM	43/4673	51/5488	0.65744399419334	0.999999998939414	0.999999998939414	25/317/1386/472/545/578/637/641/672/675/836/842/995/1020/1111/11200/64421/1869/9156/2177/3297/10524/9113/79648/9656/4193/79035/4683/142/5111/5591/10111/5888/5893/5883/11186/8243/9126/6788/7014/7157/7189/5976	43
WP536	Calcium regulation in cardiac cells	86/4673	102/5488	0.657992712082753	0.999999998939414	0.999999998939414	107/109/196883/111/112/113/115/153/154/309/408/481/483/488/490/773/775/776/784/801/808/811/8536/817/818/1131/1132/2280/2697/2701/2702/2705/10052/2767/2771/2773/2776/2783/59345/10681/2791/54331/2786/2869/2870/3708/3709/3710/3760/5569/5570/11142/5331/5350/5566/5567/5573/5575/5576/5577/5578/5579/5580/5581/5583/5588/5590/5587/5996/6001/10636/6004/64407/10287/5997/5998/5999/8490/8787/2810/6546/57620/7531/7532/10971/7534	86
WP5038	Mitochondrial immune response to SARS-CoV-2	22/4673	26/5488	0.6587868915926	0.999999998939414	0.999999998939414	1636/59272/617/1514/23586/51295/64135/9641/3661/3665/51103/4715/4790/4791/79671/27035/11331/29110/51284/7113/7187/7189	22
WP5102	Familial partial lipodystrophy (FPLD)	22/4673	26/5488	0.6587868915926	0.999999998939414	0.999999998939414	208/8815/2339/2624/2625/10365/688/687/3991/4000/4001/84823/4023/5601/11343/5290/57104/5465/5468/5396/6720/6777	22
WP4542	Leukocyte-intrinsic Hippo pathway functions	27/4673	32/5488	0.663584980735437	0.999999998939414	0.999999998939414	1236/930/83706/2308/2309/4303/50943/3683/90417/9113/26524/4023/55233/4485/10397/639/5872/5879/83593/387/60485/6788/23012/7003/8463/7004/10971	27
WP3651	Pathways affected in adenoid cystic carcinoma	48/4673	57/5488	0.664134546127452	0.999999998939414	0.999999998939414	8289/51742/84159/472/546/54880/63035/672/23774/1111/11200/55783/1387/1487/23220/2033/2064/55294/2309/93986/54756/221037/284058/7994/23135/58508/9223/9863/55534/5605/4149/23269/10933/4602/4603/9611/4781/4851/5290/5591/5728/29072/6595/6605/8243/9874/7157/29128	48
WP1544	MicroRNAs in cardiomyocyte hypertrophy	64/4673	76/5488	0.664639160132636	0.999999998939414	0.999999998939414	183/208/801/817/1022/1025/1147/1499/1906/1950/2247/2263/8321/2932/9759/10014/51564/9734/3479/3480/3551/9641/8517/3572/3976/4041/4040/5604/5605/5606/6416/5608/5609/5595/5598/2475/50804/4638/4776/4790/3084/5170/5290/5293/5294/5295/5296/8503/5320/5330/5530/5532/5579/5592/5879/1827/387/6093/9475/6774/10454/7040/7124/7474	64
WP5224	2q37 copy number variation syndrome	80/4673	95/5488	0.66726421496632	0.999999998939414	0.999999998939414	57007/116987/51281/50636/375/381/10123/51665/23192/666/10203/801/11132/1058/8837/1293/10920/6373/7852/9267/9266/9265/27128/728294/8527/27185/1841/285193/1915/1956/11337/11345/64090/10691/2817/2859/2997/9759/3069/3280/55355/3553/3611/84289/3394/3690/3705/3725/9208/84557/81631/4134/4205/4208/151507/4644/4705/4738/129807/4792/23178/5133/5154/8864/64284/5879/6194/10325/64121/23677/25992/10494/51078/7124/7157/7187/26146/140739/54658/54575	80
WP4223	Ras signaling	123/4673	146/5488	0.673656455018543	0.999999998939414	0.999999998939414	25/27/208/10000/382/572/598/8315/801/808/91860/1147/1436/1956/2002/1969/2113/55770/356/2260/2263/2261/2321/2322/2324/4303/2549/9846/2783/59345/10681/2791/54331/2786/2793/2885/3480/3551/8517/3643/3791/3815/8844/283455/5604/5605/5595/5601/4233/22808/4790/4804/4893/4915/5058/5062/10298/5156/5159/5290/5293/5295/5296/8503/51365/8399/81579/84647/5320/26279/8605/255189/8398/51196/5335/5336/5337/5338/5566/5567/5578/5579/5781/5868/5869/5878/5879/5880/5898/5899/10928/5900/5908/5922/22821/10156/8437/9462/64926/5923/5924/10125/10235/25780/115727/11186/83593/5966/5970/23179/5863/387/9610/6237/22800/6464/25759/8036/6655/6789/8831/7010/7535	123
WP4787	Osteoblast differentiation and related diseases	74/4673	88/5488	0.677305823739525	0.999999998939414	0.999999998939414	652/657/659/1499/28514/54567/2247/2252/2254/2260/2263/2261/8321/7976/8322/7855/8323/8324/8325/2736/2737/54626/23462/3549/182/3714/4041/4040/5600/6300/5603/5595/5597/5598/5601/4851/4853/4854/4855/5286/5288/5290/5293/5294/5295/5296/8503/23533/146850/5468/5578/5579/5580/5581/5583/5584/5588/5590/5587/5591/5727/3516/860/4086/4089/4090/4093/6608/6772/7481/7473/54361/7474/7483	74
WP5144	NRP1-triggered signaling pathways in pancreatic cancer 	42/4673	50/5488	0.679569811398389	0.999999998939414	0.999999998939414	208/10000/9564/898/9134/1003/1017/1105/1277/1278/1950/1956/2321/2931/3082/3791/5604/5605/5595/4233/4313/4318/4790/4791/8829/5361/5362/91584/5747/5879/5966/5970/5971/10371/55630/4089/7040/7043/7046/7048/7049/7422	42
WP2037	Prolactin signaling pathway	63/4673	75/5488	0.682571091856313	0.999999998939414	0.999999998939414	116986/836/867/1509/1978/2002/2064/2316/2353/2534/9846/2885/2932/3659/8660/3688/3716/3717/3725/5604/5605/5595/5601/2475/4752/4790/4792/4793/4843/5058/10401/5290/5294/5295/5296/5478/5479/5618/5747/5770/5781/5777/5829/5879/5970/6194/6196/6198/6464/140885/8651/8835/9021/6772/6774/6776/6777/7006/7409/7410/7532/7534/7535	63
WP4018	Clear cell renal cell carcinoma pathways	68/4673	81/5488	0.688247775001939	0.999999998939414	0.999999998939414	31/32/47/226/229/230/405/8314/8536/1012/80184/1387/64798/1956/2023/2026/2027/2033/2194/2321/2597/2821/2887/3091/3098/3099/3101/3759/8242/3791/8844/3939/3945/197257/4190/4199/2475/55193/5155/5156/5159/5211/5213/5214/5230/5236/55276/26227/5313/5315/29968/5728/6009/113675/29072/6470/6472/6513/8082/6774/7040/7043/84969/7167/7248/7249/7422/6935	68
WP205	IL-7 signaling pathway	21/4673	25/5488	0.69008356874248	0.999999998939414	0.999999998939414	572/598/595/2534/2932/3559/3561/3574/3575/3716/3718/5604/5605/5595/5295/5296/2185/6772/6774/6776/6777	21
WP4141	PI3K/AKT/mTOR - vitamin D3 signaling	16/4673	19/5488	0.691102971863229	0.999999998939414	0.999999998939414	941/942/2932/3101/3122/3939/2475/5160/5210/5290/5970/6256/6515/7248/7249/7421	16
WP127	IL-5 signaling pathway	31/4673	37/5488	0.69424729348315	0.999999998939414	0.999999998939414	596/695/1439/2002/2353/2309/2885/2931/2932/3716/3717/3725/4067/5604/5605/5595/5294/5295/5296/5781/6194/6195/6198/6199/6464/161742/6772/6774/6776/6777/6850	31
WP1971	Integrated cancer pathway	36/4673	43/5488	0.697630690234692	0.999999998939414	0.999999998939414	466/472/545/571/572/580/596/641/672/836/841/842/993/994/983/1017/1019/1026/1030/1111/11200/1869/3716/4217/4193/4312/4436/2956/10811/5347/5451/5728/10111/5925/6772/7157	36
WP4753	Nucleotide excision repair	36/4673	43/5488	0.697630690234692	0.999999998939414	0.999999998939414	902/1022/1069/8451/1642/1643/2067/2068/2071/2072/2073/2074/2965/2966/2967/3978/4331/5111/5424/5425/10714/57804/5426/5427/54107/56655/5886/5887/5981/5982/5983/5984/5985/6119/7507/7508	36
WP1434	Osteopontin signaling	11/4673	13/5488	0.697711780144636	0.999999998939414	0.999999998939414	1147/3551/3685/3690/5604/5595/4318/4790/5328/5970/6696	11
WP2435	Quercetin and Nf-kB / AP-1 induced apoptosis	11/4673	13/5488	0.697711780144636	0.999999998939414	0.999999998939414	8309/2353/3551/3725/9817/4097/4312/4790/4792/5743/7422	11
WP3644	NAD+ metabolism	11/4673	13/5488	0.697711780144636	0.999999998939414	0.999999998939414	952/10135/64802/349565/4907/142/23411/22933/23410/23408/51548	11
WP698	Glucuronidation	11/4673	13/5488	0.697711780144636	0.999999998939414	0.999999998939414	3098/5236/55276/5238/7358/54658/54575/79799/7366/7367/7364	11
WP3584	MECP2 and associated Rett syndrome	41/4673	49/5488	0.701389535691844	0.999999998939414	0.999999998939414	26084/604/50937/1052/1267/1385/10664/1869/2146/2247/2289/2521/2530/2893/3065/3185/3479/3480/3481/4155/4208/4354/2475/9611/9315/84950/5728/5978/6194/6446/25942/9126/6667/6670/6750/6872/6890/23435/54790/200424/4904	41
WP2261	Glioblastoma signaling pathways	67/4673	80/5488	0.705133281294314	0.999999998939414	0.999999998939414	208/10000/369/472/672/675/867/595/894/898/1017/1019/1021/1026/1030/1031/1869/1956/2033/2064/2065/54206/2260/2263/2308/2309/4303/2549/2885/3480/5604/5605/5606/6416/5608/5609/5595/4193/4194/4233/2956/4893/5156/5159/5170/5286/5288/5290/5293/5294/5295/5296/5335/5336/5578/5579/5580/5583/5584/5588/5590/5728/5925/10253/7157/7248/7249	67
WP4806	EGFR tyrosine kinase inhibitor resistance	67/4673	80/5488	0.705133281294314	0.999999998939414	0.999999998939414	208/10000/369/558/572/596/598/10018/595/1950/1956/1977/1978/2064/2065/2247/2263/2261/2309/2549/2621/2885/2932/3082/3479/3480/3569/3570/3716/3717/3791/5604/5605/5595/4233/22808/2475/4893/3084/5154/5155/56034/80310/5156/5159/5170/5290/5293/5295/5296/8503/5335/5336/5578/5579/5728/6194/6198/6199/6237/22800/6464/25759/6655/6774/7039/7422	67
WP3858	Toll-like receptor signaling related to MyD88	25/4673	30/5488	0.719067280032069	0.999999998939414	0.999999998939414	1147/3551/9641/8517/3654/51135/3661/3665/4615/4790/4791/5966/5970/5971/29110/7096/7097/7099/10333/51284/51311/54106/54472/7187/7189	25
WP4758	Nephrotic syndrome	30/4673	36/5488	0.719267195491168	0.999999998939414	0.999999998939414	81/56052/54443/8542/83478/396/23607/1285/1286/1287/27235/1493/8029/1871/2013/3691/3913/4000/4627/4643/57107/51196/5373/5420/5800/950/50485/11346/79809/84942	30
WP1539	Angiogenesis	20/4673	24/5488	0.720949235561011	0.999999998939414	0.999999998939414	284/405/1387/2247/2263/2321/3091/3791/4318/4846/5155/5156/5290/5335/5747/4086/7010/7077/7078/7422	20
WP4856	Intracellular trafficking proteins involved in CMT neuropathy	20/4673	24/5488	0.720949235561011	0.999999998939414	0.999999998939414	1785/1959/54332/3315/26353/9516/90678/9927/4359/8898/10397/5376/8766/9230/5865/5867/53916/7879/10567/81846	20
WP4950	16p11.2 distal deletion syndrome	20/4673	24/5488	0.720949235561011	0.999999998939414	0.999999998939414	718/930/975/3732/1380/2885/8519/3643/3717/3791/4773/5350/3276/5867/5868/79874/25970/7185/7284/7410	20
WP382	MAPK signaling pathway	162/4673	193/5488	0.725604569362521	0.999999998939414	0.999999998939414	208/10000/369/408/1386/468/773/775/776/8912/781/9254/93589/783/784/836/929/994/1147/1398/1399/1616/1649/1843/11221/80824/1844/1846/1848/1849/1850/51295/1950/1956/2002/2005/355/356/2258/2247/2252/2254/2260/2263/2261/2316/2317/2318/2353/1647/2768/2885/3303/3304/3305/3306/3310/3312/3315/3551/8517/3552/3553/3554/7850/3725/3727/8649/120892/5604/5605/5606/6416/5608/5609/4214/7786/9175/10746/4216/4217/9064/6885/1326/11184/9448/5600/6300/5603/5595/5598/9479/23162/5601/9261/7867/8550/4149/4208/2872/22808/4772/4790/4791/51701/3164/4893/4915/5058/5062/5154/5155/5159/8605/255189/5494/5495/5530/5532/5533/5534/5536/5566/5567/5578/5580/5778/5801/5879/5880/5908/5922/5923/5924/10125/10235/25780/115727/5970/5971/6197/8986/9252/6237/22800/6655/6722/6788/6789/10454/23118/57551/9344/51347/7040/7043/7046/7048/7124/7132/7157/7189	162
WP185	Integrin-mediated cell adhesion	71/4673	85/5488	0.725781129709564	0.999999998939414	0.999999998939414	208/10000/369/8874/9564/823/11132/824/726/827/23473/10753/857/858/1398/1445/1793/2534/9815/2885/3611/3672/22801/3673/3676/3678/3655/3679/8516/3680/3682/3683/3684/3685/3687/3688/3689/3690/3691/3693/3694/3695/5604/5605/5606/5608/6300/5597/5598/5058/5062/10298/5170/5296/5747/5829/5879/5880/5908/2889/6093/9475/6464/10580/7094/7145/7408/7410/10451/7414/7791	71
WP34	Ovarian infertility	15/4673	18/5488	0.726745326434519	0.999999998939414	0.999999998939414	472/894/1019/1051/1958/2701/4292/9611/8204/5618/5732/6609/23224/7421/7784	15
WP3893	Development and heterogeneity of the ILC family	15/4673	18/5488	0.726745326434519	0.999999998939414	0.999999998939414	196/8320/2625/6927/3398/3600/3606/3553/90865/3569/3574/6095/30009/7124/9760	15
WP4288	MTHFR deficiency	15/4673	18/5488	0.726745326434519	0.999999998939414	0.999999998939414	836/842/55349/1119/56994/54205/1786/1788/79813/10919/3176/4524/55471/10400/259230	15
WP5181	Roles of ceramides in the development of insulin resistance	15/4673	18/5488	0.726745326434519	0.999999998939414	0.999999998939414	2180/948/5610/2081/3643/8660/5295/5515/5590/6198/6517/55512/7124/7132/7185	15
WP2572	Primary focal segmental glomerulosclerosis (FSGS)	50/4673	60/5488	0.728357703935351	0.999999998939414	0.999999998939414	81/375790/23607/941/1026/9076/1285/1286/1287/1378/1499/1514/1759/2534/3611/3664/3685/3688/3690/3691/182/3911/3913/3987/4041/4040/4288/4311/4627/4643/4690/4851/55742/5111/5329/51196/5335/5420/5747/5800/950/50485/11346/7040/7094/7099/7402/7414/7431/10971	50
WP2880	Glucocorticoid receptor pathway	50/4673	60/5488	0.728357703935351	0.999999998939414	0.999999998939414	11057/57007/11214/241/347902/51129/221079/84002/8553/329/330/6347/6364/10602/80315/8454/29103/1907/8507/54566/9982/4616/387509/3589/3725/3895/56262/4240/8972/4791/8856/2908/5142/10769/5460/5743/5997/6256/6286/6397/5272/9792/1836/5552/2040/7049/7056/7128/84951/1831	50
WP4673	Male infertility	76/4673	91/5488	0.729776909146942	0.999999998939414	0.999999998939414	5243/27161/196/338/472/596/675/847/8812/904/905/8476/1025/9575/1191/1387/56603/11218/2033/94240/2067/2068/2119/355/356/2346/2876/3122/3159/3643/55818/3981/222229/4057/4193/4292/27030/4313/4318/4522/4524/4552/4843/4846/1728/142/10400/5192/55124/5423/5428/55170/29968/23369/5896/9985/5981/8787/6470/140885/55423/9194/113235/6648/6660/6948/7124/9319/83983/23304/7508/7516/7517/7518/7520/51087	76
WP4255	Non-small cell lung cancer	55/4673	66/5488	0.73146987829872	0.999999998939414	0.999999998939414	208/10000/369/572/578/637/836/841/842/595/1019/1021/1026/54205/1643/1869/1871/1950/1956/27436/2064/2272/2309/1647/4616/2885/3718/5604/5605/5595/4893/5163/5290/5293/5295/5296/8503/5335/5336/51426/5578/5579/5915/11186/83593/5925/6256/6257/6655/6774/6776/6777/6789/7039/7157	55
WP1602	Nicotine effect on dopaminergic neurons	10/4673	12/5488	0.741061192409532	0.999999998939414	0.999999998939414	1020/1136/1138/1644/54331/3777/5499/84152/5566/6571	10
WP247	Small ligand GPCRs	10/4673	12/5488	0.741061192409532	0.999999998939414	0.999999998939414	1269/5724/5729/5732/5733/5734/5737/1901/1903/8698	10
WP47	Hedgehog signaling pathway	10/4673	12/5488	0.741061192409532	0.999999998939414	0.999999998939414	2735/2736/2737/3549/5727/10284/6469/25942/6608/27148	10
WP5173	Disorders of galactose metabolism 	10/4673	12/5488	0.741061192409532	0.999999998939414	0.999999998939414	231/2582/2584/2592/2632/2992/8908/2997/5236/6514	10
WP3940	One-carbon metabolism and related pathways	29/4673	35/5488	0.743744748202143	0.999999998939414	0.999999998939414	64902/10768/586/587/10390/55349/1119/56994/51380/1491/1759/1788/55500/2730/2876/2877/2878/2879/2882/2937/4144/4524/10400/5337/6470/6472/6647/6648/7298	29
WP3982	miRNA regulation of p53 pathway in prostate cancer	19/4673	23/5488	0.751147273717518	0.999999998939414	0.999999998939414	317/472/637/836/841/842/11200/192668/1643/9538/4193/5366/5728/5054/143686/51246/6477/8795/7157	19
WP4900	Purinergic signaling	19/4673	23/5488	0.751147273717518	0.999999998939414	0.999999998939414	136/140/2771/2773/10161/5023/5025/5026/5027/5028/27334/64805/53829/9934/5029/5030/5031/286530/24145	19
WP5036	Angiotensin II receptor type 1 pathway	19/4673	23/5488	0.751147273717518	0.999999998939414	0.999999998939414	59272/59/183/1277/1278/3091/3589/3590/3572/3727/5608/80310/5781/6237/4089/6667/7040/7046/7048	19
WP5183	SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction	19/4673	23/5488	0.751147273717518	0.999999998939414	0.999999998939414	1636/59272/183/617/51295/3606/3569/51103/4790/114548/79671/27035/6195/51548/7014/54386/7124/7187/7189	19
WP100	Glutathione metabolism	14/4673	17/5488	0.761617559300112	0.999999998939414	0.999999998939414	290/2539/2730/2678/2687/2876/2877/2878/2879/2937/2938/2944/3417/26873	14
WP1584	Type II diabetes mellitus	14/4673	17/5488	0.761617559300112	0.999999998939414	0.999999998939414	773/2710/3551/3643/2475/5256/23533/5580/5590/6514/6517/122809/6834/7124	14
WP4784	Proteoglycan biosynthesis	14/4673	17/5488	0.761617559300112	0.999999998939414	0.999999998939414	126792/26229/124583/113189/9469/22856/55790/2132/2137/9060/1836/51000/64131/64132	14
WP4912	SARS coronavirus and innate immunity	14/4673	17/5488	0.761617559300112	0.999999998939414	0.999999998939414	59272/23586/64135/3454/3455/9641/3661/10379/3716/6772/6773/29110/7187/7297	14
WP3941	Oxidative damage response	33/4673	40/5488	0.765166282367319	0.999999998939414	0.999999998939414	317/572/9530/578/596/712/713/714/715/716/717/719/721/728/836/842/1026/1380/54205/1647/6416/4214/5603/4790/4794/5111/51567/7124/7133/10188/7185/7187/7189	33
WP49	IL-2 signaling pathway	33/4673	40/5488	0.765166282367319	0.999999998939414	0.999999998939414	596/867/894/1399/2353/2309/2534/9846/2885/3559/3560/3561/3716/3718/3725/3932/5604/5605/5595/9111/5295/2185/5781/6194/6198/6199/6464/9021/6772/6774/6776/6777/6850	33
WP4249	Hedgehog signaling pathway	28/4673	34/5488	0.767554108516185	0.999999998939414	0.999999998939414	408/596/91653/595/894/50937/1452/1453/1454/53944/1455/2121/64839/2619/2735/2736/2737/23432/64399/3549/11127/5566/5567/5727/6469/6608/57154/339745	28
WP179	Cell cycle	94/4673	113/5488	0.770672693095701	0.999999998939414	0.999999998939414	25/64682/10393/51529/25847/51434/472/545/699/9184/890/891/9133/595/894/896/898/9134/902/8556/8555/8881/991/8697/993/994/995/996/8318/990/8317/983/1017/1019/1021/1022/1026/1030/1031/1032/1111/11200/8454/10926/1869/1871/1875/2033/9700/1647/4616/2932/3065/8379/10459/4171/4172/4173/4174/4175/4176/4193/4998/4999/5000/5001/23594/5111/9088/5347/5591/9232/5885/5925/5933/5934/2810/6500/6502/4089/8243/9126/10735/7027/7029/7040/7043/7157/7272/7465/7531/7532/10971/7534	94
WP4241	Type 2 papillary renal cell carcinoma	23/4673	28/5488	0.772163776700289	0.999999998939414	0.999999998939414	405/9915/1026/1387/1513/8453/1729/1856/54583/112399/2033/2034/2271/3091/5155/29072/6513/7030/7942/7039/7040/7043/7422	23
WP4481	Resistin as a regulator of inflammation	23/4673	28/5488	0.772163776700289	0.999999998939414	0.999999998939414	208/10000/1147/3551/8517/3569/3708/5595/4790/4792/5290/5293/5294/23236/5330/5331/5333/113026/51196/5335/5336/5970/7124	23
WP481	Insulin signaling	125/4673	150/5488	0.776971046044788	0.999999998939414	0.999999998939414	208/375/382/10487/867/868/23624/1398/9265/1958/10938/30846/1977/1978/2002/5167/10211/2353/2308/2309/2549/2887/2885/2931/2932/2992/2997/3480/3551/3631/3643/8660/3725/11127/3991/5604/5605/5606/6416/5608/5609/4214/4294/7786/9175/10746/4215/4216/4217/9064/6885/1326/11184/9448/11183/5600/6300/5603/5595/5597/5598/5601/50488/2475/5170/5211/5213/5286/5288/5290/5293/5294/5295/5296/8503/5562/5578/5579/5580/5583/5584/5588/5590/5728/5770/5781/5792/5867/5879/5880/2889/5967/6009/57381/23433/6195/6196/6197/8986/9252/27330/6198/6199/6446/10110/23678/6464/25759/6513/6517/8773/8651/9021/10580/6655/6722/6812/6814/252983/9882/57761/7248/7249/6844/7494	125
WP3612	Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling	18/4673	22/5488	0.780434279666996	0.999999998939414	0.999999998939414	1244/8714/10257/368/9429/1066/2052/2353/2730/2950/3162/3725/9817/5600/6300/5603/1728/4835	18
WP5092	Interactions of natural killer cells in pancreatic cancer	18/4673	22/5488	0.780434279666996	0.999999998939414	0.999999998939414	6868/648/6347/6348/6351/6352/10666/2214/2308/2624/3002/4277/259197/374383/5551/5817/201633/7124	18
WP5114	Nucleotide excision repair in xeroderma pigmentosum 	47/4673	57/5488	0.782479463572391	0.999999998939414	0.999999998939414	672/902/1022/1069/8451/1642/1643/2067/2068/2071/2072/2074/2965/2966/2967/3150/3978/3980/4331/142/5111/5424/5425/10714/57804/5426/5427/54107/56655/5429/51426/56852/5886/5887/5981/5982/5983/5984/5985/6119/84464/7874/57654/56949/7507/7508/7515	47
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	42/4673	51/5488	0.782823625021946	0.999999998939414	0.999999998939414	25/308/348/351/8312/602/332/840/1026/1495/8454/2065/2081/2113/2149/3065/3070/3309/3315/8870/3575/3727/10276/4790/1728/3084/5062/5585/5747/2185/8767/9616/6198/26135/4092/9021/7124/8795/7185/10451/7431/8531	42
WP3876	BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation	9/4673	11/5488	0.783474961270768	0.999999998939414	0.999999998939414	10018/1499/1634/2308/4086/4090/4093/6750/54361	9
WP4504	Cysteine and methionine catabolism	9/4673	11/5488	0.783474961270768	0.999999998939414	0.999999998939414	191/875/51380/1491/23474/2805/2937/4357/6821	9
WP4842	Mammalian disorder of sexual development	9/4673	11/5488	0.783474961270768	0.999999998939414	0.999999998939414	1499/2254/2263/5600/5087/5730/23543/30812/54361	9
WP4919	Neuroinflammation	9/4673	11/5488	0.783474961270768	0.999999998939414	0.999999998939414	51008/1147/2353/3725/2475/4792/4843/5970/7099	9
WP5191	Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution	9/4673	11/5488	0.783474961270768	0.999999998939414	0.999999998939414	1240/2048/2358/1241/2475/5163/5290/5293/5294	9
WP554	ACE inhibitor pathway	9/4673	11/5488	0.783474961270768	0.999999998939414	0.999999998939414	1636/59272/183/1215/1511/3827/4846/4306/7040	9
WP4747	Netrin-UNC5B signaling pathway	37/4673	45/5488	0.784021263912555	0.999999998939414	0.999999998939414	116986/249/23365/836/6347/1003/1277/2534/3383/3552/3635/3691/3725/3791/5604/5605/5595/4756/9423/59277/5290/57475/5499/5578/5747/2185/5781/5879/56963/387/6018/54538/6401/7124/7157/219699/7412	37
WP4321	Thermogenesis	77/4673	93/5488	0.789222067711902	0.999999998939414	0.999999998939414	2180/2181/2182/51703/60/71/107/109/196883/111/112/113/115/8289/57492/1386/656/1374/1376/1385/10488/90993/64764/84699/148327/9586/8110/2260/10818/2641/2885/23028/55818/51780/152831/3991/5606/4217/5600/6300/5603/11343/2475/4881/4893/57104/5468/10891/5562/5564/5565/5566/5567/5571/51422/5592/5593/6009/6194/6195/6196/6197/27330/6198/6199/51548/788/123096/6595/6597/6601/6604/6605/6655/7248/7249/9658	77
WP2453	TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc)	13/4673	16/5488	0.795333840594068	0.999999998939414	0.999999998939414	47/48/1431/1738/2271/3417/3419/4190/5091/5105/5160/6389/8801	13
WP3678	Amplification and expansion of oncogenic pathways as metastatic traits	13/4673	16/5488	0.795333840594068	0.999999998939414	0.999999998939414	7852/9595/2034/182/51176/4851/5294/10631/6932/83439/3371/7412/7422	13
WP3967	miR-509-3p alteration of YAP1/ECM axis	13/4673	16/5488	0.795333840594068	0.999999998939414	0.999999998939414	9564/1277/1281/1289/1909/2335/10082/5090/6678/7003/8463/7004/7058	13
WP3998	Prader-Willi and Angelman syndrome	22/4673	27/5488	0.797395302234573	0.999999998939414	0.999999998939414	57194/585/595/894/990/1019/1021/1030/1031/1869/9638/9637/2562/8924/4193/4194/4692/123606/5122/5590/5925/7157	22
WP4561	Cell migration and invasion through p75NTR	22/4673	27/5488	0.797395302234573	0.999999998939414	0.999999998939414	11093/208/10000/375/1009/1942/1943/1944/1945/1946/1948/1949/3725/4313/4318/4804/4915/5058/56288/5879/387/6774	22
WP304	Kit receptor signaling pathway	46/4673	56/5488	0.799456778082302	0.999999998939414	0.999999998939414	572/596/695/867/1398/1399/1796/2033/2353/2309/2534/9846/2887/2885/2886/3635/3717/3726/3815/4254/4067/5604/5605/5595/4145/4286/5295/5296/5335/5578/5579/5781/5777/6194/6195/6197/6198/6464/8651/6772/6774/6776/6777/6909/7006/7409	46
WP437	EGF/EGFR signaling pathway	128/4673	154/5488	0.800235316745441	0.999999998939414	0.999999998939414	10006/25/160/163/382/9138/50807/466/6311/6790/9564/857/858/867/868/23624/1385/1398/1399/1445/1759/9046/1869/1950/1956/1978/2002/2005/29924/2060/58513/2064/54206/2353/2354/2308/4303/2549/9846/2697/2887/2885/3635/8826/9922/3716/3717/3725/3727/3985/5604/5605/4214/10746/4215/4216/11184/5598/5601/4205/4208/4209/2475/4605/4690/8440/8202/4734/4738/4846/5058/5111/5170/5037/10401/5295/5296/51196/5335/5337/5338/5359/5578/5579/5580/5584/5590/5728/5747/2185/5753/5781/5782/5801/7837/5868/5879/5898/5899/10928/5900/9185/9610/6093/6195/6196/6197/9252/6198/9047/30011/6464/6655/6667/10253/8027/10617/6772/6774/6776/6777/6812/8867/10188/9712/7409/7410/10451	128
WP231	TNF-alpha signaling pathway	76/4673	92/5488	0.802204392440629	0.999999998939414	0.999999998939414	317/572/598/637/329/330/8945/836/840/841/842/6347/11140/8837/1147/1387/1457/8454/1535/56616/8772/23291/2752/2885/3551/8517/3569/3725/8844/283455/8567/5606/6416/5608/5609/4214/4215/4217/6885/1326/5595/5601/4790/4791/4792/4793/4794/27035/124056/4893/56957/5347/5515/5590/5708/5790/5879/5966/117584/55312/8737/11035/6401/6500/10454/23118/257397/10010/29110/7124/7128/7132/7133/8717/7185/7295	76
WP2203	Thymic stromal lymphopoietin (TSLP) signaling pathway	36/4673	44/5488	0.803136623780407	0.999999998939414	0.999999998939414	695/6356/1978/2242/2534/9846/3055/3559/3569/3575/3716/3717/3932/4067/5604/5605/5595/5601/2475/4790/4791/4792/55361/5290/5781/5970/5971/6194/6772/6774/6775/6776/6777/7006/7292/7525	36
WP4971	Phosphoinositides metabolism	36/4673	44/5488	0.803136623780407	0.999999998939414	0.999999998939414	3635/4534/8776/10903/54545/8898/8897/9110/9107/55613/66036/4952/5286/5288/5290/5293/5294/200576/5305/79837/8394/8395/23396/23236/5330/5331/5333/113026/51196/5335/5336/9651/5728/22908/6305/81846	36
WP2853	Endoderm differentiation	91/4673	110/5488	0.806691365404355	0.999999998939414	0.999999998939414	31/324/351/10973/57198/63035/655/657/9044/55832/79577/11190/23373/1499/1601/23576/1844/1846/1847/1994/2005/26610/8320/57669/2146/3169/3170/1112/2308/2627/2736/79977/3087/6928/3198/3251/3720/9682/3915/51176/123169/10128/10459/5606/54799/22823/80155/79035/54892/51701/4830/4851/2908/26986/54623/79668/5087/5090/84295/8554/5460/23682/5916/64864/6001/27244/51460/6478/154091/4089/83595/6772/6875/6877/30009/6925/6932/83439/7040/57690/9760/27324/55809/85363/51366/10451/115825/11169/7473/23528/58499	91
WP262	Ebstein-Barr virus LMP1 signaling	17/4673	21/5488	0.808565039013266	0.999999998939414	0.999999998939414	6364/6352/1147/3551/8517/3654/4215/6885/4790/4791/4792/9260/5970/7124/8717/7185/7189	17
WP4864	Host-pathogen interaction of human coronaviruses - apoptosis	17/4673	21/5488	0.808565039013266	0.999999998939414	0.999999998939414	317/572/596/598/10018/637/836/840/841/842/8772/356/5600/6300/5603/4170/7124	17
WP4905	1q21.1 copy number variation syndrome	17/4673	21/5488	0.808565039013266	0.999999998939414	0.999999998939414	51205/607/1499/2330/2697/2702/149013/100506658/5562/5564/5565/5571/51422/26108/90780/7082/27134	17
WP4564	Neural crest cell migration during development	26/4673	32/5488	0.812679100930854	0.999999998939414	0.999999998939414	208/10000/375/1009/2048/2049/2051/2151/2353/3725/4313/4318/25791/4804/5058/5062/10298/5290/5293/5294/8503/23533/146850/5879/387/6774	26
WP5205	Clock-controlled autophagy in bone metabolism	55/4673	67/5488	0.813679982846606	0.999999998939414	0.999999998939414	55626/393/83734/9140/9776/64422/84938/9474/10533/596/8678/8553/651/652/653/654/659/8646/9575/1407/1435/115908/1513/128338/1948/3146/3479/3569/3717/4041/84557/81631/2475/4772/4851/4862/9975/5187/9842/9821/860/10371/10507/5176/4086/4089/4090/4093/7040/8792/4982/8600/7189/7415/7474	55
WP51	Regulation of actin cytoskeleton	95/4673	115/5488	0.819366259143635	0.999999998939414	0.999999998939414	60/71/87/324/2909/9138/9459/8874/10092/9564/55845/929/1073/1131/1132/1398/1445/26999/1729/81624/1793/1950/1956/55740/7430/2149/2245/2258/2247/2252/2254/2260/2263/2261/2335/28964/2768/10672/2934/8826/3672/3984/5604/5605/5595/5597/22808/4478/4628/4638/4893/5058/5062/10298/5154/5155/5156/5159/5286/5288/5290/5293/5294/5295/5296/8503/23533/5305/79837/8394/8395/23396/4659/5747/5829/5879/5880/8045/387/6093/9475/6237/22800/6548/6655/54434/85464/54961/7114/7409/7414/7429/7454/8936/10163	95
WP410	Exercise-induced circadian regulation	35/4673	43/5488	0.821494383239526	0.999999998939414	0.999999998939414	51582/11335/1051/7122/9575/1407/1408/9802/3301/1982/2120/50486/2674/2947/2950/9709/3108/3312/3422/687/8031/9975/5187/8864/5281/5516/5685/5813/9444/11030/7341/6612/23118/10381/9218	35
WP2112	IL-17 signaling pathway	21/4673	26/5488	0.821529612771976	0.999999998939414	0.999999998939414	1051/1052/2932/3551/8517/55540/54756/132014/3716/3717/6885/5595/4790/4793/5290/5970/6667/6774/7187/10758/7189	21
WP3869	Cannabinoid receptor signaling	21/4673	26/5488	0.821529612771976	0.999999998939414	0.999999998939414	107/113/196/1269/1557/1559/1576/747/221955/2166/5600/6300/5603/5595/5601/222236/5566/5567/5573/5575/5577	21
WP5122	Prostaglandin and leukotriene metabolism in senescence 	21/4673	26/5488	0.821529612771976	0.999999998939414	0.999999998939414	109/246/240/241/1026/10800/2776/3488/5600/23236/5730/5732/5733/5734/9536/5740/5742/5743/5925/23411/6916	21
WP1425	Bone morphogenic protein (BMP) signaling and regulation	8/4673	10/5488	0.824217471423295	0.999999998939414	0.999999998939414	657/659/860/4086/4089/4091/57154/10766	8
WP2815	Mammary gland development pathway - Involution (Stage 4 of 4)	8/4673	10/5488	0.824217471423295	0.999999998939414	0.999999998939414	999/1116/1869/3572/4318/9021/6774/7157	8
WP3930	EDA signaling in hair follicle development	8/4673	10/5488	0.824217471423295	0.999999998939414	0.999999998939414	1896/2735/4050/5727/5971/6469/25928/7473	8
WP5104	Acquired partial lipodystrophy / Barraquer-Simons syndrome	8/4673	10/5488	0.824217471423295	0.999999998939414	0.999999998939414	718/629/1675/2339/4000/4001/84823/9986	8
WP5187	mRNA vaccine activation of dendritic cell and induction of IFN-1	8/4673	10/5488	0.824217471423295	0.999999998939414	0.999999998939414	23586/64135/3661/3665/3140/51284/51311/8792	8
WP4536	Genes related to primary cilium development (based on CRISPR)	69/4673	84/5488	0.826700693940449	0.999999998939414	0.999999998939414	200894/403/84100/80210/27077/79738/166379/583/585/55212/25776/57545/23552/9731/153241/84984/55125/79959/79598/23059/51626/6993/84455/2121/51668/55764/9742/26160/90410/11020/112752/56912/51098/55081/80173/57560/28981/11127/9371/22920/54585/57534/8195/54903/10464/51715/11159/23322/163786/132320/79600/26123/84314/51259/79583/91147/26146/146057/79809/64927/79989/150737/123016/51174/7289/79770/51057/57728/57539	69
WP1742	TP53 network	12/4673	15/5488	0.827494876129989	0.999999998939414	0.999999998939414	25/472/596/637/666/1026/1647/4193/5366/7341/8743/7157	12
WP3	Transcriptional activation by NRF2 in response to phytochemicals	12/4673	15/5488	0.827494876129989	0.999999998939414	0.999999998939414	7965/1051/2048/2730/2939/3162/9817/4094/1728/5290/5578/23657	12
WP4872	MAP3K1 role in promoting and blocking gonadal determination	12/4673	15/5488	0.827494876129989	0.999999998939414	0.999999998939414	8312/1499/2254/2263/10023/2932/4214/4216/5600/387/6093/54361	12
WP5074	Kallmann syndrome	12/4673	15/5488	0.827494876129989	0.999999998939414	0.999999998939414	55636/2260/10818/2885/5605/5290/23129/5588/60675/5781/9723/26022	12
WP4803	Ciliopathies	104/4673	126/5488	0.832310777515523	0.999999998939414	0.999999998939414	112/54806/122481/124401/203286/200894/23568/403/84100/25814/27077/80776/92482/79738/166379/583/585/55212/57545/79140/1063/9731/153241/22897/84984/80184/95681/84131/23059/1259/79848/83479/55172/83544/51626/114327/2121/201163/2622/2736/2737/84662/23432/219844/55764/9742/26160/11020/112752/51098/55081/57560/28981/27152/27130/9657/9786/167691/54585/8195/54903/4751/91754/29922/261734/4952/5147/10464/5310/5311/10733/25886/282809/55624/51715/9364/6102/23322/89765/83861/132320/6608/6674/55812/202018/221322/79600/26123/84314/51259/79583/65062/91147/26146/22954/146057/79809/123016/23093/51057/57728/57539/63929/23090	104
WP4666	Hepatitis B infection	109/4673	132/5488	0.833582550781055	0.999999998939414	0.999999998939414	208/10000/317/369/1386/468/1388/537/572/596/637/332/843/836/841/842/1026/1147/1385/10488/90993/64764/84699/148327/9586/1387/54205/1642/1643/1654/23586/1959/1960/2002/2033/8772/355/356/2353/2885/3339/64135/3454/3551/9641/8517/3569/3654/51135/3661/3665/3716/3717/3718/3725/5604/5605/5606/6416/5608/5609/4214/6885/5600/6300/5603/5595/5601/4318/4615/4772/4773/4776/4790/4893/5111/5290/5293/5295/5296/8503/5578/5579/2185/5970/4089/6655/6772/6773/6774/6775/6776/6777/10454/23118/29110/7040/7043/7046/7048/7097/7099/7124/7187/7189/7297/7419/10971/7534	109
WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	25/4673	31/5488	0.8337637456987	0.999999998939414	0.999999998939414	904/1025/1387/2033/3065/9759/10014/51564/55869/9734/10614/7469/25920/4772/4773/4776/4790/4792/5530/5532/5533/5534/5970/6667/6827	25
WP3981	miRNA regulation of prostate cancer signaling pathways	25/4673	31/5488	0.8337637456987	0.999999998939414	0.999999998939414	10000/572/596/842/595/1026/90993/1387/1499/2308/2885/2932/8517/5604/5605/4193/2475/4790/4792/5154/5159/5290/23228/6932/7157	25
WP363	Wnt signaling pathway	39/4673	48/5488	0.834651994154323	0.999999998939414	0.999999998939414	324/8312/8313/607/595/1021/1452/1453/1454/53944/1487/1499/1856/1857/10023/2697/2931/2932/51176/4041/4040/6885/5601/2475/4773/51701/55361/8395/5468/5578/5579/5879/387/4920/6259/6925/7010/7248/7249	39
WP3878	ATM signaling in development and disease 	34/4673	42/5488	0.8390328964963	0.999999998939414	0.999999998939414	1386/472/23300/545/9212/699/983/1020/8851/1111/11200/64421/2539/9759/3150/3315/8517/10524/3930/4217/9656/2475/4683/4790/5536/5562/5591/10111/5923/5932/56254/8243/6794/7249	34
WP673	ErbB signaling pathway	63/4673	77/5488	0.839379916600115	0.999999998939414	0.999999998939414	25/27/208/10000/369/572/10018/817/818/867/868/595/1026/1398/1399/1950/1956/1978/2002/2064/2065/2069/2308/2549/2885/2932/1839/3725/5604/5605/6416/5609/5595/5601/4193/2475/4690/8440/4893/3084/5058/5062/10298/5170/5290/5293/5295/5296/8503/5335/5336/5578/5579/5747/6198/6199/6464/25759/6655/6776/6777/7039/7157	63
WP4331	Neovascularisation processes	29/4673	36/5488	0.845151752290465	0.999999998939414	0.999999998939414	94/284/7852/54567/2048/2324/3091/182/3791/3815/4254/5595/5601/4318/4790/4791/4851/4854/4855/5155/5966/5970/5971/4086/4090/4093/7040/7043/7046	29
WP4877	Host-pathogen interaction of human coronaviruses - MAPK signaling	29/4673	36/5488	0.845151752290465	0.999999998939414	0.999999998939414	1386/596/684/1649/1977/2353/3429/8519/10581/10410/3725/3726/5604/5605/5606/6416/5608/5609/4214/4294/4216/5600/6300/5603/5595/5601/6195/6196/6197	29
WP4263	Pancreatic adenocarcinoma pathway	67/4673	82/5488	0.850586867868258	0.999999998939414	0.999999998939414	208/10000/369/9459/572/578/598/675/842/595/1019/1021/1026/1147/1643/1848/1869/1871/1950/1956/2064/1647/4616/3551/8517/3716/5604/5605/5595/5601/2475/4790/5058/5062/10298/5037/5290/5293/5295/5296/8503/5337/51426/5580/5879/5880/5888/5898/5899/10928/5900/5925/5970/387/54101/6198/6199/4089/6772/6774/7039/7040/7043/7046/7048/7157/7422	67
WP2036	TNF-related weak inducer of apoptosis (TWEAK) signaling pathway	33/4673	41/5488	0.855697003991566	0.999999998939414	0.999999998939414	208/329/330/836/840/841/6347/6352/1147/1499/8772/2932/3065/3551/3569/3725/6885/5595/5601/4318/4790/4791/4792/4793/5879/5970/5971/8737/7124/51330/7185/7187/7188	33
WP4830	GDNF/RET signaling axis	11/4673	14/5488	0.857699483163553	0.999999998939414	0.999999998939414	652/1499/79633/2625/2674/2737/26585/51668/11020/5979/6092	11
WP5101	Congenital generalized lipodystrophy (CGL)	11/4673	14/5488	0.857699483163553	0.999999998939414	0.999999998939414	10555/208/857/8694/2534/2885/3091/3691/23175/64900/5290	11
WP4863	Host-pathogen interaction of human coronaviruses - autophagy	15/4673	19/5488	0.860404156076855	0.999999998939414	0.999999998939414	83734/9140/9776/89849/64422/115201/9474/10533/8678/84557/2475/9821/9706/55062/53349	15
WP3680	Physico-chemical features and toxicity-associated pathways	42/4673	52/5488	0.86088783805873	0.999999998939414	0.999999998939414	10097/10096/324/8312/8536/867/1026/1499/23002/1956/2002/2064/2335/8321/7976/8322/7855/8323/8324/8325/2876/2885/2932/3725/5604/6416/4638/4690/5058/5217/5294/5335/5515/5747/387/9475/6464/6647/6776/7039/7114/7481	42
WP4565	Neural crest cell migration in cancer	28/4673	35/5488	0.862791549772352	0.999999998939414	0.999999998939414	208/10000/375/1009/2048/2049/2051/2151/2353/3725/4313/4318/25791/4804/4915/5058/5062/10298/5290/5293/5294/8503/23533/146850/5879/387/6272/6774	28
WP524	G13 signaling pathway	28/4673	35/5488	0.862791549772352	0.999999998939414	0.999999998939414	397/9138/801/1073/11113/1729/10672/8826/10788/3984/4216/5290/5293/5296/5305/5585/5500/5879/387/85415/6093/9475/6198/6242/57630/10188/7454/8976	28
WP4674	Head and neck squamous cell carcinoma	56/4673	69/5488	0.864959498040779	0.999999998939414	0.999999998939414	84962/208/10000/329/841/595/1019/1021/1026/1499/54541/1869/1956/1977/1978/2064/8772/2260/2263/2261/2280/2549/3480/3664/9817/9794/2475/4790/4791/4851/4853/4893/5170/5290/5294/5295/5296/23533/5562/5728/5925/5966/5970/6009/6194/6199/27244/83667/4089/6794/7048/7157/7187/7248/7249/7422	56
WP4150	Wnt signaling in kidney disease	19/4673	24/5488	0.865899818712242	0.999999998939414	0.999999998939414	1499/1856/1857/8321/7976/8322/7855/8323/8324/8325/27130/4041/4040/5601/387/7481/7473/54361/7474	19
WP4521	Glycosylation and related congenital defects	19/4673	24/5488	0.865899818712242	0.999999998939414	0.999999998939414	56052/79087/79868/199857/85365/79796/2683/22845/1798/8813/8818/54344/84061/4247/7841/4351/5373/79644/7991	19
WP268	Notch signaling	32/4673	40/5488	0.87143893296178	0.999999998939414	0.999999998939414	6868/51107/83464/1387/1487/28514/54567/1840/113878/196403/151636/23220/1856/1857/3065/3280/51763/182/3714/3955/9794/55534/4242/9612/4851/4853/4854/4855/9253/5663/5664/3516	32
WP4917	Proximal tubule transport	32/4673	40/5488	0.87143893296178	0.999999998939414	0.999999998939414	5243/1244/10257/9429/358/476/481/245972/523/528/51382/9296/9550/760/762/6560/117247/6505/6575/65010/6513/6514/142680/6519/6522/8671/340024/54716/9056/23428/11136/6550	32
WP3972	PDGFR-beta pathway	23/4673	29/5488	0.872464482050678	0.999999998939414	0.999999998939414	5610/2002/2353/2885/3716/3717/3725/5604/6416/4214/5595/5159/5290/5295/5335/5578/5579/6464/6722/6772/6774/6776/6777	23
WP2034	Leptin signaling pathway	60/4673	74/5488	0.874244599493253	0.999999998939414	0.999999998939414	31/32/572/598/595/1073/1147/1385/1977/1978/2002/2064/2308/2534/2885/2931/2932/3551/8517/3553/3557/3716/3717/3840/3953/5604/5605/5595/2475/8648/4790/4846/5140/5295/5296/5335/5336/5562/5728/5747/5770/5781/5879/5966/5970/387/6093/9475/6194/6195/6198/25970/6464/8835/9021/30837/6667/6772/6774/6777	60
WP4312	Rett syndrome causing genes	27/4673	34/5488	0.879354583034294	0.999999998939414	0.999999998939414	1398/8892/3065/10014/55869/3097/3615/3766/10765/4208/9611/9612/23221/23314/85358/6594/6595/6597/8243/6812/23224/8831/9014/6907/6925/8295/56949	27
WP500	Glycogen synthesis and degradation	27/4673	34/5488	0.879354583034294	0.999999998939414	0.999999998939414	801/808/2632/2931/2932/2992/8908/2997/3098/3099/3101/80201/5236/5255/5256/5515/5516/5518/5520/5523/28227/5525/5526/5527/5528/5529/5834	27
WP286	IL-3 signaling pathway	36/4673	45/5488	0.879598063251819	0.999999998939414	0.999999998939414	572/596/598/867/969/942/1399/1439/2353/2534/9846/2885/3055/3563/3635/3716/3717/3725/4067/5604/5595/5293/5295/5296/5566/5781/5777/2889/6464/6774/6776/6777/6850/7040/7409/10971	36
WP4566	Translation inhibitors in chronically activated PDGFRA cells	36/4673	45/5488	0.879598063251819	0.999999998939414	0.999999998939414	208/10000/1457/1974/1975/1977/1978/1981/5604/5605/5606/6416/5608/5609/5595/5601/2475/27250/5163/5290/5294/5295/5296/8503/5292/11040/5566/5578/5580/6194/6195/6196/8986/9252/6198/6199	36
WP428	Wnt signaling	69/4673	85/5488	0.881182910513434	0.999999998939414	0.999999998939414	324/8312/817/818/595/894/896/1452/1454/1457/1459/1460/1487/1499/80319/23002/23500/1856/1857/10023/23401/8321/7976/7855/8323/8324/8325/2239/2932/27130/3725/83999/51176/4041/4040/6885/5601/4772/4773/4776/51701/5328/23236/5330/5331/64840/5530/5532/5533/5534/166336/5578/5579/5879/387/9475/4920/6259/5176/6423/6425/6932/83439/81839/57216/7481/7473/54361/7474	69
WP4533	Transcription co-factors SKI and SKIL protein partners	14/4673	18/5488	0.883670374329685	0.999999998939414	0.999999998939414	3065/3622/9113/26524/10461/10419/23314/25942/6497/6498/6788/7003/8463/7004	14
WP4722	Glycerolipids and glycerophospholipids	14/4673	18/5488	0.883670374329685	0.999999998939414	0.999999998939414	56895/10423/1040/56994/54675/8694/8525/55500/57678/10400/23761/5337/57104/9791	14
WP5103	Progeria-associated lipodystrophy	14/4673	18/5488	0.883670374329685	0.999999998939414	0.999999998939414	8815/2200/2339/4000/4001/84823/142/5424/5468/5965/4089/83932/7040/7486	14
WP4584	Biomarkers for pyrimidine metabolism disorders	10/4673	13/5488	0.885559233292517	0.999999998939414	0.999999998939414	1152/1806/51251/80324/6240/6241/50484/7084/1890/7298	10
WP4705	Pathways of nucleic acid metabolism and innate immune sensing	10/4673	13/5488	0.885559233292517	0.999999998939414	0.999999998939414	103/23586/64135/3661/4938/10535/79621/8635/25939/11277	10
WP5037	Riboflavin and CoQ disorders	10/4673	13/5488	0.885559233292517	0.999999998939414	0.999999998939414	27235/10229/57017/2108/2110/23590/57107/55312/55065/79581	10
WP1528	Physiological and pathological hypertrophy of the heart	18/4673	23/5488	0.885867501085116	0.999999998939414	0.999999998939414	183/801/817/1906/2353/3572/3725/5606/5600/50804/4776/5530/5532/5579/5581/5879/387/6774	18
WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	97/4673	119/5488	0.893353092788266	0.999999998939414	0.999999998939414	32/6868/249/324/572/10018/8536/836/1020/8851/1147/1385/23373/1457/1499/1739/1808/1958/1959/1965/8894/1977/1978/2002/2353/2309/10818/10817/2534/2562/2885/23426/2932/3551/8517/8660/3717/3725/3738/8844/5604/5605/4214/10746/5595/5598/5601/4082/4205/4208/2475/4684/653361/4688/4690/8440/4776/4790/4792/4804/4905/4915/5170/5295/5296/5335/5515/5562/5580/2185/5781/5792/5879/10048/5923/5970/391/6194/6195/6197/9252/6198/25970/6464/25759/140885/6272/6696/6772/6774/6776/6777/7189/7249/7410/10451/4904	97
WP244	Alpha 6 beta 4 signaling pathway	26/4673	33/5488	0.894791735100061	0.999999998939414	0.999999998939414	1978/2549/2885/8660/3655/3691/284217/3908/3909/3911/3912/3913/3914/3915/3918/5595/2475/5295/5296/5578/5580/5747/5781/5879/387/6464	26
WP4874	CAMKK2 pathway	26/4673	33/5488	0.894791735100061	0.999999998939414	0.999999998939414	8874/801/8536/10645/1131/1385/10059/2033/51024/28964/9759/3162/3383/4094/84557/5595/2475/4773/5879/5970/23411/8243/6786/7248/7412/7466	26
WP4656	Joubert syndrome	53/4673	66/5488	0.897644368711583	0.999999998939414	0.999999998939414	54806/203286/200894/402/403/80210/468/472/27077/80776/583/585/55212/57545/9738/9731/153241/22897/80184/95681/79598/1069/79848/1857/2316/27130/10524/9786/54903/2475/4644/4646/51199/261734/142/5145/5147/10464/117177/10111/6009/387/6102/23322/6469/79600/26123/51259/79583/65062/91147/123016/23090	53
WP26	S1P receptor signal transduction	17/4673	22/5488	0.904209620790588	0.999999998939414	0.999999998939414	208/10000/427/2771/2773/6300/5595/5597/5598/23236/5330/5331/29127/1901/1903/8877/56848	17
WP4537	Hippo-Yap signaling pathway	17/4673	22/5488	0.904209620790588	0.999999998939414	0.999999998939414	3627/9113/26524/11184/9448/50488/4485/10397/11186/60485/6788/23012/7003/8463/7004/23043/10971	17
WP734	Serotonin receptor 4/6/7 and NR3C signaling	13/4673	17/5488	0.904911754799425	0.999999998939414	0.999999998939414	466/1385/1958/2002/2005/3360/5604/5605/5595/9261/2908/9252/6722	13
WP2533	Glycerophospholipid biosynthetic pathway	21/4673	27/5488	0.905999699652886	0.999999998939414	0.999999998939414	8540/10423/10390/56994/54675/2710/8443/57678/2819/253430/23175/346606/10400/9489/55361/5290/5293/5294/8394/5320/9791	21
WP2870	Extracellular vesicle-mediated signaling in recipient cells	21/4673	27/5488	0.905999699652886	0.999999998939414	0.999999998939414	324/8312/1499/1956/2064/3082/4233/4240/2475/4893/23533/8842/4089/7039/7040/7043/7046/7048/7049/7103/7474	21
WP408	Oxidative stress response	21/4673	27/5488	0.905999699652886	0.999999998939414	0.999999998939414	847/1536/2353/2876/2878/3162/3726/4128/4257/4501/4784/4790/27035/1728/6647/6648/6667/25828/7296/10587/7498	21
WP5087	Malignant pleural mesothelioma	295/4673	356/5488	0.906516592134024	0.999999998939414	0.999999998939414	59/60/71/72/9510/177/84962/208/10000/154796/284/285/324/171023/1386/467/9776/472/8312/9532/578/8314/580/596/8678/648/672/8945/834/6347/6351/6352/595/894/896/898/29126/960/961/999/1009/1012/1015/64403/1001/1003/1004/1017/1019/1022/1026/11113/1282/1284/1285/1286/1287/1385/1435/1436/1440/1452/1454/1457/1459/1460/1487/115908/1495/1499/8454/2919/3627/6374/80319/54205/1649/64798/1856/1857/1869/8726/1942/1943/1944/1945/1946/1950/1956/1975/1978/1981/2002/1969/2146/2258/2247/2252/2254/2260/2263/2261/2321/2322/2324/2335/2305/2308/10023/23401/8321/7976/7855/8323/8324/8325/2885/2932/1839/3054/3082/3091/3146/3150/3620/3479/3480/3481/3553/146433/3569/3643/3672/3673/3676/3655/3685/3688/3689/3690/3691/3710/3716/3725/3791/9493/3815/4254/58508/83999/284217/3908/3909/3910/3911/3912/3913/3914/3915/3918/10319/9113/26524/51176/4041/4040/8379/4085/5604/5605/5606/6416/5608/5609/4214/4294/10746/4215/4216/4217/9064/11184/9448/5595/5598/5601/9261/4149/4170/90550/4192/4193/4194/4209/4233/50488/2872/4323/4313/4314/4318/55233/92597/4485/2475/10397/4790/4804/114548/4915/8473/5058/5062/10298/5154/5155/56034/80310/5156/5159/5163/5228/1911/5281/5290/5293/5294/5328/5420/64840/10891/5562/5564/5565/5571/51422/5728/5747/11186/9770/83937/83593/8045/9821/6009/6045/4920/6194/6195/6197/9252/6198/6199/6259/60485/6401/5176/29072/55209/6423/6425/6464/6513/8140/6667/6678/6772/6788/23012/23512/6932/83439/7003/8463/7004/7010/7039/7040/23043/7157/7248/7249/9675/29128/9706/7422/7423/7424/11091/7481/7473/54361/7474/25937/7528	295
WP4657	22q11.2 copy number variation syndrome	66/4673	82/5488	0.908117136881697	0.999999998939414	0.999999998939414	59/150209/8854/8659/421/25842/596/128977/23468/8318/8646/9076/1365/7122/1399/56603/9681/9993/85359/54487/1956/284361/2260/2263/3170/2746/2811/3280/7290/8479/84861/3837/8216/10892/51586/9611/10641/8131/4942/10298/5308/5347/5500/5625/5901/5902/5905/1104/5649/6097/57142/6469/8036/6576/6517/6545/6720/6721/6722/80764/7157/27037/10587/7450/7514/7625	66
WP4932	7q11.23 copy number variation syndrome	66/4673	82/5488	0.908117136881697	0.999999998939414	0.999999998939414	83451/31/32/468/64756/91647/9275/8678/695/63922/23332/23122/9076/1365/1364/7122/7461/1213/1499/9188/7913/1738/84277/83939/9451/2006/2074/355/2199/10516/2200/2597/2885/23426/9569/10013/3159/3306/7462/3984/5595/51085/10514/3084/23636/5111/5313/5592/5925/5982/5985/23451/8467/6804/26608/7324/10477/9246/29914/7391/6844/51160/137492/79720/55048/9605	66
WP2513	Nanoparticle triggered regulated necrosis	9/4673	12/5488	0.910716267854478	0.999999998939414	0.999999998939414	841/8772/2512/142/8737/11035/7124/7132/8717	9
WP2813	Mammary gland development pathway - Embryonic development (Stage 1 of 4)	9/4673	12/5488	0.910716267854478	0.999999998939414	0.999999998939414	249/595/999/1364/3655/3688/7040/7124/9839	9
WP3849	MAPK and NFkB signaling pathways inhibited by Yersinia YopJ	9/4673	12/5488	0.910716267854478	0.999999998939414	0.999999998939414	1147/3551/8517/5608/4214/4790/4792/6237/7189	9
WP4155	Endometrial cancer	47/4673	59/5488	0.911067484331142	0.999999998939414	0.999999998939414	208/10000/324/369/8312/8313/572/578/842/595/999/1026/1495/1499/1643/1950/1956/2002/2064/2247/2260/2263/2261/2353/2309/1647/4616/2885/2932/3611/51176/5604/5605/5595/4893/5170/5290/5293/5295/5296/8503/51426/5728/6655/6932/83439/7157	47
WP2355	Corticotropin-releasing hormone signaling pathway	56/4673	70/5488	0.913184241552528	0.999999998939414	0.999999998939414	31/408/596/8912/836/842/1385/1499/1889/2002/2081/2353/2354/2355/2697/2767/2771/2776/2783/10681/2870/2932/3283/3284/3606/3726/3727/3728/5604/4217/5595/5601/10499/4790/4792/4846/3164/4929/142/5335/5336/5578/5579/5580/5584/5588/5747/5908/10411/5970/387/6667/6822/6925/7040/7099	56
WP2374	Oncostatin M signaling pathway	51/4673	64/5488	0.916469088434149	0.999999998939414	0.999999998939414	836/840/6347/1017/1051/1385/1958/2353/2885/3091/3572/3716/3717/3718/3726/3727/3949/5604/5605/5595/5601/4312/4322/4314/2475/4790/4792/5008/9180/10401/5295/5578/5579/5580/5581/5583/2185/5781/5829/5970/6194/5054/6464/9021/6772/6774/6777/7078/7157/7297/7422	51
WP3303	RAC1/PAK1/p38/MMP2 pathway	51/4673	64/5488	0.916469088434149	0.999999998939414	0.999999998939414	284/285/9068/572/332/840/842/1147/1398/1499/9046/1956/1978/2064/2335/2308/2885/2886/3551/8517/3688/5600/6300/5603/5595/5601/4313/4436/4690/4790/4792/4843/4893/5058/5290/5295/5747/5781/5829/5879/5888/5970/6774/6776/6777/7010/7075/10318/79155/79931/7157	51
WP2038	Microtubule cytoskeleton regulation	33/4673	42/5488	0.916798731474205	0.999999998939414	0.999999998939414	25/324/9212/983/1073/23332/6249/1729/1808/2048/2151/2776/2932/11004/3984/4131/9261/22919/4139/5058/90102/5290/5566/5578/5728/5786/5879/6093/161742/6774/57551/10420/11076	33
WP1422	Sphingolipid pathway	20/4673	26/5488	0.920686203045677	0.999999998939414	0.999999998939414	427/56624/64781/29956/79603/91012/253782/9514/2629/57704/5499/5515/57515/259230/166929/8877/56848/55304/7357/7368	20
WP4204	Tumor suppressor activity of SMARCB1	20/4673	26/5488	0.920686203045677	0.999999998939414	0.999999998939414	8289/57492/1019/1021/5977/8110/8726/2146/2735/2736/2737/2738/5727/5925/6597/6601/6604/6605/6608/23512	20
WP4838	Regucalcin in proximal tubule epithelial kidney cells	20/4673	26/5488	0.920686203045677	0.999999998939414	0.999999998939414	59/317/578/836/841/842/10146/4217/90550/2475/5153/5290/5534/5588/5970/4089/7040/7046/7132/8600	20
WP4726	Sphingolipid metabolism: integrated pathway	16/4673	21/5488	0.92084524699622	0.999999998939414	0.999999998939414	427/64781/29956/79603/91012/253782/8560/123099/259230/166929/81537/6609/8877/56848/7357/7368	16
WP4815	Glycosaminoglycan degradation	12/4673	16/5488	0.923977982737752	0.999999998939414	0.999999998939414	411/2720/2799/2990/3074/10855/60495/3373/8692/3423/4669/6448	12
WP4875	Disruption of postsynaptic signaling by CNV	12/4673	16/5488	0.923977982737752	0.999999998939414	0.999999998939414	817/818/1739/5595/57555/9378/9379/9369/6804/8831/7082/7532	12
WP5027	nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell	12/4673	16/5488	0.923977982737752	0.999999998939414	0.999999998939414	1965/8894/1968/8661/8662/8663/8664/3646/8665/8667/8668/8669	12
WP732	Serotonin receptor 2 and ELK-SRF/GATA4 signaling	12/4673	16/5488	0.923977982737752	0.999999998939414	0.999999998939414	2002/2005/2776/3708/5604/5605/5595/9261/4893/5923/10125/6722	12
WP4298	Acute viral myocarditis	59/4673	74/5488	0.926320188139962	0.999999998939414	0.999999998939414	25/27/60/199/596/598/637/663/79886/834/835/836/839/840/841/842/857/595/1234/920/959/1604/941/54108/1385/1525/7852/54205/1906/1981/1982/2021/2534/2932/3108/3569/3611/3683/3689/3716/51528/3908/5595/4318/4791/64127/26986/142/5295/29108/5880/6443/6444/8651/6772/6774/7040/7099/7124	59
WP4861	Endoplasmic reticulum stress response in coronavirus infection	32/4673	41/5488	0.927410235966989	0.999999998939414	0.999999998939414	468/22926/596/1649/5610/9451/1965/2081/3309/84557/8720/51360/5499/5500/6992/4659/4660/23368/26472/54866/23645/84919/84988/26051/84152/79660/5509/90673/5511/55607/84687/7494	32
WP4538	Regulatory circuits of the STAT3 signaling pathway	54/4673	68/5488	0.92937118480322	0.999999998939414	0.999999998939414	1271/1387/1438/1439/1441/64798/1844/1956/2149/2151/9002/2690/3454/3455/3459/3460/163702/3587/3588/3590/3595/3601/50615/58985/9466/3559/3560/3561/3563/3570/3572/3575/3716/3717/3718/5600/6300/5603/5595/5597/5598/5601/2475/9180/5156/5159/10401/5579/5788/5789/80854/9021/6774/7297	54
WP35	G protein signaling pathways	63/4673	79/5488	0.930798244786224	0.999999998939414	0.999999998939414	107/109/196883/111/112/113/115/8165/9590/11214/9495/9472/9465/10142/9138/801/2767/2768/10672/9630/2769/2771/2773/2774/2776/2783/10681/2791/2786/2793/3708/3760/4893/5153/5137/5142/5143/5144/5150/5151/8622/5331/5530/5533/5566/5567/5573/5575/5576/5577/5578/5579/5580/5581/5583/5584/5588/5590/5587/23683/387/6237/6548	63
WP2290	RalA downstream regulated genes	8/4673	11/5488	0.932864165163368	0.999999998939414	0.999999998939414	55770/149371/4893/5879/5880/5898/10928/8531	8
WP692	Sulfation biotransformation reaction	8/4673	11/5488	0.932864165163368	0.999999998939414	0.999999998939414	2539/9061/9060/6817/6799/27284/6783/6822	8
WP2035	Follicle stimulating hormone (FSH) signaling pathway	15/4673	20/5488	0.93572135870837	0.999999998939414	0.999999998939414	26060/1385/1978/2308/2870/5595/2475/5566/5578/6009/6194/6198/6199/6446/7249	15
WP4725	Sphingolipid metabolism overview	15/4673	20/5488	0.93572135870837	0.999999998939414	0.999999998939414	427/64781/29956/79603/253782/8560/123099/259230/166929/81537/6609/8877/56848/7357/7368	15
WP4336	ncRNAs involved in Wnt signaling in hepatocellular carcinoma	48/4673	61/5488	0.940282252698751	0.999999998939414	0.999999998939414	324/8312/595/894/896/1452/1454/1457/1459/1460/1487/1499/80319/1856/1857/1994/2146/10023/23401/8321/7976/7855/8323/8324/8325/2932/3725/9314/83999/51176/4041/4040/92140/51701/5328/64840/4920/6259/5176/6423/6425/83595/6932/83439/7481/7473/54361/7474	48
WP4685	Melanoma	48/4673	61/5488	0.940282252698751	0.999999998939414	0.999999998939414	208/10000/369/572/578/801/808/91860/595/999/1019/1021/1026/1385/1643/1869/1871/2002/2113/2353/1647/4616/2885/3791/3815/8649/5604/5605/5595/4193/4286/4893/5058/5290/5293/5295/5296/8503/51426/80243/5728/5879/5925/25759/6655/8859/7157/7414	48
WP4970	Galanin receptor pathway	11/4673	15/5488	0.940762152505855	0.999999998939414	0.999999998939414	10018/1026/1385/2353/3569/5468/10891/5580/6517/6844/7422	11
WP61	Notch signaling pathway	43/4673	55/5488	0.944457776578654	0.999999998939414	0.999999998939414	6868/51107/83464/595/1026/8454/28514/54567/1840/2033/55294/2273/2625/2932/3065/3280/23462/3091/182/3714/3717/3932/9794/84441/55534/9611/9612/4790/4851/4853/4854/4855/9253/5295/5296/5663/5664/3516/8819/6500/23013/6774/7088	43
WP722	Serotonin HTR1 group and FOS pathway	22/4673	29/5488	0.944742482119035	0.999999998939414	0.999999998939414	1385/2002/2005/2353/2771/2773/3708/5604/5605/5606/5608/4214/5595/9261/7867/5170/5290/5923/10125/387/9252/6722	22
WP313	Hepatocyte growth factor receptor signaling	26/4673	34/5488	0.944962479313805	0.999999998939414	0.999999998939414	1398/1399/1793/2002/2353/2549/2885/3082/3672/3688/3725/5604/5605/11184/5595/4233/5058/5290/5728/5747/2185/5781/5829/5908/2889/6774	26
WP2197	Endothelin pathways	18/4673	24/5488	0.945770548203736	0.999999998939414	0.999999998939414	153/488/790/10203/801/1264/1889/1906/1909/1910/2769/10681/5604/4638/4846/4886/23236/5578	18
WP5180	DYRK1A	42/4673	54/5488	0.951241538241529	0.999999998939414	0.999999998939414	51107/351/23621/836/842/595/1019/1021/1385/1408/1452/10238/64798/28514/1759/1875/2247/2308/2735/51053/2932/3280/3092/26524/91750/286826/2475/4772/4851/5663/23132/5933/5934/5978/23411/10253/7023/7027/7029/7157/7248/7249	42
WP4942	15q13.3 copy number variation syndrome	7/4673	10/5488	0.95177139090639	0.999999998939414	0.999999998939414	6352/1139/1387/22909/2177/2534/871	7
WP400	p38 MAPK signaling pathway	25/4673	33/5488	0.953673277631466	0.999999998939414	0.999999998939414	1386/1385/1616/1649/2002/2885/3150/3315/6416/5608/4214/4217/6885/9261/8550/4149/4209/5879/5923/8737/9252/6464/6772/7046/8717	25
WP2363	Gastric cancer network 2	21/4673	28/5488	0.954266111030701	0.999999998939414	0.999999998939414	29028/55299/962/63922/1499/79075/1956/157769/55215/3930/84823/92140/51316/5983/5984/255488/6277/7153/7157/11065/29089	21
WP4225	Pyrimidine metabolism and related diseases	10/4673	14/5488	0.955208608614928	0.999999998939414	0.999999998939414	790/1806/51251/5009/6240/6241/50484/7084/1890/7298	10
WP2324	AGE/RAGE pathway	50/4673	64/5488	0.955424575672899	0.999999998939414	0.999999998939414	177/249/1386/836/841/842/1147/54205/1650/1729/1956/7430/2308/4303/3091/3551/3643/51135/3717/3725/5604/5595/5601/4322/4323/4313/4316/4318/4478/4615/653361/4790/4792/4843/4846/5578/5579/5580/5590/5879/5970/387/6093/6464/6647/6667/6772/6774/6776/6777	50
WP4357	NRF2-ARE regulation	17/4673	23/5488	0.956178959956091	0.999999998939414	0.999999998939414	7965/1051/2048/2534/2730/2932/2939/3162/3643/9817/4094/1728/192111/5290/5578/23657/7525	17
WP4767	FGFR3 signaling in chondrocyte proliferation and terminal differentiation	17/4673	23/5488	0.956178959956091	0.999999998939414	0.999999998939414	9474/652/1026/1267/2254/2261/3549/5604/5605/5600/6300/5603/5595/5515/5933/6772/7067	17
WP3879	4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression	13/4673	18/5488	0.960139344020746	0.999999998939414	0.999999998939414	1977/1978/5604/5605/5606/5608/4217/5595/2872/2475/55872/5562/7248	13
WP2828	Bladder cancer	28/4673	37/5488	0.961085212189763	0.999999998939414	0.999999998939414	369/595/999/1019/1026/23604/1613/1869/1950/1956/2064/2261/1839/5604/5605/4193/4312/4313/4318/4893/5295/5296/11186/5925/9252/7157/1890/7422	28
WP2873	Aryl hydrocarbon receptor pathway	24/4673	32/5488	0.96141645550987	0.999999998939414	0.999999998939414	196/218/405/10486/11140/23491/1545/1956/2033/2939/3280/3553/3725/3726/3727/4257/26509/8648/1728/51426/8140/7040/7124/54658	24
WP4216	Chromosomal and microsatellite instability in colorectal cancer 	53/4673	68/5488	0.96240761503383	0.999999998939414	0.999999998939414	208/10000/324/26060/369/8312/8313/572/578/596/10018/332/836/842/595/1026/1452/1499/54205/1643/55770/2353/1647/4616/2932/3725/51176/5604/5595/5601/4292/4436/2956/9423/5366/51426/5743/5879/5880/5898/5899/5900/5966/387/4089/29110/6932/83439/7040/7043/7046/7048/7157	53
WP3865	Novel intracellular components of RIG-I-like receptor (RLR) pathway	40/4673	52/5488	0.96304857938278	0.999999998939414	0.999999998939414	9140/9474/64343/843/841/1147/3627/1540/1654/23586/79132/8772/64135/3551/9641/8517/3661/3665/9636/4214/6885/5600/6300/5603/5601/4790/4792/4793/79671/5970/8737/54941/10010/29110/9755/7124/8717/7187/7189/7706	40
WP3668	Hypothesized pathways in pathogenesis of cardiovascular disease	16/4673	22/5488	0.965206916877906	0.999999998939414	0.999999998939414	285/2022/2200/2201/2316/4052/4053/5595/10631/860/5054/6464/4089/7046/7048/7049	16
WP3853	ERK pathway in Huntington's disease	9/4673	13/5488	0.967319595618889	0.999999998939414	0.999999998939414	836/840/1385/1950/1956/2002/5609/4915/9252	9
WP366	TGF-beta signaling pathway	101/4673	127/5488	0.968946516980833	0.999999998939414	0.999999998939414	351/1386/467/8312/9564/8945/857/9133/595/983/1026/1030/1278/10987/1387/8454/1601/55802/1875/2033/2113/2335/2353/2354/50943/2885/3065/3673/3688/3690/3691/3725/3726/3727/8462/1316/3985/5604/5605/5606/6416/5608/6885/11184/5601/4205/4208/4233/4312/4321/23327/4739/9972/8021/5062/5163/8554/9063/5295/5296/64219/5371/5494/5576/5747/5879/5933/5934/387/6093/860/6464/150094/25942/6497/6498/6500/4089/4092/57154/6667/57559/11171/7341/10454/7027/7040/7041/7046/7048/7049/7050/3371/7157/7189/7329/51377/6935/9839/9765/9372	101
WP3874	Canonical and non-canonical TGF-B signaling	12/4673	17/5488	0.969736929789738	0.999999998939414	0.999999998939414	657/659/26585/4015/4016/4017/84171/5601/4089/7040/7046/7048	12
WP4534	Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms	30/4673	40/5488	0.972479137856159	0.999999998939414	0.999999998939414	59/60/71/72/999/1495/1499/3688/3689/3690/3691/3693/3694/3695/9113/11184/9448/11183/5601/4485/5058/5062/10298/60485/259230/6788/7003/8463/7004/10971	30
WP712	Estrogen signaling pathway	15/4673	21/5488	0.972911637988745	0.999999998939414	0.999999998939414	596/1147/1385/2002/2353/2852/3551/8517/3725/5604/5601/4790/5290/5566/6667	15
WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	22/4673	30/5488	0.974162104055633	0.999999998939414	0.999999998939414	9776/572/1978/2308/2309/4303/2887/2932/2475/4846/4893/5163/5290/5294/5295/5296/8503/5728/9821/6009/7942/7249	22
WP4871	Kisspeptin/kisspeptin receptor system in the ovary	22/4673	30/5488	0.974162104055633	0.999999998939414	0.999999998939414	208/408/3283/5604/5605/5595/4318/4790/4893/5163/5290/5293/5294/23236/5330/5331/5578/5579/5580/5581/5583/5588	22
WP2526	PDGF pathway	29/4673	39/5488	0.977074929855968	0.999999998939414	0.999999998939414	23647/1147/2002/2353/2885/3716/3725/5604/6416/4214/5595/4790/4792/5058/5154/5155/5159/5295/5335/5781/5879/387/6464/6722/6772/6774/7409/7410/8976	29
WP4535	Envelope proteins and their potential roles in EDMD physiopathology	29/4673	39/5488	0.977074929855968	0.999999998939414	0.999999998939414	107/109/196883/111/112/113/115/8815/2010/2885/3930/23592/5604/5605/5595/4893/5339/387/4089/6655/6722/23353/23345/23224/161176/7040/7043/79188/7112	29
WP4577	Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway	32/4673	43/5488	0.980531739925628	0.999999998939414	0.999999998939414	31/83734/9140/9776/22863/23130/64422/115201/9474/10533/23400/8678/83636/1356/64798/79152/2512/54676/84557/2475/80025/8398/5562/9821/6009/6342/6794/7248/7249/11152/55062/26100	32
WP4539	Synaptic signaling pathways associated with autism spectrum disorder	28/4673	38/5488	0.981083826367805	0.999999998939414	0.999999998939414	208/10000/775/1742/1978/116443/2932/5595/2475/4893/4915/5290/5293/5295/5296/8503/5562/5564/5565/5571/51422/5728/6009/6198/85358/8831/7248/7249	28
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	24/4673	33/5488	0.98206492985228	0.999999998939414	0.999999998939414	93/64798/8892/1977/114907/2932/3479/3480/3488/3611/3688/51528/84557/2475/4790/5163/5294/5337/10891/5564/5728/6198/7132/8976	24
WP422	MAPK cascade	24/4673	33/5488	0.98206492985228	0.999999998939414	0.999999998939414	369/2002/2885/3725/8649/5604/5605/5606/6416/5608/5609/4214/7786/10746/4215/6300/5595/4155/4893/5331/22821/6237/6494/6655	24
WP3676	BDNF-TrkB signaling	20/4673	28/5488	0.983601467011028	0.999999998939414	0.999999998939414	107/1385/1742/29904/1978/2549/9846/2885/5604/2475/4893/4915/5294/5335/6009/6195/6198/6464/7248/7249	20
WP4923	Autophagy	20/4673	28/5488	0.983601467011028	0.999999998939414	0.999999998939414	55626/9140/9776/22863/64422/9474/10533/79065/8678/64798/81631/2475/5562/5564/5565/5571/51422/9821/7405/26100	20
WP3859	TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition	10/4673	15/5488	0.984101520833074	0.999999998939414	0.999999998939414	999/1004/2335/3397/5595/860/4089/7040/3371/7431	10
WP5085	Vasopressin-regulated water reabsorption	27/4673	37/5488	0.984548932784793	0.999999998939414	0.999999998939414	109/112/115/396/397/1385/10488/90993/64764/84699/148327/9586/10671/1778/1781/51143/51626/140735/4905/5566/5567/8766/9230/5868/5869/5878/6844	27
WP3933	Kennedy pathway from sphingolipids	7/4673	11/5488	0.984859035956677	0.999999998939414	0.999999998939414	10390/1119/56994/55500/10400/23761/9791	7
WP2032	Thyroid stimulating hormone (TSH) signaling pathway	46/4673	61/5488	0.985925016986757	0.999999998939414	0.999999998939414	109/328/896/898/1017/1019/1385/1869/1958/2353/2768/10672/2771/2773/2776/54331/3480/3716/3717/3725/5604/5606/5608/5595/2475/103910/7849/5144/5170/5290/5295/5296/23236/5337/5900/5908/5909/5925/5934/6194/6195/6198/23513/6772/6774/8458	46
WP4258	lncRNA in canonical Wnt signaling and colorectal cancer	50/4673	66/5488	0.986092894050059	0.999999998939414	0.999999998939414	324/467/8312/8313/595/894/896/1021/1452/1454/1457/1459/1460/1487/1499/80319/1856/1857/2146/10023/23401/8321/7976/7855/8323/8324/8325/2932/283120/3725/83999/51176/4041/4040/6885/51701/5328/64840/4920/8607/6259/5176/6423/6425/6932/83439/7481/7473/54361/7474	50
WP2636	Common pathways underlying drug addiction	19/4673	27/5488	0.987234844179074	0.999999998939414	0.999999998939414	60/71/72/107/369/801/1385/2705/2893/5604/5605/5595/5499/5500/5566/5567/5578/5579/5908	19
WP3915	Angiopoietin-like protein 8 regulatory pathway	96/4673	123/5488	0.988145629096305	0.999999998939414	0.999999998939414	64240/64241/208/10487/867/868/23624/1398/1555/1576/1734/1977/1978/2194/2203/10211/2308/2309/2931/2932/2997/3643/8660/4023/5604/5605/5606/6416/5608/5609/4214/4294/7786/9175/10746/4215/4216/4217/9064/6885/1326/11184/9448/11183/5600/6300/5603/5595/5597/5598/5601/50488/51085/2475/5105/5170/5286/5288/5290/5293/5294/5295/5296/8503/5562/5564/5565/5571/51422/5770/2889/6009/23433/6195/6196/6197/8986/9252/27330/6198/6199/6256/6319/143686/6464/25759/6567/6513/6517/6655/6720/6721/7067/7068/7248/7249	96
WP4906	3q29 copy number variation syndrome	37/4673	50/5488	0.988254027127972	0.999999998939414	0.999999998939414	840/84984/1739/51626/140735/83658/6993/6990/200933/55294/3077/3091/3725/9587/10445/23077/4686/22916/375387/5062/54965/80235/8503/5829/255812/205564/23411/30061/200931/123264/6776/6777/7037/7040/7334/26043/348793	37
WP710	DNA damage response (only ATM dependent)	74/4673	96/5488	0.988295705584657	0.999999998939414	0.999999998939414	25/208/10000/324/472/8312/572/578/596/10018/604/638/847/595/894/896/901/1026/1499/1856/1857/2064/356/2309/10023/2885/2932/3146/3643/3725/3949/51176/4214/4216/6885/5601/4193/197259/4790/4791/4893/5106/5163/5286/5288/5290/5293/5294/5295/5296/8503/23533/5328/5366/5527/5529/5728/5879/5880/5934/387/6342/6464/4089/6648/6655/6932/83439/7040/7157/7481/7473/54361/7474	74
WP4022	Pyrimidine metabolism	57/4673	75/5488	0.988441716809351	0.999999998939414	0.999999998939414	790/978/51727/129607/1503/56474/1633/1635/79077/1806/1841/1854/5167/953/956/4830/4832/29922/87178/5422/23649/5424/5425/10714/57804/5426/5427/54107/56655/84172/5433/5436/5437/5438/5439/5440/55703/661/10621/10622/84265/171568/51728/5557/5558/6240/6241/50484/7083/7084/1890/7298/83549/7371/54963/7378/139596	57
WP4142	Metabolism of spingolipids in ER and Golgi apparatus	12/4673	18/5488	0.988932101327722	0.999999998939414	0.999999998939414	8706/8708/8707/2683/64781/57452/166929/81537/8877/56848/7357/7368	12
WP4928	MAPK pathway in congenital thyroid cancer	9/4673	14/5488	0.989119372226019	0.999999998939414	0.999999998939414	2002/2353/3725/8844/5604/5605/5595/6464/6655	9
WP5200	Dravet syndrome	9/4673	14/5488	0.989119372226019	0.999999998939414	0.999999998939414	801/5600/2475/4790/5290/55615/79899/6328/6330	9
WP4483	Relationship between inflammation, COX-2 and EGFR	15/4673	22/5488	0.989421754654826	0.999999998939414	0.999999998939414	208/10000/1956/5595/4312/4893/5290/5293/5294/51365/5732/5733/5734/80142/5743	15
WP2369	Histone modifications	25/4673	35/5488	0.990027719699594	0.999999998939414	0.999999998939414	55870/84444/8726/79813/10919/2145/2146/4297/58508/8085/55904/7799/6418/23067/29072/84193/55209/79918/80854/133383/83852/6419/114826/6839/79723	25
WP5222	2q13 copy number variation syndrome	31/4673	43/5488	0.992426067949102	0.999999998939414	0.999999998939414	64682/382/10018/150468/1435/10563/2621/2625/2885/3552/3553/3554/3556/3557/3569/10461/5336/84172/5435/5437/5440/5747/5879/727851/8651/9021/6772/84910/150465/376940/84524	31
WP4205	MET in type 1 papillary renal cell carcinoma	37/4673	51/5488	0.994330497657681	0.999999998939414	0.999999998939414	208/10000/369/572/867/1026/1398/1399/2113/2549/2885/3082/3718/3725/5604/5605/5595/4233/4893/5058/5062/10298/5290/5293/5295/5296/8503/5335/5747/5781/5879/5908/2889/6135/6655/6774/7030	37
WP581	EPO receptor signaling	16/4673	24/5488	0.994613678245402	0.999999998939414	0.999999998939414	2885/8660/3717/5604/5605/5595/5163/5294/5788/10076/6464/8651/6772/6774/6776/6777	16
WP2643	Nanoparticle-mediated activation of receptor signaling	18/4673	27/5488	0.996233425909098	0.999999998939414	0.999999998939414	10000/1277/1956/2335/2885/3672/3688/5604/5605/5600/6300/5603/5601/4893/5293/5747/5829/7094	18
WP4352	Ciliary landscape	152/4673	194/5488	0.996400687744621	0.999999998939414	0.999999998939414	2181/10939/10555/124401/203286/324/57136/26286/396/92482/583/585/55212/801/875/9859/80184/79598/23059/23019/9318/8533/51138/10987/50813/64708/10920/1345/1387/1499/5476/80344/10238/1655/8526/23549/1857/1778/1781/51143/140735/83658/6993/6990/1892/80258/9343/23301/30845/55770/10640/54536/23233/149371/23404/54512/23016/5393/2664/79018/54994/2717/2720/3065/51668/55764/9742/26160/90410/11020/112752/56912/51098/55081/80173/57560/28981/27152/9657/8826/10788/128239/167691/3934/10128/25804/54585/10982/55388/4171/4172/4173/4174/4175/4176/84515/254394/54903/4436/4637/140465/4698/4704/140609/4790/22981/10726/4927/5048/10424/5704/5706/5718/5719/5713/5714/23011/5866/79874/5879/5899/57610/10048/5925/57414/64795/64777/8732/6103/10051/6629/55812/8636/2040/9882/85456/26146/79989/92104/150737/123016/7322/7328/55245/10083/9217/7431/27183/7465/65125/63929/79699	152
WP1471	Target of rapamycin (TOR) signaling	23/4673	34/5488	0.997520208803524	0.999999998939414	0.999999998939414	54541/1978/2280/3156/3422/2475/5562/5564/5565/5571/51422/5578/55615/79899/5879/6009/6198/10325/64121/7248/7249/9706/25989	23
WP107	Translation factors	32/4673	46/5488	0.998131912600095	0.999999998939414	0.999999998939414	23277/1915/1933/29904/5610/9451/1967/8892/8891/1965/8894/1968/8661/8662/8663/8664/3646/8665/8667/8668/8669/1974/1975/1977/1978/1979/1981/1984/3692/2107/23708/26986	32
WP2586	Aryl hydrocarbon receptor pathway	27/4673	41/5488	0.999522884213981	0.999999998939414	0.999999998939414	196/405/948/11140/1017/1026/1545/1869/1956/2033/1316/4023/5604/135112/9612/4790/1728/4893/8204/5325/84722/5743/5925/5970/5979/7124/7422	27
WP405	Eukaryotic transcription initiation	27/4673	41/5488	0.999522884213981	0.999999998939414	0.999999998939414	902/1022/2068/2071/2959/2960/2961/2965/2966/2967/3611/4331/84172/5435/5436/5437/5438/5439/5440/55703/661/171568/51728/6883/6884/6877/6879	27
WP4301	Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells	10/4673	18/5488	0.999538161315568	0.999999998939414	0.999999998939414	369/5595/22808/4893/10015/5868/5869/5878/6237/22800	10
WP4549	Fragile X syndrome	66/4673	93/5488	0.999880286518821	0.999999998939414	0.999999998939414	18/5825/116986/27161/9495/7915/160/163/351/369/8536/1211/1212/1213/1374/1385/26999/64798/23405/1742/1759/1785/1915/1977/1979/1981/2043/54869/2534/2549/2561/10243/2885/23426/3218/3708/4131/5604/5605/4318/2475/4915/5163/23236/5335/5499/5526/5530/5566/5573/5578/5728/5781/5909/6009/6198/6455/6464/6566/8831/6895/51256/9524/7248/7249/9675	66
WP411	mRNA processing	78/4673	122/5488	0.999999998939414	0.999999998939414	0.999999998939414	51362/10658/10659/1198/53981/51692/1478/23283/1479/11218/1665/1659/23405/22826/9343/2521/3181/3182/3183/3184/3188/3191/4670/10236/51690/56339/4686/22916/4841/8106/5094/84844/5496/3276/3275/9128/55660/8899/24148/10594/5681/5725/84991/10181/8732/8731/10921/10291/8175/23451/23450/10262/8243/9410/6625/6626/6627/6628/6629/6632/6634/6637/6729/6732/6733/6426/10772/6427/6428/6430/6431/6432/57794/10147/10972/6434/22803/4904	78
